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  8-hydroxy-2’-deoxyguanosine DNA glycosylase is the first step and rate-limiting
enzyme involved in the removal of 8-hydroxy-2’-deoxyguanosine via the base excision
repair pathway. Transcriptional regulation of human Ogg1 is sensitive to redox changes
via modulation of intracellular glutathione. In response to changes in glutathione,
changes in hOgg1 transcription occur similar to genes regulated by the transcription
factor Nrf2. It was determined that positions – 47 to – 44 in the hOgg1 promoter are
necessary for basal transcription of Ogg1 determined by site-directed deletion. This
region is capable of interacting with nuclear protein determined by binding assays.
Furthermore, transcription factor Nrf2 is identified as binding to this region determined
by parallel, and competition EMSA binding assays. Exposure to arsenic has also been
associated with oxidative stress and damage to DNA, specifically oxo8dG. This study
identified significant increases in the cellular antioxidant glutathione, and alterations in
superoxide dismutase activities subsequent to arsenite exposure in actively dividing and
NGF treated PC12 cells. Assessment of Ogg1 activity and mRNA levels demonstrated a
significant decrease for both measures subsequent to arsenite exposure.  The effect seen
was due in large part to alterations in gene transcription since direct testing revealed no
effect by arsenite on Ogg1 activity.  Levels of oxo8dG did not significantly change
subsequent to arsenite exposure, however increased trends were evident. Characterization
of Sp1 binding revealed that treatment with sodium arsenite could decrease Sp1 binding
at two unique Sp1 sites in the human Ogg1 promoter. In summary, transcription factor
Nrf2 is an important factor in the inducible regulation of Ogg1. Transcriptional changes
in Ogg1 are further dependent on the redox status of the cell. Despite the role of Nrf2 in
response to oxidative stress, sodium arsenite disrupted both the transcription and activity
of Ogg1 in PC12 cells. This disruption occurred despite the induction of cellular stress
response via increases in GSH and Mn SOD activity. This suggests that arsenite is acting
through other mechanisms potentially through disruption of the Sp1 transcription factor.
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CHAPTER ONE
Introduction and Relevant Background
Redox Balance and Oxidative Stress
Maintenance of the cellular environment is one of the fundamental requirements
for normal cellular physiology.  Proper homeostasis of the cell’s internal and external
environment is essential for cell growth, proliferation and survival.  Homeostasis is
accomplished by robust and redundant balances of numerous components of the cell
including but not limited to structural integrity, energy levels, nutrient/waste exchange,
and the cellular redox state.  Deficiencies in any of these can have detrimental effects on
cell function or survival.  However, redox alterations appear to be a convergent pathway
associated with numerous pathologies.  Redox state is simply defined as the balance of
oxidants to reductants in the cellular environment and when that balance is disrupted
conditions can shift to more oxidizing conditions.  When this shift in redox balance leads
to cellular dysfunction, it is referred to as oxidative stress (Halliwell 1999).
Oxidative stress can occur as a result of a variety of conditions ranging from
exposure to toxic substances, xenobiotic metabolism, inflammatory response and
alterations in normal cellular processes such as ATP synthesis.  Cellular systems exist to
prevent and reduce the impact of these conditions via different protective mechanisms.
Some effects of oxidative stress can involve oxidation of important cellular
macromolecules such as proteins, lipids, and DNA.  In some instances damaged cellular
macromolecules undergo a process of turnover where the oxidized components are
broken down, eliminated, and replaced by newly synthesized components.  In other
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situations the cell needs to repair the damaged element due to the element having a more
fixed or stable function in cellular organization.
Sources of cellular oxidation
As stated previously there are many potential sources for free radical production.
This discussion will be limited to endogenously produced free radicals and some of the
pathways capable of generating them.  Antioxidant defenses are mentioned, however they
will be covered in greater detail in the following section.
Superoxide anion is one of the major reactive oxygen species present in cellular
systems.  It is produced as a result of both normal and abnormal cellular processes.  In
mitochondria, it is produced as a byproduct of cellular respiration.  This is facilitated by
the single electron reduction of molecular oxygen by distinct components of the electron
transport chain; a process that can be exacerbated by changes in the mitochondrial redox
state and/or changes in endogenous defense systems (Giulivi, Boveris et al. 1995;
Halliwell 1999; Cadenas and Davies 2000).  In mitochondria, manganese superoxide
dismutase (discussed later) readily converts superoxide to the less reactive H2O2, which is
converted to H2O and molecular oxygen via the activities of catalase and/or glutathione
peroxidase (Gpx) (Fridovich 1995).  However, under unique conditions, such as in the
presence of transition metals, H2O2 can undergo a single electron reduction to produce
hydroxyl radical.
Hydroxyl radical formation was first characterized as the Haber-Weiss reaction
where it was described as the reaction of superoxide with H2O2 to produce hydroxyl
radical (Haber 1934).  It has since been adapted to biological systems as the Fenton
reaction.  The Fenton reaction is similar to the Haber-Weiss reaction in that it describes
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the same single electron reduction of H2O2.  The key difference is that the Fenton
reaction occurs in the presence of a transition metal such as Cu+ or Fe2+ that is acting as
the electron source instead of superoxide (Kehrer 2000).  Due to the presence of
intracellular reducing equivalents such as ascorbate, the transition metal can be readily
oxidized and reduced allowing it to participate in the reaction multiple times.
Fenton Reaction: Fe2+  + H2O2   →   Fe
3+  +  OH•  +  OH-
Hydroxyl radical is considered the most detrimental free radical produced in biological
systems because of its ability to react with and oxidize most cellular components.  The
ability of hydroxyl radical to damage cellular macromolecules is limited to the high
reactivity and regional production limiting its effective range of damage to its immediate
area of production.  Included in the list of macromolecules that hydroxyl radical can
damage are lipids, proteins and DNA; hydroxyl radical formation is therefore the focus of
numerous studies (Halliwell 1999).  Despite the large number of macromolecules that are
targets of oxidative damage by free radicals, damage to DNA appears to be more
detrimental to cellular function and will be discussed later in greater detail.
Antioxidant Defense
Cells have evolved concerted mechanisms to reduce hydroxyl radical formation.
Integral components of cellular defense are antioxidant molecules and enzymes whose
purpose is to react with, and remove different oxidative moieties like reactive oxygen
species (ROS) and reactive nitrogen species (RNS); both commonly referred to as free
radical compounds.
Molecules capable of directly interacting with, and negating free radicals, mainly
via one-electron transfer, are a part of endogenous antioxidant systems.  The antioxidant
4
glutathione (GSH) is composed of the amino acids L-glutamate, L-cysteine and L-
glycine.  Its main role in antioxidant defense is to protect protein thiol groups (SH) and
scavenge free radicals such as hydroxyl radical and peroxynitrite (Kalyanaraman, Karoui
et al. 1996).  In its reduced form, the thiol functional group of cysteine is the active
component in antioxidant defense as the sulfur atom is capable of accepting and donating
electrons.  Upon interaction with free radicals, reduced GSH accepts the free electron
creating a transient thiyl radical (GS•). GS• then reacts with another GS• to produce the
oxidized form of GSH (GSSG) (Halliwell 1999).
GSH oxidation: GS•  +  GS•  →  GSSG
It is the balance between reduced and oxidized GSH that is commonly used as a
marker for oxidative stress.  Under normal conditions the typical molar ratio of
GSH/GSSG is ten to one depending on species and tissue examined.  That ratio however
can rapidly shift in oxidizing conditions.  It is at this point that cellular systems rely on de
novo synthesis and recycling of GSH to replenish the reduced form.
As stated, a main function of GSH is participating in cellular defense against
oxidative stress (Griffith 1999; Sies 1999) and changes in GSH have been regarded as an
assessment for shifts in redox state.  The first enzyme in the synthetic pathway is the rate-
limiting component for GSH synthesis and involves glutamate cysteine ligase (GCL); a
dimeric enzyme composed of a catalytic (GCLc) and modulatory (GCLm) subunit
(Huang, Anderson et al. 1993).  In this reaction, GCL catalyzes the coupling of L-
glutamate to L-cysteine in an ATP dependent manner (Meister and Anderson 1983).
Glutamate-cysteine ligase:  L-glutamate  +  L-cysteine  →  γ-L-glutamyl-L-cysteine
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What is unique in this reaction is the creation of a peptide bond between the γ-carboxyl
group of glutamate and the amine group of cysteine.  Secondary in the pathway is
glutathione synthetase (GS) that catalyzes the addition of glycine to γ-glutamylcysteine
(Meister and Anderson 1983; Griffith 1999) producing the reduced and functional form
of GSH.
Glutathione synthetase:    L-γ-Glutamyl-L-cysteine  +  L-glycine  →  GSH
Glutathione reductase (GR) is an integral part in maintaining basal levels of
reduced GSH.  The role of GR is to convert the oxidized form of GSH (GSSG, see
below) back to the reduced form.  This reaction requires the cellular reductant NADPH
(Kehrer and Lund 1994).
Glutathione Reductase: GSSG  +  2 NADPH  →  2 GSH  +  2 NAD+
Enzymatic defense systems are present in addition to GSH and are crucial
elements in the clearance of ROS.  Superoxide dismutase enzymes (SOD) are capable of
scavenging the free radical superoxide (O2•-) by converting it to hydrogen peroxide
(H2O2) via enzymatic dismutation (Fridovich 1995).  There are two main SOD enzymes;
a cytosolic isoform and mitochondrial isoform; Copper/Zinc SOD (Cu/ZnSOD) and
Manganese SOD (MnSOD) respectively.  Cu/ZnSOD relies on the activity of the
transition metal copper to react with O2•- to produce H2O2 and O2.  The mitochondrial
form manganese SOD (MnSOD) catalyzes the same reaction however utilizing
manganese as the transition metal instead of copper.  The interesting component of this
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reaction is producing hydrogen peroxide via SOD activity, a substrate for hydroxyl
radical formation is produced.  Fortunately additional enzymes exist to clear hydrogen
peroxide from cellular compartments.
Superoxide dismutase: 2 O2•-  +  2 H+  →  H2O2  +  O2
Involved in the clearance of H2O2, catalase and glutathione peroxidase enzymes
rapidly convert H2O2 to water and molecular oxygen in a dismutation reaction similar to
SOD (Lardinois 1995).  Catalase, however ,utilizes iron as the transition metal ion.
Glutathione peroxidase (Gpx) is similar to catalase in its activities and is responsible for
the mitochondrial clearance of H2O2 (Chance, Sies et al. 1979).  Gpx catalyzes
dismutation of H2O2 to water and molecular oxygen and utilizes selenium as the
transition metal.
Catalase, Glutathione peroxidase: H2O2  →  H2O  +  1 O2
      2
Antioxidants from dietary sources can also help counteract the damaging effects
of free radicals; included in this group are ascorbic acid (vitamin C) and tocopherol
compounds (vitamin E), most notable being α-tocopherol.  The antioxidant capacity is
facilitated in both molecules by scavenging unpaired electrons similar to the actions of
GSH.  The role of these antioxidant compounds is not characterized by their individual
action but the combined activities of numerous systems.
In summary, the main role of antioxidant molecules and enzymes is the
conversion of free radicals to less reactive constituents. It is important to acknowledge,
however, that although discussed individually, it is the cumulative effort of the
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aforementioned systems that maintain cellular antioxidant defense and redox
homeostasis.  In relation to DNA damage, these defense systems work concertedly to
prevent hydroxyl radical formation and its subsequent deleterious effects on DNA.  This
is due in large part to the importance of genomic maintenance.  Damage to DNA can lead
to genetic mutation, blockage of gene transcription, and induction of apoptotic pathways.
Oxidative Damage to DNA; Formation of 8-hydroxy-2’-deoxyguanosine
Oxidative damage to DNA occurs from a variety of endogenous and
environmental sources.  Oxidative DNA damage has been found after exposure to
ionizing radiation (Kasai, Crain et al. 1986; Breen and Murphy 1995; Hamilton, Guo et
al. 2001; Jeong, Youn et al. 2004), genotoxic compounds including heavy metals such as
Fe, Cu, Cr (Kehrer 2000; Qi, Reiter et al. 2000; Welch, Davis et al. 2002) and singlet
oxygen, an additional ROS shown to induce DNA damage (Devasagayam, Steenken et al.
1991).  Damage to DNA also occurs as a consequence of normal metabolic processes
such as ATP synthesis where reactive oxygen species are produced as a byproduct of
electron transfer (Giulivi, Boveris et al. 1995; Cadenas and Davies 2000).  Although
reports are varied as to the projected number, it has been proposed that there can be up to
103 oxidative attacks on DNA per day in human cells (Helbock, Beckman et al. 1998).
While multiple types of damage can occur to DNA, one specific form of DNA
damage is the lesion 8-hydroxy-2’-deoxyguanosine (oxo8dG) that is formed via purine
oxidation of guanine.  The reaction is facilitated by oxidative attack of hydroxyl radical at
the C8 position of guanine generating a guanine-adduct radical.  Further oxidation of the
guanine-adduct radical forms oxo8dG one of the final products in this reaction pathway
(Figure 1) (Breen and Murphy 1995; Dizdaroglu, Jaruga et al. 2002).  Recent evidence
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has demonstrated that oxo8dG can undergo further oxidation in both artificial and cellular
systems.  The relevance of these further oxidized guanine lesions is still being
characterized.  However, their production has been established in the presence of the
metal chromium (VI) and cellular reductants, and presents an alternative hypothesis for
chromium mediated genotoxicity (Hailer, Slade et al. 2005; Slade, Hailer et al. 2005).
This suggests that oxo8dG serves as an intermediate for further oxidative damage to
DNA.  However, in biological systems, oxo8dG formation is the first event in this
oxidative cascade, lending support to a need for understanding the role of oxo8dG in
pathological processes, and in the existing mechanisms of repair.
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FIGURE 1
Adapted from (Breen and Murphy 1995; Dizdaroglu, Jaruga et al. 2002)
10
Figure 1
The reaction pathway for oxidation of guanine in DNA by hydroxyl radical producing
oxo8dG.  Hydroxyl radical reacts with the C-8 position of guanine producing the C-8OH-
adduct guanine radical.  Further oxidation stabilizes the adduct creating the final product
oxo8dG.
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Of the four nucleic acid bases in DNA, guanine has the lowest oxidation potential
making it the most frequently oxidized DNA base (Crespo-Hernandez, Close et al. 2007).
Based on this physical property, in vivo levels of oxo8dG are considered a reliable
biomarker for oxidative stress and DNA damage (Dizdaroglu, Jaruga et al. 2002).
Increased oxo8dG has been shown subsequent to both environmental (Qi, Reiter et al.
2000; Cardozo-Pelaez, Cox et al. 2005; Piao, Ma et al. 2005), and industrial exposures
(Kamendulis, Jiang et al. 1999).  Table 1 is a literature summary identifying increased
levels of oxo8dG subsequent to a variety of exposures to environmental and chemical
conditions.  There are two main points to be considered; (i) the breadth of literature
investigating oxidative damage to DNA and (ii) elucidating the relationship between
increased oxidative DNA damage and toxin-related pathologies.  These two points
identify a significant area in the literature that needs to be addressed in regards to the
relevance of oxo8dG formation.  These two points also put forward the issue of whether
increased levels of oxo8dG merely serve as a marker of global oxidative stress, or
whether increased levels of oxo8dG are a pre-cursor for cellular toxicity.
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Table 1.  Literature summary outlining studies identifying increased levels of
oxo8dG as a result of different environmental and chemical exposures.
 (Fraga, Shigenaga et al. 1990; Chen, Marsh et al. 1996; Cadenas and Barja 1999; Kamendulis, Jiang et al.
1999; Barber, Borras et al. 2000; Stedeford, Cardozo-Pelaez et al. 2001; Piao, Ma et al. 2005; Bolin, Basha
et al. 2006; Gabelova, Valovicova et al. 2007)
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Elevated levels of oxo8dG have also been associated with the aging process, and a
number of disease states including carcinogenesis and neurodegenerative disorders
(Halliwell 1999).  In the context of aging, the levels of oxo8dG in heart and brain
mitochondrial DNA have been demonstrated to inversely correlate with lifespan in
mammalian species ranging from guinea pigs to horses (Barja and Herrero 2000).
Furthermore, levels of oxo8dG were increased with age in human and different rodent
models, however these increases were not shown cumulatively throughout the entire
organism.  Table 2 summarizes studies measuring changes in oxo8dG as a function of
aging in human and various animal species.  It is worth noting the species and tissue
dependent variation in levels of oxo8dG contained within these studies.  However, the
reported association of increased oxo8dG and lifespan is under debate.  It remains unclear
whether increased levels of oxo8dG are a result of diminished clearance, diminished
repair, increased oxidative stress, or a combination of all.
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Table 2.  Literature summarizing changes in oxo8dG as a function of aging in
different species and model systems.
(Fraga, Shigenaga et al. 1990; Mecocci, MacGarvey et al. 1993; Agarwal and Sohal 1994; Hirano, Yamaguchi et al.
1996; Cardozo-Pelaez, Song et al. 1998; Cardozo-Pelaez, Song et al. 1999)
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Studies show a relationship between increased levels of DNA damage and
neurodegenerative diseases.  Increased levels of oxidation have been suggested as a
mechanism of injury to neuronal populations in these disorders. In relation to oxo8dG,
increased levels have been found in the brain regions affected in Alzheimer’s disease
(AD) (Lyras, Cairns et al. 1997; Gabbita, Lovell et al. 1998), and Parkinson’s disease
(PD) patients (Sanchez-Ramos 1994) when compared to age-matched controls.  Increased
levels of oxo8dG have also been found in the urine, plasma, and cerebrospinal fluid of
patients diagnosed with amyotrophic lateral sclerosis (ALS) (Bogdanov, Brown et al.
2000) suggesting that these diseases can be associated with global oxidative stress.
The existence of increased oxo8dG in association with distinct tissues and cellular
populations (PD, dopaminergic neurons; AD, glutamatergic neurons; ALS, motor
neurons) reveals the existence of different regional capacities for removal and repair of
oxo8dG.  This was demonstrated in studies assessing repair of oxo8dG in brain tissue
from patients diagnosed with PD or AD.  Fukae et al identified increased levels of the
mitochondrial isoform of the enzyme responsible for initiating repair (see below) of
oxo8dG in the substantia nigra isolated from PD brains (Fukae, Takanashi et al. 2005).
Assessment of neuronal loss revealed significant reductions in dopaminergic neurons
localized to the substantia nigra of sectioned midbrains.  It was suggested that increased
repair enzyme levels in the mitochondria account for the survival of remaining neurons in
the substantia nigra.  Full interpretation of the results is difficult however as no
assessment of the nuclear isoform of the repair enzyme was done.  However, it implicates
that the discovery of regulatory mechanisms involved in removal of oxo8dG are a
16
necessary area of investigation to understand neuronal fate in disease, or after
toxicological challenges.
8-hydroxy-2′-deoxyguanosine DNA Glysoylase (Ogg1)
In the event that antioxidant systems (described above) fail to prevent oxo8dG
formation, mechanisms have evolved to compensate for oxidative damage to DNA by
repairing damaged bases.  Oxo8dG is removed from DNA by an active mechanism called
base excision repair (BER), a process that repairs single DNA base modifications.  The
initial step in repairing oxo8dG is the recognition and incision of the oxidized guanine
base, a process carried out by a specific N-glycosylase 8-hydroxy-2'-deoxyguanosine
DNA glycosylase (Ogg1) (Boiteux and Radicella 2000).  To date Ogg1 is considered the
primary enzyme involved in initiating the repair of oxo8dG and it is the rate-limiting
enzyme in the oxo8dG BER pathway (Klungland, Rosewell et al. 1999; de Souza-Pinto,
Eide et al. 2001).  Figure 2 outlines the main components involved in the BER pathway
for oxo8dG and the sequence in which they occur.  Recognition of oxo8dG paired with
cytosine occurs first, followed by incision of the N-glycosidic bond leaving an apurinic
(AP) site in the DNA strand.  Activity by AP endonuclease (APE) creates a single strand
break at the AP site by cleaving the phosphodiester bond.  DNA polymerase inserts a
guanine nucleotide in the empty site, with ligase activity re-establishing the
phosphodiester bond.  The final product of BER is the repaired DNA strand with an intact
G:C base pair (Aspinwall, Rothwell et al. 1997; Hazra, Izumi et al. 1998) (Figure 2).
17
FIGURE 2
Adapted from (Wilson and Thompson 1997; Bohr 2002)
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Figure 2
Base excision repair pathway for removal and replacement of oxo8dG.  Initial oxidation
of guanine by ROS produces oxo8dG across from cytosine.  1:  Recognition of oxo8dG
and incision of the N-glycosidic bond by Ogg1 leaves an apurinic (AP) site in the DNA
strand.  2: Activity by AP endonuclease creates a single strand break at the AP site.  3:
DNA polymerase β (Polβ) inserts a guanine nucleotide in the empty site opposite
cytosine.  DNA ligase activity re-establishes the phosphodiester bonds creating an intact,
repaired DNA strand.
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Ogg1 is expressed ubiquitously, however in humans greater levels of expression
have been demonstrated in the testes, kidney, and brain suggesting tissue specificity for
the regulation of Ogg1 expression (Nishioka, Ohtsubo et al. 1999).  In mice, low basal
levels of Ogg1 mRNA were measured in all tissues sampled with the exception of the
testes (Rosenquist, Zharkov et al. 1997).  Levels of oxo8dG have also been demonstrated
as variable among different animal species and tissues examined (Hamilton, Guo et al.
2001).  Hamilton et al showed that higher basal levels of oxo8dG were present in
mitochondrial DNA analyzed from different murine tissues (Hamilton, Guo et al. 2001)
suggesting differential expression patterns for Ogg1 existing in different cellular
compartments.  Higher basal levels of oxo8dG have been found in discrete brain regions
of C57BL/6 mice; specifically cerebellum, cortex and pons medulla.  It was also
determined that increased oxo8dG in these brain regions correlated with lower basal Ogg1
activity (Cardozo-Pelaez, Brooks et al. 2000).
These studies suggest the existence of regulatory facets for Ogg1 expression and
or activity that are dependent on multiple factors; including species, tissue, and cell type.
These findings reinforce the importance of determining the regulatory mechanisms and
how they are associated with the differential expression of Ogg1 and its relation to
oxo8dG levels in specific cellular populations.
Regulatory Aspects of Ogg1
The hierarchical regulation of Ogg1 can be characterized in studies showing both
post-transcriptional and post-translational modifications.  Two main splice variants of
mRNA have been demonstrated showing both nuclear (Ogg1-α), and mitochondrial
(Ogg1-β) transcripts for the human isoform of Ogg1.  The mitochondrial transcript is
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produced by alternative splicing of exon 8 in place of exon 7 in the transcribed strand.
Exon 7 is the region where the nuclear localization signal (NLS) is contained.  In this
process the NLS is removed from the transcribed strand of RNA producing the β-form
and shifting the final destination of Ogg1 from the nucleus to the mitochondria.  The two
main splice variants can also be differentiated based on their final protein products with
the α-form and β-forms being 345 and 424 amino acids in length respectively (Nishioka,






Adapted from (Boiteux and Radicella 2000)
22
Figure 3
(A) The genomic organization of the human Ogg1 gene showing exon-intron distribution
of the gene.  Mitochondrial targeting sequence is located in exon1, nuclear localization
signal in exon 7.  Exon 8 is located downstream (~ 10 Kb) from the main cluster of exons
1 through 7.
(B) Organization of the α-form and β-form splice variants of Ogg1.  The α-form
(nuclear) is produced by sequential joining of exons 1 to 7; the  β-form (mitochondrial) is
produced by excision of exon 7 with exon 8 splicing in its place thus effectively
removing the NLS from the transcript.
(C) Linear representation of the α-form and β-forms of the human Ogg1 enzyme
produced by alternative splicing events.  The α-form (nuclear) is 345 amino acids in
length.  The β-form (mitochondrial) is 424 amino acids in length.
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Besides the existence of alternative splice variants, post-translational regulation of
Ogg1 has been shown to occur by a variety of mechanisms.  Some of these regulatory
events occur via amino acid modifications to the Ogg1 enzyme.  Ogg1 has been reported
to contain redox sensitive amino acids capable of modulating its activity.  In particular,
cysteine residues have been implicated in direct modulation of Ogg1 activity.  A human
lymphoblast culture line was used to demonstrate that hOgg1 activity was decreased as a
consequence of oxidative stress from cadmium chloride exposure.  It was also shown that
recovery of hOgg1 activity could be accomplished by the addition of reducing agents to
nuclear extracts and purified hOgg1 (Bravard, Vacher et al. 2006).  This suggests that
redox homeostasis is an essential component in maintaining basal Ogg1 activity.  It also
suggests that compounds participating in oxidative stress can have an indirect effect on
Ogg1 activity if cellular levels of GSH are changed.
Phosphorylation of Ogg1 has also been shown to directly modulate enzymatic
activity.  Protein kinase C (PKC) was the first reported enzyme capable of in vivo
phosphorylation of hOgg1.   It was further shown, in vitro, that PKC was capable of
phosphorylating Ogg1 in both purified and nuclear extracts (Dantzer, Luna et al. 2002).
Phosphorylation of Ogg1 was also demonstrated in a yeast model system and it was
suggested that both interaction and phosphorylation by Cdk4 protein kinase led to
increases in Ogg1 activity.  An additional protein kinase, c-abl, had no effect on incision
activities but was also shown to phosphorylate Ogg1 (Hu, Imam et al. 2005) suggesting
the existence of different protein kinase pathways involved in the regulation of Ogg1.
The aforementioned studies suggest that there are many levels involved in Ogg1
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regulation ranging from post-transcriptional, to direct modification of the functional
Ogg1 enzyme.  The studies also demonstrate that different regulatory aspects of Ogg1
should be considered collectively when characterizing different mechanisms of Ogg1
regulation, as it is clear that there are many variables involved.
Transcriptional Regulation of Ogg1
Despite the investigations into post-transcriptional and -translational regulatory
mechanisms, little has been investigated regarding the pre-transcriptional pathways
involved in modulating Ogg1 transcription.  Numerous studies suggest that modulation of
Ogg1 can occur at different levels in the hierarchy of gene expression.  Table 3
summarizes these studies based on the different techniques used for assessment, and the
corresponding changes in Ogg1 following treatment with different species and model
systems.  Measurement of Ogg1 activity is the most common determination with the
measurement of Ogg1 mRNA levels being the second.  While measurement of mRNA
levels is a reliable assessment for changes in gene transcription, few of these studies
address pre-transcriptional changes; specifically the function of distinct transcription
factor pathways and their role in modulating Ogg1 (Table 3).
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Table 3.  Literature summary of changes in Ogg1 activity, expression and transcription
subsequent to various exposure regiments.
(Kim, Morimoto et al. 2001; Cardozo-Pelaez, Stedeford et al. 2002; Hodges and Chipman 2002; Lan, Li et
al. 2003; Potts, Watkin et al. 2003; Lee, Kim et al. 2004; Youn, Kim et al. 2005)
(Lin, Cao et al. 2000)
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Previous characterization of the promoter for human Ogg1 (hOgg1) isolated from
a human genomic library was performed in HeLa cells.  The results suggest that hOgg1 is
a housekeeping gene whose basal expression is constitutive and unchanged during the
cell cycle.  This conclusion is based largely on the absence of putative TATA or CAAT
boxes (Dhenaut, Boiteux et al. 2000).  A section of the promoter spanning 135 bp
upstream of the transcription initiation site is essential for basal transcription of hOgg1




Adapted from (Dhenaut, Boiteux et al. 2000)
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Figure 4
Map of a 2.1 Kb span of the human Ogg1 promoter.  Putative or unverified transcription
factor binding sites are enclosed in brackets.  Binding sites for Sp1 (Youn, Kim et al.
2005), NF-YA (Lee, Kim et al. 2004) transcription factors have been previously
confirmed and are located in a GC rich span of the promoter.  A p53 and TAp63γ binding
site has been identified between positions –785 to –750 (Chatterjee, Mambo et al. 2006;
Upadhyay, Chatterjee et al. 2007).  The putative binding site for Nrf2 (**) is located
upstream of the transcription initiation site at position –47 to –44.
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Few studies have linked transcriptional regulation of Ogg1 to specific transcription factor
pathways.  Of the existing reports, distinct transcription factors have been elucidated as
interacting with the promoter for hOgg1, and having subsequent effects on transcriptional
activity.  The transcription factor NF-YA was reported to play a role as an inducible
mechanism for hOgg1 upon exposure to the DNA alkylating agent methylmethane
sulfonate.  This was demonstrated by transcription factor binding to inverted CAATT
motifs located at positions –97 and –71 of the hOgg1 promoter.  This area of the
promoter also contains a large CpG island suggesting that modulation of Ogg1
transcription can occur due to changes in promoter methylation (Lee, Kim et al. 2004).  It
was also demonstrated that Sp1 was important in the basal transcriptional of hOgg1 and
this process could be negatively influenced by cadmium chloride via down regulation of
gene transcription (Youn, Kim et al. 2005).
Recent evidence suggests the role of p53 in transcriptional regulation of hOgg1.
Both p53 and Tap63γ, a homologue of p53, have been shown to bind and modulate
hOgg1 transcription (Chatterjee, Mambo et al. 2006; Upadhyay, Chatterjee et al. 2007).
It has also been demonstrated that p53 can directly interact with hOgg1/ APE complexes,
both being the first two enzymes involved in the oxo8dG BER pathway.  It was also
suggested that interaction of p53 with hOgg1 and APE is facilitating an increase in both
enzyme activities (Achanta and Huang 2004), however the mechanism by which such
facilitation occurs remains uncharacterized.
These previous studies are the only ones linking defined transcription factor
pathways to modulation of hOgg1, however work by Dhenaut & colleagues suggests the
presence of a number of putative transcription factor binding sites in the hOgg1 promoter
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(see Figure 4) (Dhenaut, Boiteux et al. 2000).  Whether these putative transcriptional
binding sites play a role in Ogg1 transcription, and under what conditions remains
unresolved.
Many of the exposures outlined in Table 3 have a common aspect, specifically
their association with oxidative stress and the induction of cellular stress response
pathways. Under this notion, these studies can help to gain insight into the mechanism
involved in the modulation of Ogg1 in the presence of compounds that effect levels of
GSH (Cardozo-Pelaez, Stedeford et al. 2002; Merrill, Ni et al. 2002).  Analysis of the
hOgg1 promoter region reveals the existence of a putative Nrf2 binding site at positions
–47 to – 44 (Dhenaut, Boiteux et al. 2000), however this site currently remains unverified
in regards to its interaction with Nrf2 and cellular stress response.  It does propose an
interesting question; is Nrf2 capable of interacting with the hOgg1 promoter and is it
involved in transcriptional regulation of Ogg1 expression?
Transcription Factor Nrf2
Nuclear-factor Erythroid factor 2 (NF-E2-related factor 2, Nrf2) is involved in
regulating a well-characterized transcription factor pathway involved in the regulation of
phase II xenobiotic metabolism and antioxidant genes including Nrf2 itself.  A short list
of these genes includes glutathione S-transferases (GST), NADP(H) quinone
oxidoreductase (NQO1), GSH maintenence enzymes (GCL, GS, GR), hemeoxygenase I
(HO-1), and system xc transporter (Rushmore and Pickett 1990; Venugopal and Jaiswal
1996; Itoh, Chiba et al. 1997; Alam, Stewart et al. 1999; Chan and Kwong 2000; Sasaki,
Sato et al. 2002; Lee, Calkins et al. 2003).
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Nrf2 is considered the model redox/stress response pathway because its activation
and translocation has been associated, in part, with changes in the cellular redox state.
GSH is regarded as the first line of defense against cellular oxidative stress (Griffith
1999; Sies 1999) and changes in GSH have been regarded as a measure for shifts in
cellular redox status.  Work by others suggests that modulation of GSH via depleting
agents acts as a regulator of cell response to oxidative stress by induction of Nrf-2
regulated genes (Prosperi, Ferbus et al. 1998; Dinkova-Kostova, Holtzclaw et al. 2002;
Hansen, Watson et al. 2004).  It is therefore plausible that changes in GSH could regulate
the transcription of Ogg1 as previously suggested.  A 6 hr in vivo exposure to diethyl
maleate led to decreased levels of GSH and increased Ogg1 activity in specific brain
regions (Cardozo-Pelaez, Stedeford et al. 2002).  A similar exposure was performed in
the human Hep G2 cell line.  6 hr exposure to etoximir resulted in significantly reduced
levels of GSH, and significantly increased levels of hOgg1 mRNA (Merrill, Ni et al.
2002).  It can then be suggested that increased hOgg1 transcription is occurring in an
Nrf2 dependent manner as increased transcripts from a number of Nrf2-regulated genes
(HO-1, GCLm, GR, MnSOD) were also demonstrated (Merrill, Ni et al. 2002).
Expanding the role for Nrf2 in stress response are studies showing its activation
by components of signal transduction pathways; most notably map kinase pathways (Yu,
Chen et al. 2000), phosphatidylinositol 3 kinase (PI3K) (Salinas, Diaz et al. 2003; Martin,
Rojo et al. 2004), and protein kinase C (PKC) (Bloom and Jaiswal 2003; Hu, Imam et al.
2005).
Structurally Nrf2 is a basic leucine zipper (bZip) transcription factor that under normal
conditions remains sequestered in the cytosol (Moi, Chan et al. 1994; Venugopal and
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Jaiswal 1998).  Sequestration of Nrf2 is facilitated by interaction with its inhibitory
partner, kelch-like protein 1 (KEAP1) (Itoh, Wakabayashi et al. 1999; Dinkova-Kostova,
Holtzclaw et al. 2002).  Under basal conditions Nrf2-KEAP1 complexes are maintained
in the cytosol tethered to the actin cytoskeleton where Nrf2 is continually targeted to the
proteasome via an ubiquitin-dependent pathway (Nguyen, Sherratt et al. 2003).
However, in the presence of ROS, xenobiotics or enzymatic activation, Nrf2 is released
from KEAP1 and translocates to the nucleus where it interacts in partnership with small
Maf binding proteins.  The final function of active Nrf2 is to interact with its cognate
binding sequence (reviewed in; (Itoh, Tong et al. 2004; Lee and Johnson 2004; Nguyen,
Yang et al. 2004) a unique area in the promoter region of Nrf2 regulated genes called the
antioxidant response element (ARE).  Subsequent to the formation of Nrf2-Maf
dimerization and transcription complex binding, genes containing ARE binding





The pathways of activation for transcription factor Nrf2 in mammalian cells.  Sequestered
Nrf2 represents the inactive form of Nrf2 and its ubiquitin-dependent degradation via the
proteasome.  Activity by PKC (as of yet distinct isoforms unidentified) leads to
phosphorylation and subsequent activation of Nrf21.  The presence of ROS (GSH
modulation), has also been shown to activate Nrf2 via modification of thiol groups on
KEAP12.  Electrophilic compounds (tBHQ) has been shown to activate Nrf2 by both of
the aforementioned mechanisms1,2.  Activated Nrf2 translocates in to the nucleus
interacting with small Maf proteins and binds to the ARE.  RNA transcription complexes
are formed leading to transcription of Nrf2-regulated genes.
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The core ARE sequence was identified by Rushmore and colleagues as being
analogous to AP-1 binding sites, however, the ARE differed in its core binding sequence
(see below) (Rushmore and Pickett 1990).  Dhenaut and colleagues analysis of the hOgg1
promoter (Dhenaut, Boiteux et al. 2000) identified an additional core ARE sequence that
has since been characterized as interacting with Nrf2 in an equivalent manner
(Ongwijitwat and Wong-Riley 2004).  However, whether the proposed Nrf2 binding
sequence located in the hOgg1 promoter (Dhenaut, Boiteux et al. 2000) is involved in the
regulation of Ogg1 gene transcription remains unverified.
Antioxidant Response Element Core Binding Sequence
5′ – GTGACnnnGC – 3′  (Rushmore and Pickett 1990)
5′ – TTCC – 3′  (Dhenaut, Boiteux et al. 2000; Ongwijitwat and Wong-Riley 2004)
The redox sensitivity of Nrf2 activation has been identified by two unique
characteristics of the KEAP1-Nrf2 dimeric complex.  The first is a string of amino acids
located in the Neh2 domain of Nrf2.  The motif is composed of glu-thr-gly-glu (ETGE)
and is characterized as the docking region for KEAP1 (Itoh, Wakabayashi et al. 1999;
McMahon, Thomas et al. 2004).  The second, and redox sensitive characteristic, is the
presence of distinct cysteine residue located in KEAP1.  Specifically, cysteines 257, 273,
288 and 297 have been identified as the most reactive residues (Dinkova-Kostova,
Holtzclaw et al. 2002) in a cysteine rich region of KEAP1.  Figure 6 demonstrates the
structural and redox-sensitive features of both Nrf2 and KEAP1.
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FIGURE 6
Adapted from (Itoh, Wakabayashi et al. 1999; Dinkova-Kostova, Holtzclaw et al. 2002)
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Figure 6
Protein map and structural organization of Nrf2 and KEAP1.  Highlighted features
include the KEAP1 binding domain consisting of an ETGE motif located in the Neh2
domain of Nrf2.  The linker region of KEAP1 is composed of multiple cysteine residues
with four highly reactive residues present in close proximity to one another.  The linker
region has been identified as the redox-sensitive portion of KEAP1 capable of
undergoing cysteine oxidation.
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Recent evidence suggests an integral role for C273, C288 in Zn2+ coordination.  This was
characterized by the displacement of zinc from KEAP1-Nrf2 complexes in the presence
of Nrf2 inducing compounds.  Zinc displacement resulted in subsequent cysteine
modifications, and conformational changes in KEAP1 that led to the release of Nrf2
thereby initiating the first component of Nrf2 activation (Dinkova-Kostova, Holtzclaw et
al. 2005).
To date no link has been established between Nrf2 and Ogg1 regulation despite
published data suggesting response trends for Ogg1 that are similar to Nrf2 regulated
genes (Table 3).  Previous work has demonstrated an inducible response by Ogg1 that
follows decreased levels of GSH (Cardozo-Pelaez, Stedeford et al. 2002; Merrill, Ni et al.
2002) however these studies have not identified any mechanism responsible for this
induction.  Despite the lack of evidence for Ogg1 regulation via Nrf2, it is worth noting
that in mice deficient for Nrf-2 expression (-/- null phenotype), basal levels of oxo8dG are
higher than levels in wild-type controls (Li 2004); the activity for Ogg1 however was not
assessed in this study.  Increased levels of oxo8dG in the Nrf-2 -/- mice were also
demonstrated after exposure to diesel exhaust particles and cigarette smoke (Aoki, Sato et
al. 2001; Rangasamy, Cho et al. 2004).  It is difficult to establish the cause of increased
oxo8dG levels in these studies, as a lack of Nrf2 constitutes the decreased expression of
many antioxidant genes.  However, the increased levels of oxo8dG present in Nrf2 null
mice suggest Ogg1 as a potential Nrf2-regulated gene for investigation.
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CHAPTER TWO
Transcriptional Regulation of 8-hydroxy-2’-deoxyguanosine DNA Glycosylase by
the Cellular Redox State and Transcription Factor Nrf2
Abstract
8-hydroxy-2’-deoxyguanosine DNA glycosylase is the rate-limiting enzyme
involved in the removal of 8-hydroxy-2’-deoxyguanosine via the base excision repair
pathway.  Transcriptional regulation of human Ogg1 is sensitive to redox changes via
modulation of intracellular GSH in HEK 293T cells.  In response to changes in GSH,
changes in hOgg1 transcriptional activity occur similar to genes regulated by the
transcription factor Nrf2.  It was determined that a four base pair run (TTCC) located at
positions – 47 to – 44 in the hOgg1 promoter is essential for basal transcription of the
Ogg1 gene as determined by site-directed deletion.  In addition, the putative Nrf2 site is
capable of interacting with nuclear protein extracts from HEK 293T cells as determined
by electrophoretic mobility shift assays (EMSA).  Further investigation suggests the
involvement of the transcription factor Nrf2 as determined by parallel, and competition
EMSA using consensus Nrf2 and Sp1 oligonucleotides.  Additional evidence for Nrf2
binding to this region of the hOgg1 promoter was demonstrated by increased binding
subsequent to exposure by tert-butylhydroquinone, a known Nrf2 inducing agent.  We
conclude that the transcription factor Nrf2 is an important factor in the inducible
regulation of Ogg1 and that these changes are ultimately dependent on the redox status of
the cell, mainly via intracellular levels of GSH.
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Introduction
Oxidative damage to DNA occurs from a variety of sources including
environmental causes such as ionizing radiation as well as genotoxic compounds like
heavy metals and peroxides (Kehrer 2000).  It can also occur during normal cellular
processes such as ATP synthesis where reactive oxygen species are produced as a
byproduct of electron transfer (Giulivi, Boveris et al. 1995).  One specific form of DNA
damage is the lesion 8-hydroxy-2’-deoxyguanosine (oxo8dG) that occurs via oxidation of
the DNA base guanine.  Oxo8dG is one of the most commonly formed DNA lesions and
is considered a cellular biomarker for both oxidative stress and DNA damage
(Dizdaroglu, Jaruga et al. 2002).  Cellular systems are in place to regulate levels of
genomic oxo8dG by repairing the damaged base.  The repair process is accomplished by
an enzymatic pathway called base excision repair (BER).  The initial step in BER
involves the recognition and incision of oxo8dG, a process carried out by a specific N-
glycosylase Ogg1 (Boiteux and Radicella 2000).  Ogg1 is the main enzyme involved in
initiating the repair of oxo8dG and is the rate-limiting enzyme in the BER pathway
(Klungland, Rosewell et al. 1999; de Souza-Pinto, Eide et al. 2001).  Ogg1 is expressed
ubiquitously, however greater levels of expression have been detected in the testes,
kidney, and brain of humans indicating a tissue specific organization for the regulation of
Ogg1 expression (Nishioka, Ohtsubo et al. 1999).  These results suggest the existence of
regulatory mechanisms for Ogg1 expression and/or activity that are specific to tissue and
cell type.
Different aspects of Ogg1 regulation have been demonstrated in studies showing
both post-transcriptional and post-translational modifications.  Evidence for these
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modifications included the existence of nuclear and mitochondrial targeted transcript
splice variants (Nishioka, Ohtsubo et al. 1999) and amino acid modifications via both
oxidation and phosphorylation. (Dantzer, Luna et al. 2002; Hu, Imam et al. 2005; Bhakat,
Mokkapati et al. 2006; Bravard, Vacher et al. 2006).  These studies demonstrate that
modulation of Ogg1 can occur at different levels in the hierarchy of gene expression.
Despite the discovery of the aforementioned post-transcriptional and post-
translational regulatory mechanisms, little has been investigated regarding the pre-
transcriptional pathways involved in regulating Ogg1 transcription.  The promoter for
hOgg1 has been sequenced and hOgg1 was characterized as a housekeeping gene whose
expression is constitutive and unchanged during the cell cycle (Dhenaut, Boiteux et al.
2000; Lee, Kim et al. 2004). Evidence for the transcriptional regulation of hOgg1 was
demonstrated via the transcription factor Sp1, an integral component in the basal
transcription of Ogg1 (Youn, Kim et al. 2005).  Of the studies investigating changes in
Ogg1, many identify a unique aspect; the association with oxidative stress and the
induction of cellular stress response pathways.  Transcription factor Nrf2 regulates a
well-characterized stress response pathway involved in the induction of phase II
xenobiotic metabolism, and antioxidant genes (Itoh, Chiba et al. 1997).  Nrf2 is further
characterized as a molecular redox switch because its activation and translocation are
intimately associated with levels of intracellular GSH (Dinkova-Kostova, Holtzclaw et al.
2002; Hansen, Watson et al. 2004). Dhenaut and colleagues reported the existence of a
potential/putative Nrf2 binding site in the hOgg1 promoter (Dhenaut, Boiteux et al.
2000).  Published data implies response trends for Ogg1 that are similar to Nrf2 regulated
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genes making Nrf2 a candidate for investigation as a transcriptional regulator of Ogg1
(Cardozo-Pelaez, Stedeford et al. 2002; Merrill, Ni et al. 2002).
The goal of these experiments was to test the hypothesis that the DNA repair
enzyme Ogg1 is transcriptionally regulated by the transcription factor Nrf2, and that
transcriptional changes in Ogg1 are mediated by the intracellular antioxidant GSH.  To
test the hypothesis the following objectives were designed:
1) Characterize the transcriptional activity of the putative Nrf2 binding site located
at positions –47 to –44 of the human Ogg1 promoter.
2) Characterize nuclear protein interaction at the putative Nrf2 binding site located at
positions –47 to –44 of the human Ogg1 promoter.
3) Characterize the changes in hOgg1 transcriptional activity subsequent to exposure
to Nrf2 inducing compounds and modulation of cellular GSH.
To accomplish this, reporter gene expression vectors under the regulation of the
hOgg1 promoter were constructed.  Site-directed deletion of the putative Nrf2 binding
site (–47 to –44) in the hOgg1 promoter was used to assess the transcriptional relevance
of this region.  Changes in promoter activity were measured by changes in GFP reporter
gene expression.  Assessment of nuclear protein interaction with the Nrf2 site was
determined by electrophoretic mobility shift assays.  Nuclear extracts were utilized from
both untreated and tBHQ (an Nrf2 inducer) treated HEK 293T cells.  Redox response
capacity of Ogg1 transcription was determined using a more sensitive reporter gene
system involving luciferase expression vector regulated by the hOgg1 promoter.
Changes in luciferase reporter gene activity were measured.  These assays were
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performed using Nrf2 inducing compounds t-butyl hydroquinone, diethyl maleate, and a
membrane permeable GSH analog, glutathione monoethyl ester.  As a surrogate measure
of stress response and redox status, GSH was measured from cell cultures exposed to the
latter conditions; Nrf2 induction and GSH modulation.
Materials & Methods
Cell Culture and Transient Transfections
HEK 293T human embryonic kidney cells (ATCC, #CRL-11268) were grown in
1X Dulbecco’s Modification of Eagle’s Medium with 4.5 g/L glucose and L-glutamine,
10% fetal bovine serum, 1 mM sodium pyruvate, 1X non-essential amino acids, 1000
international units penicillin, 1 mg/mL streptomycin, 50 µg/mL gentamicin sulfate.  All
media reagents were purchased from CellGro technologies (Mediatec Inc., Herndon,
VA) and incubated at 37°C in a humidified 5% CO2 atmosphere.  Transfections were
performed using PolyFect lipid transfection reagent (QIAGEN, Valencia, CA).  Cell
densities for FACS measurement of GFP was performed at a starting density of 3.0 x 105
cells/well in 6-well tissue costar tissue culture plates (Corning Life Sciences, Lowell,
MA) and grown in normal growth media for 24 hr.  Two µg total plasmid DNA/well was
used with 20 µL PolyFect reagent for GFP transfections.  Cell density for luciferase
assays was performed at a starting density of 1.5 x 105 cells/ well in 24-well tissue costar
tissue culture plates (Corning Life Sciences, Lowell, MA) and grown in normal growth
media for 24 hr.  0.5 µg of target vector was co-transfected with 10 ng of reference vector
and 5 µL of PolyFect reagent.  For over-expression of Nrf2, luciferase expression
vectors were co-transfected with 0.5 µg of pEF-Nrf2, or an empty control vector (pEF-
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Basic) to ensure specificity.  Twenty four hr post-transfection HEK 293T cells were
treated with normal growth media or media containing 25 µM tert-butylhydroquinone
(tBHQ) (Alfa Aesar, Ward Hill, MA) 25 µM diethyl maleate (DEM) (Sigma, St Louis,
MO), or 1 & 2 mM glutathione monoethyl ester (GSH-mee) (EMD Bioscience, San
Diego, CA).
Construction of the Expression Vector pAM/hOgg1-hrGFP-WPRE-BGH-polyA
All plasmids were constructed using basic molecular biology protocols.  A GFP
reporter gene expression vector (pAM/hOgg1-hrGFP-WPRE-BGH-polyA) was produced
by ligation of a 2.1 Kb fragment of the human Ogg1 promoter into the linearized
promoterless pAM/-hrGFP-WPRE-BGH-PolyA expression vector.  The hOgg1 promoter
fragment was generated by polymerase chain reaction using primers with unique
restriction sites Asp718 and BamHI (see Appendix A, section 3).  PCR reactions were
composed of the following reagents and set up in sterile 0.25 mL reaction tubes (Axygen
Scientific, Union City, CA): 5 µL of 10X PCR buffer (Invitrogen Life Technologies,
Carlsbad, CA), 1.5 µL of 50 mM MgCl2 (Invitrogen Life Technologies, Carlsbad, CA),
2.5 µL of 2.5 mM dNTP’s (Roche Applied Science, Indianapolis, IN), 2.5 µL of 5 µM
forward and reverse primers (Integrated DNA Technologies Inc., Coralville, IA), 0.25 µL
Taq polymerase (Invitrogen Life Technologies, Carlsbad, CA), 50 ng template DNA
isolated from SHSY-5Y neuroblastoma cells, with a final volume of 50 µL using sterile
nuclease free H2O.  Reactions were run using a DNA Engine thermal cycler (MJ
Research, Waltham, MA) as follows: 94° C for 3 min, **94° C for 45 sec, 65° C for 30
sec, 72° C for 90 sec, **amplification steps repeated 33X, 72° C 10 min.  Blunt ended
PCR products were ligated into the pCR-Blunt II-TOPO (Invitrogen Life Technologies,
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Carlsbad, CA) sequencing vector.  TOPO reactions were set up under the following
conditions: 4 µL fresh hOgg1 promoter PCR reaction, 1 µL TOPO salt solution
(Invitrogen Life Technologies, Carlsbad, CA), 1 µL pCR-Blunt II-TOPO sequencing
vector.  Reactions were mixed gently and incubated at 25° C for 5 min.  Following
incubation TOPO reactions were transformed into DH5α chemically competent
Escherichia coli (Invitrogen Life Technologies, Carlsbad, CA) via heat shock protocols
setup as follows: 50 µL of competent cells were transferred to a sterile 1.5 mL eppendorf
tube on wet ice, 6 µL of the TOPO reaction was gently added, mixed and incubated on
ice for 30 min.  Reactions were heat shocked at 42° C for 20 sec and placed on ice for 2
min.  450 µL of S.O.C. recovery media (Invitrogen Life Technologies, Carlsbad, CA)
was added to transformation reactions and incubated at 37° C, shaker speed 225 rpm for
60 min.  Transformation reactions were grown overnight at 37° C on LB agar plates
containing (100 µg/mL) ampicillin to select transformed colonies via antibiotic
resistance. Single colonies were selected and grown in liquid LB broth containing
ampicillin (100 µg/mL).  TOPO vectors were extracted and purified using Mini-prep
plasmid DNA purification kits (QIAGEN, Valencia, CA).  The purified TOPO vector
containing the 2.1 Kb hOgg1 promoter fragment underwent restriction digest analysis
using Asp718 and BamHI restriction enzymes (Roche Applied Science, Indianapolis, IN)
to verify the presence of the 2.1 Kb fragment in the TOPO vector.  Promoter sequencing
was performed by Murdock Sequencing Facility, University of Montana.  Following
verification by restriction digest analysis and sequencing, the 2.1 Kb fragment was
resolved and separated on a 0.8% agarose gel containing 1.5 µg/mL ethidium bromide to
visualize the separated fragments via ultra-violet light.  The fragment was cut from the
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agarose gel and purified using the QIAquick gel purification system (QIAGEN, Valencia,
CA) with final purified promoter fragments suspended in sterile nuclease free H2O.
Promoter fragments were ligated into a linearized promoterless pAM/-hrGFP-WPRE-
BGH-polyA expression vector.  The linearized vector was generated by restriction
enzyme digest of the pAM/CAG-hrGFP-WPRE-BGH-polyA expression vector using
Asp718 and BamHI restriction enzymes.  Separation and purification of the linearized
pAM/promoterless vector was performed as described above with the final linearized
vector suspended in sterile nuclease free H2O.  The linearized vector underwent further
processing by reacting the vector with shrimp alkaline phosphatase (SAP) (Roche
Applied Science, Indianapolis, IN) under the following conditions in sterile 0.25 mL
reaction tubes (Axygen Scientific, Union City, CA): 50 ng of linearized vector, 1X SAP
buffer, 1 U SAP enzyme, final volume brought to 10 µL using sterile nuclease free H2O.
Reactions were run using a DNA Engine thermal cycler (MJ Research, Waltham, MA)
under the following conditions: 37° C for 10 min, 65° C for 15 min to heat inactivate the
SAP enzyme.  Ligation reactions were set up as a 3:1 molar ratio using the following
calculation:
ng of insert to use = ng of vector  x  size of insert (Kb)  x  molar ratio   3
size of insert (Kb)       1
Based on the molar ratio calculation, ligation reactions were set up as follows in sterile
0.25 mL reaction tubes (Axygen Scientific, Union City, CA): 60 ng insert (hOgg1
promoter fragment), 1X T4 ligation buffer, 1 U T4 DNA ligase (Promega, Madison, WI),
final volume brought to 10 µL using sterile nuclease free H2O.  Ligation reactions were
incubated overnight at 4° C.  Ligation reactions were transformed, amplified and purified
as described above.  Verification of the newly constructed pAM/hOgg1-hrGFP-WPRE-
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BGH-polyA expression vector was performed by restriction digest analysis as described
above.
Construction of the Deletion Vector pAM/hOgg1(Δ -47 – 44)
The Nrf2 deletion plasmid was generated from the pAM/hOgg1-hrGFP-WPRE-
BGH-polyA expression vector (described above) using Stratagene Quick-Change
mutagenesis system (Stratagene, Cedar Creek, TX) and site-specific mutagenesis primers
(see Appendix A, section 4) to generate a new GFP reporter construct.  A four nucleotide
run upstream of the transcription initiation site spanning from position – 47 to – 44 was
deleted from the human Ogg1 promoter and was designated as pAM/hOgg1(Δ -47 - 44).
Mutagenesis reactions were set up using a control reaction and an experimental reaction.
The control reaction is based on the mutagenesis of a non-functional β-galactosidase gene
into a functional one capable of utilizing X-GAL and producing a β-gal+, blue colony
phenotype therefore indicating successful mutation of parental plasmid DNA.  Control
reactions were set up according to manufacturer’s instructions as follows in sterile 0.25
mL reaction tubes (Axygen Scientific, Union City, CA): 1X reaction buffer, 10 ng
pWhitescript 4.5 Kb control plasmid 125 ng control primer # 1, 125 ng control primer #
2, 1 µL dNTP’s, volume brought to 50 µL with sterile nuclease free H2O, and 2.5 U Pfu
Turbo polymerase.  Experimental reactions were set as follows in separate sterile 0.25
mL reaction tubes (Axygen Scientific, Union City, CA):  1X reaction buffer, 25 ng
pAM/hOgg1-hr-GFP-WPRE-BGH-polyA expression vector, 125 ng forward deletion
primer, 125 ng reverse deletion primer, 1 µL dNTP’s, volume brought to 50 µL with
sterile nuclease free H2O and 2.5 U Pfu Turbo polymerase.  Reactions were run using a
DNA Engine thermal cycler (MJ Research, Waltham, MA) under the following
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conditions: [Control rxn, 95° C for 30 sec, **95° C for 30 sec, 55° C for 60 sec, 68° C for
5 min, **repeat amplification cycle 12X]; [Experimental rxn, 95° C for 30 sec, **95° C
for 30 sec, 55° C for 60 sec, 68° C for 5 min, **repeat amplification cycle 16X].
Reactions were placed on ice for 2 min following thermal cycling to cool reactions to 37°
C.  10 U of Dpn I restriction enzyme was added to each reaction and gently mixed and
incubated at 37° C for 60 min to digest parental plasmids.  Reactions were placed on ice
and transformed into XL-1 Blue supercompetent cells (Stratagene, Cedar Creek, TX).
Heat shock transformation of XL-1 Blue cells was performed under the following
conditions: 50 µL XL-1 Blue cells were transferred to a pre-chilled 14 mL Falcon (BD
Biosciences) polypropylene tube on wet ice.  1 µL of Dpn I digested reaction was added
and gently mixed.  Transformations were incubated on ice for 30 min and heat shocked at
42° C for 45 sec.  Transformations were placed on ice for 2 min prior to the addition of
0.5 mL of NYZ+ recovery broth pre-heated to 42° C. Transformations were incubated at
37° C, shaker speed of 225 rpm for 1 hr.  Following incubation, both control and
experimental transformations were plated at volumes of 250 µL on LB ampicillin (100
µg/mL) plates also containing 20 mM IPTG and 80 µg/mL X-GAL.  Mutation efficiency
was calculated based on the percentage of blue colonies present on the control reaction
plate.  Single colonies grown on the experimental plates were selected and grown in
liquid LB ampicillin broth (100 µg/mL).  The pAM/hOgg1(Δ -47 - 44) vectors were
extracted and purified using Mini-prep plasmid DNA purification kits (QIAGEN,
Valencia, CA).  The purified vector underwent restriction digest analysis using Asp718
and BamHI restriction enzymes (Roche Applied Science, Indianapolis, IN) to verify the
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presence of the 2.1 Kb fragment.  Deletion constructs were sequenced by Murdock
Sequencing Facility, University of Montana.
Construction of the Expression Vector pGL3/hOgg1-Luc+
A vector expressing the firefly luciferase enzyme, designated as pGL3/hOgg1-
Luc+, was constructed by ligation of the same 2.1 Kb fragment from the hOgg1 promoter
(described above) into the pGL3-Basic expression vector (Promega, Madison, WI) using
Asp718 and BglII restriction sites.
Mammalian Nrf2 Expression Vectors
Mammalian Nrf2 expression vectors, pEF-Basic and pEF-Nrf2, were kindly
provided by Dr. Jeffrey Johnson (University of Wisconsin School of Pharmacy, Madison,
Wisconsin).
FACS Analysis of GFP Expression
HEK293T cells were transfected using PolyFECT reagent (QIAGEN, Valencia,
CA) as described above.  Four different transfection groups were set up using the
following vectors and one group receiving no plasmid DNA: pAM/CAG-hrGFP-WPRE-
BGH-polyA, pAM/hOgg1-hrGFP-WPRE-BGH-polyA, pAM/hOgg1(Δ -47 - 44).  Cells
were harvested in culture media and centrifuged at 1500 rpm for 5 min at 4° C.  Cells
were washed 1X in cold sterile PBS and centrifuged again at 1500 rpm for 5 min at 4° C.
Final cell suspensions were diluted to 5 x 105 cells/mL and in cold, sterile PBS and
measurement of GFP was performed using a FACS Aria Flow cytometer (BD
Biosciences, San Jose, CA).  Excitation was set at λ = 488nm with an Argon gas laser,
emission was measured at λ = 510 nm using a 530/30 filter set.  Total fluorescence was
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calculated from 10,000 cells per group with final results expressed as the median
population fluorescence.
PCR Verification of GFP Plasmid Transfections
Cultures of HEK 293T cells transfected with GFP expression vectors as described
above were processed for genomic isolation of DNA using a Wizard Genomic DNA
Purification Kit (Promega, Madison, WI).  Extraction procedures were performed by
transferring cell suspensions to 1.5 mL sterile eppendorf tubes and centrifuging at 13,000
rpm, 25° C for ~ 10 sec.  Supernatants were removed and cells were suspended in
residual PBS followed by addition of 600 µL of Nuclei Lysis Solution.  3 µL of 4 mg/mL
RNAse A suspended in10 mM Tris-HCl pH = 7.4, 1 mM EDTA pH = 8.0 (TE) was
added to each sample and mixed by inversion 6X.  Samples were incubated in a 37° C
water bath for 30 min and cooled to 25° C for 5 min.  200  µL of Protein Precipitation
Solution was added to each sample and vortexed for 20 sec.  Samples were incubated on
ice for 5 min and centrifuged at 13,000 rpm, 25° C for 4 min.  Supernatants were
carefully removed and transferred to a new sterile 1.5 mL eppendorf tube.  600 µL of 25
C 2-propanol added to each sample and gently mixed by inversion until white thread like
strands of DNA appeared.  Samples were centrifuged at 13,000 rpm, 25° C for 1 min with
the supernatant carefully removed so as not to disturb the DNA pellet.  600 µL 70%
ethanol was added as a wash step and samples were centrifuged at 13,000 rpm 25° C for
1 min.  Ethanol was carefully removed and sample tubes dried on bench paper for 10 – 15
min or until tubes were absent of ethanol.  100 µL of TE buffer was added to each
sample, mixed well, and rehydrated overnight at 4 C.  Purified DNA was utilized for PCR
of the hrGFP gene as verification of positively transfected cell cultures.  PCR reactions
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were set up as described above using 25 ng total DNA and run using a DNA Engine
thermal cycler (MJ Research, Waltham, MA).
Synthetic Oligonucleotide Radio Labeling
Synthetic oligonucleotide probes containing transcription factor binding sites
were radio-labeled with γ-[32ATP] prior to annealing to a complementary strand
(Integrated DNA Technologies Inc., Coralville, IA).  Reactions were set up under the
following conditions: 39 µL ddH2O, 5 µL 10X T4 kinase buffer, 2 µL (20 pmoles) of
sense strand synthetic oligonucleotide, 3 µL of γ-[32ATP] (7,000 mCi / mmole) (MP
Biomedicals, Solon, OH), 1 µL of T4 polynucleotide kinase (Roche Applied Science,
Indianapolis, IN) to a 500 µL eppendorf tube.  The reaction mixture was mixed well and
incubated at 37° C for 30 min.  Subsequent to incubation, the reaction mixture was added
to a pre-spun G25 sephadex column and allowed to sit for 2 min.  The column was spun
at 5000 rpm for 3 min.  5 µL of labeling buffer was added composed of the following
reagents: 10 mM Tris-HCl, 1 mM EDTA pH = 7.9, 33 mM NaCl, pH = 8.0.  Following
addition of labeling buffer, 2 µL (20 pmoles) of the synthetic complement
oligonucleotide (Integrated DNA Technologies Inc., Coralville, IA) was added.  The
mixture was heated to 95° C in a water bath and allowed to cool to 25° C overnight.  The
radio labeled double stranded probes were stored at –20° C until utilized.  Unlabeled
(cold) double stranded oligonucleotide probes were prepared under the following
conditions at a final concentration of 20 pmoles/µL:  30 µL of labeling buffer, 10 µL
(1000 pmoles) sense strand oligonucleotide, 10 µL (1000 pmoles) of anti sense strand
oligonucleotide.  Annealing reactions were heated to 95° C in a water bath and allowed to
cool to 25° C overnight.
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Nuclear Protein Extraction
Nuclear proteins from cultured HEK 293T cells were extracted according to the
protocol published by Basha et al. (Basha, Wei et al. 2005) with modifications.  Cell
cultures were extracted using sterile PBS containing 1.3% protease inhibitor cocktail
(Roche Applied Science, Indianapolis, IN), transferred to a 15 mL conical vial, and
centrifuged at 125 x g for 6 min.  Samples were washed using 1 mL sterile PBS with
protease inhibitors, transferred to a sterile 1.5 mL eppendorf tube and centrifuged at 125
x g for 5 min.  The wash step was repeated and the PBS supernatant removed following
centrifugation.  Sample pellets were suspended in 250 µL of buffer A containing the
following reagents: 10 mM HEPES buffer pH = 7.9, 1.5 mM MgCl2, 0.5 mM DTT, 0.5
mM EDTA, and 0.2 mM phenylmethanesulfonyl fluoride (PMSF).  Samples were mixed
well and homogenized using a VirSonic Ultrasonic Cell Disruptor 100 (VirTis,
Gardiner, NY) using five consecutive 2 sec bursts on ice.  Following homogenization,
samples were centrifuged at 6000 rpm for 2 min at 4° C with the supernatant carefully
removed.  150 µL of buffer A was added and samples were sonicated and centrifuged.
The supernatant was removed and samples were suspended in 100 µL of buffer C
composed of the following reagents: 20 mM HEPES buffer pH = 7.9, 1.5 mM MgCl2, 0.5
mM DTT, 0.5 mM EDTA, 420 mM NaCl, 20% glycerol, 0.2 mM PMSF, 2 ng/mL
aprotinin, 0.5 ng/mL leupeptin, 6 µL of 6% Triton X-100.  Samples were vortexed and
sonicated for 2 sec on ice.  Final suspensions were centrifuged at 14000 rpm for 10 min at
4° C, snap frozen in liquid N2 and stored at – 80° C until utilized for gel mobility shift
assays.  Total protein values were obtained using the bicinchoninic acid (BCA) protein
determination assay (Pierce, Rockford, IL).
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Electrophoretic Mobility Shift Assay EMSA
Changes in transcription factor binding were performed using the gel
electrophoretic mobility shift assay (EMSA).  Nuclear extracts were collected from
HEK293T cells as described above.  Oligonucleotides containing sequences
corresponding to transcription factor binding sites from the human Ogg1 promoter were
obtained from a commercial source (Integrated DNA Technologies Inc., Coralville, IA):
Consensus Nrf2 binding site, putative hOgg1 Nrf2 binding site, Sp1 Oligo Set 1 (detailed
oligonucleotide sequences can be referenced in Appendix A, Section 2).
Oligonucleotides were 5’ end labeled using [γ-32P] ATP and binding reactions were set
up as follows: 0 to 30 µg of nuclear extract normalized to equal volumes of 20 µL, 0.4
pmoles of labeled probe, 10 µL of binding buffer containing the following reagents: 20%
glycerol, 5 mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 250 mM NaCl, 50 mM Tris-Hcl
pH = 7.5, 0.2 µg/µL poly dI-dC.  Binding reactions were incubated at 25° C for 30 min
and separated on a 6% native polyacrylamide gel composed of the following reagents:
3.42 mL 40% acrylamide/ bis-acrylamide, 2 mL of 10X TBE buffer, 17.16 ddH2O, 210
µL 10% ammonium persulfate, 21 µL N,N,N’,N’-Tetramethylethylenediamine (BioRad).
Gel reagents were mixed and cast into glass gel plates at a volume of 22.5 mL and
allowed to polymerize.  Samples were loaded and run in 0.5X TBE buffer for 2 hr at 200
V to resolve protein-DNA complexes.  Following complex separation, the gel was
removed using a 7 x 9 inch piece of blot paper (Bio-Rad Laboratories, Hercules, CA),
encased in cellophane plastic wrap and placed into an imaging cassette holder (Bio-Rad
Laboratories, Hercules, CA).  An imaging plate (Fuji Film Life Science, Stamford, CT)
was exposed to gels for approximately 30 to 60 min.  Imaging plates were read using a
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FLA-3000 Series Fuji Film Fluorescent Image Analyzer (Fuji Film Life Science,
Stamford, CT) and ImageGauge version 4.22 analysis software (Fuji Photo Film Co.,
LTD, Stamford, CT).
Fluorescent Measurement of Cellular GSH
Assessment of intracellular GSH was measured fluorescently as described
previously (Cox 2007)(Appendix B).  Media containing Hoechst 33342 (Molecular
Probes, Carlsbad, CA, USA) was added to a final concentration of 0.5 µg/mL Hoechst
33342/well and incubated for 30 min at 37° C.  Plates were drained of media and a 40
µM solution of dibromobimane suspended in sterile pre-warmed phosphate buffered
saline was gently added to a final volume of 200 µL/well and incubated at 37° C for 30
min.  Fluorescent measurement was performed using a SPECTRAmax Gemini XS
fluorescent plate reader (Molecular Devices, Sunnyvale, CA).
Dual Luciferase Reporter Gene Assays
HEK293T cells were co-transfected as described above with luciferase expression
plasmids (pGL3-hOgg1-Luc+, pRL-TK-renilla-Luc+), or control plasmid (pGL3-Basic).
Following timed exposures, lysates were collected and measured for firefly and renilla
luciferase activities using the Dual Luciferase Assay (DLR) system (Promega, Madison,
WI).  Individual wells were lysed using 100 µL 1X PLB lysis buffer and rocked for 30
min.  Lysates were collected and stored at – 80° C until utilized.  DLR assays were set up
as follows with all reagents equilibrated to room temperature: 100 µL of LARII firefly
luciferase substrate was added to 20 µL lysate for measurement of firefly luciferase
activity under regulation of the hOgg1 promoter fragment (pGL3-hOGG1).  100 µL of
substrate STOP & GLO reagent was added to assess the reference vector activity (pRL-
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TK-renilla-Luc+).  Endpoint luminescence was measured for both reactions using a
SpectraMAX Gemini XS Micro-plate reader (Molecular Devices, Sunnyvale, CA) with
the following settings: firefly luciferase emission λ = all wavelengths, renilla luciferase
emission λ = 488 nm, PMT setting = Auto, measurement frequency = 10 reads/well.
Values were normalized by the ratio of firefly luciferase activity to renilla luciferase
activity and expressed as percent change from day and time-matched control.
Experimental data was combined from independent experiments collected from
independent days.
Statistical Analysis
One-way ANOVA analysis was used with the students Neuman-Keuls post-hoc
test to evaluate differences between control and experimental groups for changes in GSH
and luciferase activity.  Statistical tests were performed using GraphPad Prism
statistical software (Sorrento, CA) with a p < 0.05 considered statistically significant.
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Results
To evaluate the putative Nrf2 binding site capacity for modulating hOgg1
promoter function, a 2.1 Kb fragment of the hOgg1 promoter fragment was cloned into a
GFP expression vector (pAM/hOgg1-promoter).  Using site-directed mutagenesis, a four
base pair run at position -47 to -44 (TTCC), proposed to be a binding site for Nrf2, was
deleted from that region of the hOgg1 promoter.  Twenty-four hr post-transfection, GFP
expression in the non-specific pAM/CAG control vector and in the pAM/hOgg1-
promoter GFP expression vector was strong, indicating that the cells were functionally
expressing GFP (Figure 7A, top & middle).  However, deletion of four base pairs from
the hOgg1 promoter resulted in a visual attenuation of GFP expression compared to both
the pAM/CAG and pAM/hOgg1-promoter expression vectors (Figure 7A, bottom).  The
reduction in GFP expression was visually equivalent to the no plasmid control cultures









Microscopic analysis of GFP expression in HEK293T cells under the regulation of
different promoters. (A) Non-specific CAG promoter [pAM/CAG-promoter], hOgg1
promoter [pAM/hOgg1-promoter], hOgg1 promoter with the putative Nrf2 binding site
deleted by site-directed mutagenesis, pAM/hOgg1-(Δ-47-44).  (n = 6 per transfection
group).
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The experiment was independently repeated and assessed by flow cytometry revealing
similar results.  Deletion of the putative Nrf2 binding site decreased fluorescence to
levels near the no plasmid control (Figure 7B) consistent with the results seen in Figure
7A.  The results indicate that this area of the hOgg1 promoter is necessary for basal
transcription as indicated by the loss of GFP expression in the absence of the putative





Flow cytometric analysis of GFP expression from the promoters outlined in Figure 7A.
Data is represented as mean ± S.E.M. (n = 6 to 9)  * Denotes significant difference from
no plasmid control fluorescence.  # Denotes significant difference in fluorescence from
experimental vectors pAM/CAG-promoter & pAM/hOgg1-promoter.  P < 0.05.
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To verify transfection efficiencies, PCR was performed on DNA extracts from
HEK 293T cells transfected with the different GFP expression vectors.  This was
performed to verify successful transfection via the presence or absence of the hrGFP
reporter gene.  Figure 7C summarizes the results revealing the absence of DNA
amplification in the no plasmid control cultures (lane 2).  PCR amplification from the
pAM/hOgg1 vector was positive in lanes 3 and 4 that contained stock plasmid DNA and
extracted pAM/hOgg1 vector DNA respectively.  Lanes 5 and 6 also had positive PCR
amplification from the pAM/hOgg1-(Δ-47-44) stock and extracted cellular DNA






PCR verification of the presence of the hrGFP gene from transfected HEK293T cultures
(n = 2 per transfection group).  PCR reactions from 25 ng DNA of transfected cultures:
Lane 1 DNA size ladder, Lane 2 no plasmid control, Lane 3 stock pAM/hOgg1 vector
DNA, Lane 4 DNA extracted from pAM/hOgg1 transfected cultures, Lane 5 stock
pAM/hOgg1-(Δ-47-44) vector, Lane 6 DNA extracted from pAM/hOgg1-(Δ-47-44)
transfected cultures.
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            Gel mobility shift assays have been successfully used to identify protein
interaction with specific sequences of DNA.  To evaluate protein interaction with the
reported putative Nrf2 site in the hOgg1 promoter, nuclear extracts from untreated and
tBHQ treated HEK 293T cells were incubated with γ-32P labeled, double stranded
oligonucleotides containing a 25 base pair span of the hOgg1 promoter (H-Nrf2)
containing the sequence that could serve as a Nrf2 binding site.  As shown in figure 8A,
untreated nuclear extracts incubated with the labeled hOgg1 probe produced a shifted
band whose density increased with increasing amounts of total protein (Left Panel).  This
band intensity decreased with co-incubation of an equivalent amount of unlabeled (cold)
hOgg1 probe indicating specificity for protein interaction with that sequence of the
hOgg1 promoter (Left Panel).  Figure 8A also demonstrates that incubation with the
consensus Nrf2 probe yields a band that shifts to an equivalent distance as the hOgg1-
Nrf2 shifts, and yields an increase in density with increasing amounts of total protein
(Right Panel).
Nrf2 has been shown to activate and translocate to the nucleus upon addition of
inducing compounds including tert-butylhydroquinone (tBHQ).  This leads to an increase
in the nuclear levels of Nrf2 (Lee, Moehlenkamp et al. 2001; Hansen, Watson et al.
2004).  Nuclear extracts from HEK 293T cells exposed to 25 µM tBHQ for 6 hr resulted
in increased binding that remained constant at 10 and 20 µg total protein when compared
to untreated control bands (Figures 8A Middle Panel).  This is further summarized in
Figure 8C by the representative bar plot.  The intensity of the band produced with 20 µg
of protein from the tBHQ treated cells had an equivalent density as the band produced at
30 µg protein from untreated cells (Figure 8C).  The increase in binding seen with tBHQ
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exposure is expected considering tBHQ increases nuclear levels of Nrf2 via activation
and translocation of the transcription factor subsequent to tBHQ exposure (Lee,
Moehlenkamp et al. 2001).  It also demonstrates that binding to the putative Nrf2 site of
the hOgg1 promoter is also increased by tBHQ treatment as evidenced in Figure 8A




              
        







EMSA binding analysis of the putative Nrf2 binding site in the hOgg1 promoter.  EMSA
was performed using γ-32P labeled, double stranded oligonucleotide probes containing the
putative Nrf2 binding site from the hOgg1 promoter.  Arrows point to Nrf2 shifted bands
and unbound probe.
(A) Binding reactions using nuclear extract from untreated HEK293T cells over a protein
range of 0 to 30 µg total protein incubated with labeled hOgg1-Nrf2 or consensus Nrf2
probe (Left & Right Panels).  Addition of 2X unlabeled (cold) hOgg1-Nrf2 probe to 30
µg of total protein (indicated by 30*) outcompetes the labeled (hot) hOgg1 probe for
binding (Left Panel).  Binding reactions using nuclear extracts from HEK293T cells
treated for 6 hr with the Nrf2 inducing compound tBHQ (25 µM) (Middle Panel).
(B) Representative plot of relative band densities from EMSA reactions in Figure 8A
with increasing amounts of total protein from untreated HEK 293T cells (representing
Figure 8A Left & Right Panels).
(C) Representative plot of relative band densities from EMSA reactions in Figure 8A
using nuclear extracts from untreated HEK293T cells, and cells treated for 6 hr with 25
µM of the Nrf2 inducing compound tBHQ (representing Figure 8A Left & Middle
Panels).
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In order to determine the binding specificity of the putative Nrf2 recognition
sequence with nuclear protein, cross-competition EMSA analysis was done against the
consensus sequence for Nrf2.  As seen in Figure 9A the consensus Nrf2 probe (C-Nrf2)
shifts to an equivalent migration distance as the hOgg1 probe (H-Nrf2) similar to the data
in Figure 8.  Cross competition experiments were also performed to determine binding
specificity for both consensus Nrf2 and hOgg1-shifted bands.  Co-incubation of labeled
consensus Nrf2 probe with unlabeled hOgg1 probe outcompetes protein interaction with
the consensus Nrf2 probe.  Similarly co-incubation of the hOgg1 probe with unlabeled
consensus Nrf2 probe outcompetes binding with the hOgg1 fragment suggesting the
protein binding to the hOgg1 promoter can bind to a consensus Nrf2 sequence with an
equivalent specificity.  It is worth noting that although there are two other bands present
in the hOgg1-Nrf2 binding reactions, those bands are not outcompeted by the presence of
unlabeled consensus Nrf2 probe (Figure 9A).
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FIGURE 9A
        Left Panel Right Panel
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Figure 9A
Competitive binding analysis of the putative Nrf2 site in the hOgg1 promoter.
Competition EMSA were performed using 30 µg nuclear extracts from untreated
HEK293T cells, and γ-32P labeled probes containing the consensus (C-Nrf2) and putative
hOgg1 Nrf2 binding site (H-Nrf2).  Arrows point to the Nrf2 shifted band and unbound
probe.  Left Panel: Labeled consensus Nrf2 was co-incubated with 100X unlabeled
hOgg1-Nrf2 probe (indicated by C-Nrf2 + Cold H-Nrf2).  Right Panel: Labeled hOgg1-
Nrf2 was co-incubated with 100X unlabeled C-Nrf2 probe (indicated by H-Nrf2 + Cold
C-Nrf2).
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To assess the specificity for binding on the consensus Nrf2 probe, competition EMSA
was performed using a radiolabeled probe containing a binding sequence for Sp1
transcription factor (Figure 9B).  Co-incubation of unlabeled (cold) consensus Nrf2 probe
with labeled probe containing an Sp1 binding sequence derived from the hOgg1 promoter
shows that the unlabeled consensus Nrf2 probe has no effect on Sp1 binding (Figure 9B).
Furthermore co-incubation of an unlabeled different Sp1 probe disrupts interaction with
the hOgg1 Sp1 probe.  These findings reaffirm that binding is similar between the
consensus Nrf2 and hOgg1 fragments, and also shows that the consensus Nrf2 binding





Competitive protein binding analysis of the putative Nrf2 site in the hOgg1 promoter.
Competition EMSA were performed using γ-32P labeled, double stranded oligonucleotide
probes containing an Sp1 binding site from the hOgg1 promoter and the consensus Nrf2
(C-Nrf2) binding site.  The Sp1 shifted bands are indicated by the bracket and unbound
probe by the arrow.  Additional competition EMSA showing displacement of Sp1
binding by unlabeled Sp1 probe (H-Sp1 + Cold Sp1) but not unlabeled consensus Nrf2
probe (H-Sp1 + Cold C-Nrf2).
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It has been established that changes in the redox state of the cell lead to changes
in the transcription of genes regulated by the transcription factor Nrf2.  To test the role of
Nrf2 in the transcriptional regulation of hOgg1 in relation to levels of GSH, the 2.1 Kb
fragment of the hOgg1 promoter was cloned into a firefly luciferase expression vector
and transcriptional changes were assessed using known Nrf2 inducing compounds; tBHQ
and DEM (Lee, Moehlenkamp et al. 2001).  As a surrogate measure of antioxidant
response, levels of GSH were also measured in parallel with each dual luciferase reporter
(DLR) assay (Figures 10 through 13).  Figure 10 summarizes the changes in GSH and
hOgg1 transcriptional activity associated with treatment of 25 µM tBHQ for 24 hr.  As
shown in Figure 10A tBHQ increases GSH after a 24 hr exposure indicative of an Nrf2
mediated change.  The activity of hOgg1 transcription (luciferase activity) yielded similar
results with an increase in luciferase activity at 24 hr compared to untreated controls
(Figure 10B).  Serving as transfection control, the promoterless, pGL-Basic vector








Analysis of GSH levels and modulation of the hOgg1 promoter in HEK293T cells treated
for 24 hr with 25 µM tBHQ.  (A) Levels of GSH are reported as percent of untreated
control values assessed by changes in dibromobimane fluorescence.  Data is represented
as mean ± S.E.M.  (n = 30).  * Denotes significant difference from control GSH values.
P < 0.05.
 (B) Transcriptional modulation of the hOgg1 promoter by tBHQ assessed by
measurement of dual luciferase enzymes.  Final values were calculated by normalization
to Renilla luciferase activity and expressed as percent of untreated control.  Data is
represented as mean ± S.E.M. (n = 5 - 10).  * Denotes significant difference from day and
time-matched control luciferase activity, P < 0.05.
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To further investigate modulation of Ogg1, a different, known Nrf2 inducing
compound, DEM (Lee, Moehlenkamp et al. 2001; Kaur, Kalia et al. 2006), was used to
determine changes in GSH and hOgg1 transcription activity in HEK 293T cells.  Figure
11A demonstrates that at 18 hr, a dose of 25 µM DEM caused no change in GSH when
compared to untreated controls while at 24 hr there was a significant increase in GSH
(Figure 11A).  The transcriptional activity of hOgg1 yielded similar results to the levels
of GSH with no change in luciferase activities occurring at 18 hr, and a significant
increase at 24 hr of DEM exposure relative to the untreated control and 18 hr treatment
groups (Figure 11B).  Serving as transfection control, the promoterless pGL-Basic vector
yielded values less than 5% of luciferase activities in both untreated and DEM treated
cultures (Figure 11B).  This pattern of induction of hOgg1 promoter activity by exposure
to Nrf2 inducing compounds is similar to previous work looking at other Nrf2 regulated
genes; including the induction of NQO1 by tBHQ (Lee, Moehlenkamp et al. 2001), and
the induction of GCL, and MnSOD by DEM (Kaur, Kalia et al. 2006).  These findings
suggest that modulation of hOgg1 transcription is sensitive to intracellular levels of GSH








Analysis of GSH levels and modulation of the hOgg1 promoter in HEK293T cells treated
for 18 and 24 hr with 25 µM DEM.  (A) Levels of GSH are reported as percent of
untreated control values assessed by changes in dibromobimane fluorescence.  Data is
represented as mean ± S.E.M. (n = 6).  * Denotes significant difference from control
GSH values.  # Denotes significant difference from 18 hr exposure group. P < 0.05.
 (B) Transcriptional modulation of the hOgg1 promoter by DEM assessed by
measurement of dual luciferase enzymes.  Final values were calculated by normalization
to Renilla luciferase activity and expressed as percent of untreated control values.  Data is
represented as mean ± S.E.M. (n = 5 - 16).  * Denotes significant difference from control
luciferase activity.  # Denotes significant difference from 18 hr exposure group.  P <
0.05.
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Both tBHQ and DEM are known inducers of Nrf2, however mechanistically it is
reported that their mode of induction differs (Lee, Moehlenkamp et al. 2001).  Activation
of Nrf2 by DEM is a process more dependent on cellular oxidative stress initially
facilitated by a reduction in GSH; a reduction that recovers via activation of Nrf2, and
expression of genes involved in synthesis and homeostasis of cellular GSH.  The redox-
mediated modulation of hOgg1 transcriptional activity was tested by administration of
the GSH derivative glutathione monoethyl ester (GSH-mee); ultimately shifting the
cellular environment to a more reductive state.  As shown in Figure 12A, levels of GSH
were increased as early as 1 hr post-administration of 1 and 2 mM GSH-mee.  At the 1
mM dose, levels of GSH remained increased until 18 hr where they returned close to
control levels and remained at that level at 24 hr.  The 2 mM dose was still elevated at 18
hrs and did not return to control levels until 24 hr (Figure 12A).  Figure 12 B and C
represent the 18 and 24 hr time points shown in Figure 12A expressed as percent of
control GSH.  Considering the early time points (Figure 12A), the levels of GSH were
increased significantly for a substantial period of time (> 12 hr), creating a shift in the
cellular redox environment to a more reductive state.
Promoter activity was subsequently assessed at the 18 and 24 hr time points to
determine what effects 1 and 2 mM GSH-mee have on modulation of hOgg1
transcriptional activity.  Figure 12C shows that at 18 hr, both 1 and 2 mM GSH-mee
modulate hOgg1 transcriptional activity in a negative manner by decreasing
transcriptional activity.  The reduction in hOgg1promoter activity recovers by 24 hr
suggesting that modulation of the hOgg1 promoter by GSH is a temporal event.  It also
suggests an Nrf2 dependent mechanism as others have shown that administration of
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reducing agents can attenuate the induction of Nrf2 (Lee, Moehlenkamp et al. 2001; Kim,
Hu et al. 2003) keeping it bound and sequestered in the cytosol by its inhibitory protein







Analysis of GSH levels in HEK293T cells treated for 0 to 24 hr with 1 and 2 mM GSH-
mee assessed by changes in dibromobimane fluorescence.
(A).  Levels of GSH are reported as the level of dibromobimane fluorescence normalized
to Hoechst 33342 fluorescence.  Data is represented as mean ± S.E.M.  (n = 5 - 6).  *
Denotes significant difference from control GSH values.  # Denotes significant difference
from 18 hr exposure group.  P < 0.05.
(B) Analysis of GSH levels in HEK293T cells treated for 18 and 24 hr with 1 and 2 mM
GSH-mee assessed by changes in dibromobimane fluorescence.  Levels of GSH are
reported as percent of untreated control values assessed by changes in dibromobimane
fluorescence.  Data is represented as mean ± S.E.M.  (n = 5 - 6).  * Denotes significant
difference from control GSH values.  # Denotes significant difference from 18 hr






(C) Transcriptional modulation of the hOgg1 promoter by 1 and 2 mM GSH-mee
assessed by measurement of dual luciferase enzymes.  Final values were calculated by
normalization to Renilla luciferase activity and expressed as percent of untreated control
values.  Data is represented as mean ± S.E.M. (n = 5 - 16)  * Denotes significant
difference from day and time matched control luciferase activity.  P < 0.05.
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These results support the notion that hOgg1 transcriptional regulation can occur
similar to Nrf2 regulated genes by the presence of tBHQ and DEM (Figures 10 and 11B).
They also show that an increased level of cellular GSH attenuates hOgg1 transcriptional
activity (Figure 12C).  To directly test the influence of Nrf2 in GSH mediated regulation
of hOgg1 transcriptional activity, the addition of a mammalian Nrf2 expression vector
was done in tandem with the DLR vectors.  Figure 13 demonstrates that in the presence
of empty control vector (pEF-Basic) and 1 mM GSH-mee for 18 hr, hOgg1-regulated
luciferase activity is decreased when compared to untreated controls; results similar to
those in Figure 12C.  However, the addition of an additional vector expressing Nrf2
(pEF-Nrf2) showed no change from control in the presence of 1 mM GSH-mee for 18 hr.
This suggests that over expression of Nrf2 was sufficient to recover the down modulation
of hOgg1 transcriptional activity by 1 mM GSH-mee (Figures 12C and 13) supporting





Analysis of Nrf2 overexpression on modulation of hOgg1 promoter activity.  HEK293T
cells co-transfected with control vector (pEF-Basic) or an Nrf2 expression vector (pEF-
Nrf2) were treated with 1 mM GSH-mee for 18 hr.  Transcriptional modulation of the
hOgg1 promoter was assessed by measurement of dual luciferase enzymes.  Final values
were calculated by normalization to Renilla luciferase activity and expressed as percent
of untreated time and vector matched control.  Data is represented as mean ± S.E.M.  (n =
8 - 10).  * Denotes significant difference from day and time-matched control luciferase
activity.  # Denotes significant difference from the control vector (pEF-Basic) GSH-mee
exposed group. P < 0.05.
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Conclusions
A four base pair run (TTCC) located at positions – 47 to – 44 in the hOgg1
promoter is essential for basal transcription of hOgg1-regulated GFP expression as
determined by site-directed deletion and subsequent loss of GFP reporter gene
expression.  This region of the hOgg1 promoter is also capable of interacting with nuclear
proteins from HEK293T cells as determined by electrophoretic gel mobility shift assays.
In addition parallel-binding experiments using consensus Nrf2 oligonucleotides produced
an equally shifted band as the hOgg1-Nrf2 experimental oligonucleotide.  Further
investigation into binding specificity suggests the involvement of the transcription factor
Nrf2 as determined by competition experiments using consensus Nrf2, and Sp1
oligonucleotides.  The transcriptional regulation of hOgg1 is sensitive to cell redox status
as established by changes in both hOgg1-regulated luciferase activities and intracellular
GSH in HEK293T cells exposed to the GSH modulating compounds tBHQ, DEM
(increased transcription) and GSH-mee (decreased transcription).  In addition, both
increases and decreases in hOgg1 transcriptional activity were mediated temporally
demonstrating changes characteristic of an acute stress response.  Nrf2 over expression
was able to counteract decreased hOgg1 transcriptional activity produced by GSH-mee
again suggesting a role for Nrf2.  In conclusion the transcription factor Nrf2 is important
in the inducible regulation of Ogg1 and these changes are dependent on the redox status
of the cell via modulation of intracellular GSH.
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CHAPTER THREE
Effects of Sodium Arsenite on 8-hydroxy-2’-deoxyguanosine DNA Glycosylase
Transcription and Activity
ABSTRACT
Arsenic (As) is a naturally occurring element found widely distributed in the
environment.  Arsenic is also considered an environmental toxin and has been associated
with a myriad of adverse health effects.  This statement is firmly supported by the high
prevalence of health issues in areas of the world with high levels of arsenic in their
drinking water.  Exposure to arsenic has also been associated with oxidative stress and
damage to DNA; specifically oxo8dG.  This study identified dramatic increases in the
cellular antioxidant GSH, and varied changes in SOD activities subsequent to arsenite
exposure in actively dividing and NGF treated PC12 cells.  Assessment of Ogg1 activity
and Ogg1 mRNA levels demonstrated a significant decrease for both subsequent to
arsenite exposure.  Further testing revealed no direct effect by arsenite on Ogg1 activity.
Levels of oxo8dG did not significantly change subsequent to arsenite exposure however
increased trends were evident.  Characterization of Sp1 binding revealed that treatment
with sodium arsenite could decrease Sp1 binding at two unique Sp1 sites in the human
Ogg1 promoter.  We conclude that sodium arsenite can disrupt both the transcription and
activity of Ogg1 in PC12 cells.  This occurred despite the induction of cellular stress
response via increases in GSH and Mn SOD activity.
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INTRODUCTION
Arsenic and the Environment
Arsenic (As) is a naturally occurring element found widely distributed in both
organic and inorganic forms.  Inorganic arsenic is found environmentally in two main
oxidation states; pentavalent arsenate As (V) and trivalent arsenite As (III) forms.  The
majority of environmental exposures to arsenic occur through drinking water, however to
a lesser extent exposure can also occur via dietary consumption.  An FDA study reported
the average adult has a daily intake of 53 µg, 20% being in the inorganic forms (Brown
and Ross 2002).
Occupational exposure to arsenic also occurs mainly via inhalation from smelting
processes, and power plant combustion of fossil fuels.  Arsenic contamination of soils
and groundwater can also occur as a consequence of other anthropogenic activities such
as mineral extraction, waste processing, and pesticides (Bates, Smith et al. 1992).
Despite the numerous anthropogenic sources, most arsenic related health effects
occur from exposure to natural sources, mainly through drinking water.  Epidemiological
studies identify unique locations associated with arsenic related health effects.  For
example, in countries such as India, Bangladesh, and Taiwan arsenic levels in drinking
water are found in high concentrations.  In some of these countries drinking water levels
can range from 10 to as high as 1000 part per billion (ppb) depending on the geographical
region (Rahman, Tondel et al. 1999; Berg, Tran et al. 2001; Nordstrom 2002; Pi,
Yamauchi et al. 2002).  In some rural areas of the United States, levels of arsenic in
drinking water can reach between 50 to 100 ppb (Lewis, Southwick et al. 1999);
concentrations well above the maximum contaminant level of 10 ppb set by the EPA in
2001.  The prevalence of high drinking water levels of arsenic in distinct geographical
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regions reveals a dire need for determining the significance of arsenic-related health
effects.
Epidemiologic Evidence of Arsenic-related Health Effects
Numerous adverse health effects have been associated with arsenic exposure in
both dose and time-dependent relationships.  Epidemiologic studies have examined areas
of the world identified with high levels of arsenic in drinking water to assess this
relationship.  Studies looking at dose-response relationships have demonstrated increased
mortality rate ratios in populations as a function of increasing water arsenic levels.  This
was demonstrated in the Taiwanese general population in relation to various organ
cancers (Bates, Smith et al. 1992).  Increased mortality rates associated with various
cardiovascular diseases were demonstrated in a study identifying U.S. based populations
exposed to more moderate levels of arsenic in drinking water (~5 to 100 ppb) (Engel and
Smith 1994).  A study in Bangladesh suggested a dose-response relationship between
arsenic exposure levels and hypertension based on populations exposed to well water
arsenic ranging in concentrations of ~10 to 1000 ppb (Rahman, Tondel et al. 1999).
In addition to dose-response studies, exposure duration of arsenic has been
investigated as a factor of arsenic-mediated health effects.  Chronic arsenic exposure was
assessed in three villages located in southwestern Taiwan.  The study concluded that
residents were at greater risk for ischemic heart disease when exposed to arsenic for
longer periods of time (Huang, Tseng et al. 2007).
Cumulatively, the epidemiologic evidence suggests a stronger incidence of
adverse health effects in populations exposed to significant levels of arsenic in their
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drinking water.  These studies also reinforce the concept that both level and duration of
arsenic exposure are relevant factors in the corresponding health effects.
Arsenic Uptake and Metabolism
Many of the mechanisms regarding uptake and distribution of inorganic arsenic
are still uncertain, however some distinct cellular components have been identified in the
aforementioned processes.  The inorganic forms are the main arsenic species facilitating
human exposure.  Both As (V) and As (III) are capable of uptake and distribution in
mammalian cells.  As (V) has been shown to enter cells via cellular phosphate carrier
systems.  As (III) was initially thought to enter cells by passive diffusion.  However,
recent evidence implicates an active transport mechanism responsible for arsenite uptake
in mammalian cells (Liu, Shen et al. 2002; Aposhian, Zakharyan et al. 2004).
The metabolism for arsenic is a multi-step, multi-enzyme process.  Figure 14
outlines the most current metabolic pathways for arsenic metabolism.  Arsenate is
reduced to the more toxic inorganic form arsenite, by the enzymatic activity of arsenate
reductase (Figure 14, Reaction 1) by utilization of sulfhydryl groups on lipoic acid as one
source of electrons.  Further conversion can occur via arsenite methyltransferase by the
addition of methyl groups to produce different organic forms of arsenate (MMA V, and
DMA V) containing either one or two methyl groups (Reactions 2 & 4).  The methyl
donor for these reactions has been identified as S-adenosylmethionine.  Methylated
arsenic species can undergo further reduction via the enzymatic activity of MMAV and
DMAV reductase producing methylated arsenite compounds (MMA III, and DMA III).
The antioxidant GSH can serve as an electron donor in these reactions and is rate limiting
in the production of MMA III (Reactions 3 & 5).
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FIGURE 14
Adapted from (Wallace 1998; Aposhian, Zakharyan et al. 2004)
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FIGURE 14
Metabolic pathways identifying the reduction and methylation that inorganic arsenic
compounds undergo in mammalian systems.  Reactions 1, 3, and 5 identify arsenic
reduction reactions reliant on sulfhydryl groups as the electron source.  Reactions 2 and 4
identify reactions facilitating the addition of methyl groups reliant on S-
adenosylmethionine.  Metabolic transformation is performed via enzymatic activities.
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All six different metabolites have been identified in humans.  The presence of such a
diverse number of arsenic metabolites is a large confounder when studying arsenic
toxicity because each form has been shown to be toxic to mammalian cells (Aposhian,
Zakharyan et al. 2004).  The non-methylated forms of arsenic (As V, and As III) are
considered more cytotoxic while the methylated forms considered more genotoxic (MMA
DMA V, and MMA DMA III), (Wanibuchi, Salim et al. 2004).
Arsenic and Oxidative Damage to DNA
Epidemiological studies and evidence from animal exposures indicate that
exposure to inorganic arsenic increases the risk of cancer in different organs including the
lungs, kidneys and skin (Bates, Smith et al. 1992; Germolec, Spalding et al. 1998;
Wanibuchi, Salim et al. 2004; Mo, Xia et al. 2006).  Despite the high association between
arsenic exposure and cancer risk a clear cellular mechanism for arsenic induced
carcinogenesis has not been identified.  One mechanism proposed for arsenic-mediated
toxicity and its role in carcinogenesis is the overproduction of free radicals.  ROS-
mediated cellular damage from arsenic has been demonstrated in studies of arsenic
exposure in both acute and chronic conditions.  Acute exposures at low micro-molar
levels of As(III) have been shown to increase different ROS including superoxide anion,
hydrogen peroxide, peroxynitrite, and hydroxyl radical (Barchowsky, Klei et al. 1999;
Barchowsky, Roussel et al. 1999; Liu and Jan 2000; Bunderson, Brooks et al. 2004).
Increased superoxide anion production was attributed largely to increased activity of
NADPH oxidase of which superoxide is a product of enzymatic activity (Smith, Klei et
al. 2001).  As discussed in Chapter 1, superoxide can be converted to hydrogen peroxide
via SOD activity.  Superoxide can also react with nitric oxide and form peroxynitrite, a
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free radical compound capable of nitrating tyrosine residues of proteins (Beckman and
Koppenol 1996).  Hydrogen peroxide, also shown to be elevated after arsenic exposure,
can participate as a substrate in the Fenton reaction producing hydroxyl radical.  This
demonstrates multiple ways that an overproduction of superoxide can lead to the
formation of more harmful free radicals.  Increased oxidative stress has been
demonstrated in a study looking at the effects of chronic arsenic exposure in humans.
The results showed correlations between increased lipid peroxidation and the levels of
arsenic in serum and whole blood.  It was also shown that chronic exposure resulted in
decreased levels of the antioxidant GSH measured in whole blood (Pi, Yamauchi et al.
2002).  Additional support for free radical mediated toxicity has been gathered from
studies demonstrating that the administration of antioxidants compounds such as ascorbic
acid, α-tocopherol, and N-acetylcysteine can reduce arsenic toxicity in both acute and
chronic models of exposure (Flora 1999; Ramanathan, Balakumar et al. 2002).
The interaction of arsenic-induced ROS with DNA has been reported to generate
DNA protein cross-links and oxidative lesions including oxo8dG (Yamanaka,
Takabayashi et al. 2001; Bau, Wang et al. 2002; Pu, Jan et al. 2007).  Oxo8dG has also
been reported as pro-mutagenic due to the tendency to pair with adenine over cytosine
during DNA replication, a process that can facilitate GC to TA transversions (Figure 15)






Molecular pathway for GC to TA transversions.  Initial oxidation of guanine forms
oxo8dG paired with cytosine.  In the absence of oxo8dG removal, DNA polymerase pairs
adenine with oxo8dG during replication.  An additional round of replication incorporates
thymine with adenine completing the transversion.
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It is worth noting that increased GC to TA transversions can precede cellular
transformation, and this type of genetic mutation has been identified in the p53 tumor
suppressor gene of human cancers (Hollstein, Sidransky et al. 1991; Yu, Berlin et al.
2002).
Whether arsenic exposure mediates cancer by this mechanism is unresolved,
however increased levels of oxo8dG have been demonstrated subsequent to arsenic
exposure.  A study examining skin samples from patients diagnosed with arsenic-related
Bowen’s carcinoma showed increased levels of oxo8dG suggesting arsenic as the
causative agent (Matsui, Nishigori et al. 1999).  Increased damage was also seen in mice
exposed to arsenic by demonstrating increased levels of oxo8dG in target organs
associated with arsenic induced carcinogenesis; lungs, liver, kidney, bladder and skin
(Yamanaka, Takabayashi et al. 2001).  Additional evidence has been collected from
genetic models deficient in repair of oxo8dG.  In Ogg1 null mice chronically exposed to
arsenic in drinking water, examination of the liver revealed elevated levels of oxo8dG in
conjunction with increased tumor development in the liver, lungs and lymph nodes when
compared to both wild type and heterozygous littermates (Wanibuchi, Salim et al. 2004).
These reports present a strong association between exposure to arsenic and increased
levels of oxo8dG.  In addition these reports present evidence that increased DNA damage
is a process associated with the carcinogenic process.  However, by not defining a clear
role for oxo8dG in the carcinogenic process, only presents the data in a descriptive
fashion.  The most compelling evidence for the role of oxo8dG in carcinogenesis is from
studies utilizing the Ogg1 null model that suggests a decreased capacity to repair oxo8dG
may facilitate carcinogenic processes.
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Cells have evolved mechanisms to compensate for oxidative damage to DNA by
repairing damaged nucleotides.  Oxo8dG is removed from DNA by the BER pathway
carried out by the specific DNA-glycosylase Ogg1 (Boiteux and Radicella 2000).  Ogg1
is constitutively expressed (Dhenaut, Boiteux et al. 2000) and it is the main enzyme
involved in initiating the repair of oxo8dG (Klungland, Rosewell et al. 1999; Minowa,
Arai et al. 2000; de Souza-Pinto, Eide et al. 2001).  Studies have shown a modulation of
Ogg1 in response to oxidative stress from various sources (Table 1).  In rats exposed to
diesel exhaust particles, both Ogg1 activity and mRNA were decreased in lung tissue
post-exposure (Tsurudome, Hirano et al. 1999).  Studies using cadmium chloride, another
carcinogenic metal, have shown effects on Ogg1 transcription and activity.  In vitro
experiments using purified enzyme extracts of murine Ogg1 showed decreased enzyme
activity in the presence of cadmium (Zharkov and Rosenquist 2002).  It was also
demonstrated in rat lung that cadmium chloride decreased the levels of Ogg1 mRNA
(Potts, Watkin et al. 2003).  Exposure of cadmium has also shown to negatively effect
human Ogg1 activity and transcription suggesting the existence of a conserved
mechanism among different species for down regulation of Ogg1 (Youn, Kim et al.
2005).  Arsenic however, has not been described as having any distinct effect on Ogg1
activity, however changes in Ogg1 mRNA levels from whole blood has been linked to an
increased risk of skin hyperkeratosis in males chronically exposed to well water arsenic
(Mo, Xia et al. 2006).
Whether changes in oxo8dG subsequent to arsenic exposure are related to changes
in DNA repair capacity remains uncharacterized, however studies have shown an inverse
relationship between Ogg1 activity and levels of oxo8dG (Cardozo-Pelaez, Brooks et al.
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2000; Cardozo-Pelaez, Stedeford et al. 2002) suggesting that increased levels oxo8dG can
be a result of attenuated DNA Ogg1 capacity.  Based on the similarities between
cadmium and arsenic (oxidative stress, oxo8dG, carcinogenesis), and the data showing
down regulation of Ogg1 transcription by cadmium, the effect that arsenic exposure has
on transcriptional regulation of Ogg1 is a likely venue of investigation.
The goal of these experiments was to test the hypothesis that increased levels of oxo8dG
induced by an acute exposure to sodium arsenite are a result of changes in antioxidant
and Ogg1 response capacity.  To test the hypothesis the following objectives were
designed:
1)  Characterize the dose-response to sodium arsenite via measurement of cell
viability in PC12 cells.
2)  Characterize changes in antioxidant systems via measurement of intracellular
GSH and Cu/Zn, Mn SOD activities in PC12 cells subsequent to sodium arsenite
exposure.
3)  Characterize changes in Ogg1 transcription and activity, and levels of oxo8dG in
PC12 cells subsequent to sodium arsenite exposure.
An additional goal of these experiments was to elucidate differential effects in
antioxidant and DNA repair capacity between non-NGF, and NGF treated PC12 cells.





All chemicals and reagents were obtained from Sigma Aldrich, (St Louis, MO)
unless otherwise indicated.
Preparation of arsenite-treated samples
PC12 rat pheochromocytoma cells obtained from American Type Culture
Collection (ATCC # CRL-1721) were grown in 1X RPMI 1640 media containing 5%
fetal bovine serum, 10% horse serum, 2 mM L-glutamine, 1mM sodium pyruvate, 25
U/mL penicillin G / streptomycin; all media reagents were obtained from CellGRO
Technologies (MediaTech, Herndon, VA).  Cells were plated on 100 mm costar tissue
culture dishes coated (Corning Life Sciences, Lowell, MA) with 0.05 mg/mL collagen
from calfskin and incubated at 37° C in a humidified 5% CO2 atmosphere.  Cells were
grown in normal growth media until approximately 80 - 90% confluent.  Normal growth
media was removed at this point and plates divided into two groups either receiving
normal growth media, or growth media supplemented with NGF at a final concentration
of 50 ng/mL.  The NGF treated group was allowed to incubate until a differentiated
phenotype was observed as assessed by conversion from round to polygonal morphology,
and process extension.  Media was replaced under the following conditions: Control
groups received normal or NGF supplemented growth media, exposure groups received
normal or NGF supplemented growth media containing sodium arsenite at a final
concentration of 10 µM.  Cultures were harvested and processed at 24 hr post sodium
arsenite exposure.
Cell samples were harvested and washed 2X with 5 mL sterile PBS, with a
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subsequent 1 mL wash in 10 mM EDTA, pH 7.0.  Cells were sonicated in 300 µL of 10
mM EDTA, pH 7.0 using a VirTis VirSonic Ultrasonic Cell Disruptor 100 (VirTis,
Gardiner, NY).  Following centrifugation at 14,000 rpm, 4° C for 15 min, supernatants
were divided for GSH and SOD activity analysis.  Aliquots for GSH were analyzed the
same day while aliquots for SOD, and remaining cell pellets were stored at - 80° C until
subsequent analysis and extractions were performed. Protein concentration in each
cytosolic extract was determined using a Bio-Rad Protein Assay Kit (Bio-Rad
Laboratories, Hercules, CA).
Cell Viability Assays
Cell viabilities were determined using an LDH Cytotoxicity Detection kit
according to manufacturer’s protocols (Roche Applied Science, Indianapolis, IN).  The
assay measures the activity of lactate dehydrogenase released from the cytosol of
damaged cells into the media.  Briefly, PC12 cells were seated at a density of 3 x 104
cells / well in collagen-coated 96-well costar plates (Corning Life Sciences, Lowell, MA)
using normal or 50 ng/mL NGF supplemented growth media at a final volume of 300 µL.
Cells were grown overnight and washed 2X the following day with fresh media.
Following wash protocols a subsequent replacement of 300 µL of regular, or NGF
supplemented growth media was performed.  Actively dividing and NGF treated PC12
cells were then exposed to either untreated or 10 µM sodium arsenite treated media with
one cell group exposed to 2 % Triton-X as a positive control.  24 hr later, 100 µL of
media was removed from each well and placed into a new 96-well plate.  100 µL of a
reaction mixture containing manufacturer catalyst, Diaphorase/NAD+, iodotetrazolium
chloride, and sodium lactate was prepared fresh and added to each well and incubated at
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15 - 25° C for 30 min in the absence of light.  Absorbance was measured at λ 490 – 492
nm with a reference wavelength of λ 600 nm using a SpectraMax© 340 96-well plate
reader (Molecular Devices, Sunnyvale, CA) and quantified using SOFTmax PRO
software (Molecular Devices, Sunnyvale, CA).  Percent of cell viability relative to
control was calculated using the following formula with values defined as such:
Equation 1  Value = (measured O.D. – average blank O.D.)
Equation 2 % Cytotoxicity = (experimental value – untreated ctrl value)   x 100
                                (Triton ctrl value – untreated ctrl value)
Quantification of Total Reduced GSH
Protein was precipitated from cytosolic extracts (see above) using 6.5 %
sulfosalicylic acid (SSA) centrifuged at 10,000 rpm, 4° C for 10 min.  Levels of total
reduced GSH were determined in each sample as previously described (Cardozo-Pelaez,
Brooks et al. 2000).  95 µL of cytosolic supernatant and 30 µL of 10 mM EDTA were
added in duplicate to individual wells in costar 96-well microplates (Corning Life
Sciences, Lowell, MA).  A reaction mixture containing 5,5’-dithio-bis-2-nitrobenzoic
acid (DTNB) suspended in 0.5 M Na2HPO4 buffer at a final concentration of 10 mM was
added at a volume of 200 µL per well bringing the final volume per well to 325 µL.
Reactions were then incubated for 15 min at room temperature.  Optical densities were
determined at λ = 412 nm using a SpectraMax© 340 96-well plate reader (Molecular
Devices, Sunnyvale, CA).  The content of GSH in the samples was quantified using
SOFTmax PRO software (Molecular Devices, Sunnyvale, CA) by comparison to a
standard curve constructed with known amounts of total GSH suspended in 10 mM
EDTA at final volume of 325 µL. The standard curve for GSH ranged from 0 to 100
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nmoles in concentration.  Final values were expressed as nanomoles GSH per milligram
of protein per sample using the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules,
CA).
Measurement of Total, Copper/Zinc, and Manganese SOD Activities
SOD activity was measured as previously described with slight modifications
(Cardozo-Pelaez, Song et al. 1998).  This assay is based on the formation of a
chromogenic complex via reaction of an artificially generated superoxide anion (O2•
-)
with hydroxylamine as an intermediate electron carrier.  A subsequent reaction is carried
out reacting the hydroxylamine intermediate with α-napthylamine, producing a
chromogenic nitrite compound that is measurable at λ = 593 nm.  In the presence of SOD
activity there is an inhibition of the production of the chromogenic compound.
Supernatant from PC12 cell homogenates were incubated for 20 min in a 25° C water
bath with reaction mixture 1 composed of the following reagents: 150 µL of 65 mM
KH2PO4 buffer, 15 µL of xanthine stock solution (1.5 mM suspended in 0.025 N NaOH),
and 15 µL hydroxylamine chloride stock solution (1 mM in KH2PO4 buffer).  The
reaction was initiated by the addition of 75 µL of xanthine oxidase stock solution (0.2 mg
protein/mL suspended in ice cold H2O).  An aliquot of 100 µL of reaction mixture 1 was
added to 100 µL of reaction mixture 2 composed of the following reagents: sulfanilic
acid stock solution (19mM suspended in 75 % H2O, 25 % glacial acetic acid) and 100 µL
of α-napthylamine stock solution (7 mM suspended 75 % H2O, 25 % glacial acetic acid)
in a costar 96-well microplate (Corning Life Sciences, Lowell, MA) and incubated for 20
min at room temperature.  Optical densities were determined at λ = 539 nm using a
SpectraMax© 340 micro-plate reader (Molecular Devices).  The activity of total SOD
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was determined using SOFTmax PRO (Molecular Devices, Sunnyvale, CA) software
by comparing samples to a standard curve of percent inhibition of nitrite formation
relative to SOD activity, constructed using known amounts of purified bovine liver SOD.
Mn SOD activity was differentiated from Cu/Zn SOD activity with the addition of
potassium cyanide stock solution (5 mM suspended KH2PO4 buffer) in reaction mixture
1.  The difference between total and KCN-inhibited SOD activities was defined as Mn
SOD activity.   Data was expressed as units of SOD activity per milligram of protein per
sample using the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA).
Synthetic Oligonucleotide Radio Labeling
A 24 bp synthetic oligonucleotide probe containing the following nucleotide
sequence, 5′ - GAA CTA GTG XAT CCC CCG GGC TGC - 3′ (X=oxo8dG), was labeled
with γ-[32ATP] prior to annealing to its complementary strand  (Trevigen, Gaithersburg,
MD).  Reactions were set up under the following conditions: 39 µL ddH2O, 5 µL 10X T4
kinase buffer, 2 µL (20 pmoles) of synthetic oligonucleotide containing the oxo8dG
lesion, 3 µL of γ-[32ATP] (7,000 mCi / mmole) (MP Biomedicals, Solon, OH), 1 µL of
T4 polynucleotide kinase (Roche Applied Science, Indianapolis, IN) to a 500 µL
eppendorf tube.  The reaction mixture was mixed well and then incubated at 37° C for 30
min.  Subsequent to incubation, the reaction mixture was added to a pre-spun G25
sephadex column and allowed to sit for 2 min.  The column was spun at 5000 rpm for 3
min.  5 µL of labeling buffer was added followed by 2 µL (20 pmoles) of the synthetic
complement oligonucleotide (Trevigen).  The mixture was heated to 95° C in a water
bath and allowed to slowly cool to room temperature overnight.  The labeled double
stranded probe was stored at –20° C until utilized.  Prior to use, the labeled probe was
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diluted 1:200 (5 µL into 1000 µL) using nuclease free sterile H2O.
Determination of Ogg1 Activity
Nuclear protein extracts were prepared from leftover nuclear pellets by
homogenization at 4° C in 250 µL of glycosylase extraction buffer containing the
following reagents:  20 mM Trizma-base pH = 8.0, 1 mM EDTA, 0.5 mM spermine, 0.5
mM spermidine, 1 mM DTT , 50% Glycerol , and 1.3 % Protease Inhibitor Cocktail
(Roche Applied Science, Indianapolis, IN).  Following the addition of 25 µL of 2.5 M
KCl, the homogenate was rocked for 30 min at 4° C.  Samples were centrifuged at 14,000
rpm for 30 min.  Supernatants were removed and stored along with the remaining pellet
at – 80° C until utilized.  Total protein was determined in each sample using the Bio-Rad
protein assay (Bio-Rad Laboratories, Hercules, CA).
Ogg1 activity was determined by incubation of glycosylase extracts with the radio
labeled probe.  The reaction was initiated by incubating 30 µg of total protein in
glycosylase extracts and the double stranded, labeled probe in 15 and 5 µL each of the
following reaction buffers respectively:  [Cold Nicking Buffer; 20 µL of 0.5 M HEPES
buffer, pH = 7.9, 40 µL of 0.1 M EDTA, 40 µL of 5 mM DTT, 40 µL 100X bovine
serum albumin (New England Biolabs, Ipswich, MA), 255 µL of ddH2O]; [Hot Nicking
Buffer; 20 µL of 0.5 M HEPES buffer, pH = 7.9, 40 µL of 0.1 M EDTA, 40 µL of 5 mM
DTT, 40 µL 100X bovine serum albumin, 250 µL of ddH2O, 5 µL of the 1:200 diluted
labeled probe].  Reaction mixtures were incubated for 2 hr at 37° C in a heating block and
placed on ice.  20 µL of loading buffer containing 90 % formamide, 10 mM NaOH and
1X blue-orange dye (Promega, Madison, WI) was added to each sample.  After 3 min of
heating at 95° C, samples were placed back on ice, briefly centrifuged and loaded into a
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20 % acrylamide denaturing gel composed of the following reagents: 22.5 mL of 40 %
acrylamide/ bis-acrylamide 7M urea, 200 µL of 10 % ammonium persulfate, 20 µL
N,N,N',N'-Tetramethylethylenediamine (Bio-Rad Laboratories, Hercules, CA), mixed
well and cast into gel plates at a volume of 22.5 mL.  Following gel polymerization at
room temperature, samples were loaded and run using 1X TBE running buffer for 2 hr at
400 mV.  Following fragment separation the gel was removed and encased in cellophane
plastic wrap in an imaging cassette holder (Bio-Rad Laboratories, Hercules, CA).  An
imaging plate (Fuji Film Life Science, Stamford, CT) was exposed to the gels for
approximately 16 to 20 hr.  Gels were imaged and quantified using a FLA-3000 Series
Fuji Film Fluorescent Image Analyzer (Fuji Film Life Science, Stamford, CT) and
ImageGauge version 4.22 analysis software (Fuji Photo Film Co., LTD, Stamford, CT).
The capacity of the extract to incise oxo8dG was expressed as a percentage of the ratio of
cleaved synthetic probe to the total probe used using the following formula, (DU =
densitometric units):
% Activity =            DU cut fragment              x 100
DU cut and uncut fragments
Determination of oxidative damage to DNA (oxo8dG)
To quantify oxo8dG levels in each sample, the pellet left over from the
glycosylase extraction was utilized to isolate genomic DNA.  Purified DNA was prepared
for HPLC analysis by resolving it into deoxynucleoside components.  Nuclear pellets
were rinsed 1X in 1 mL of DEB buffer containing the following reagents:  0.1 M Tris-
HCl, 0.1 M NaCl, and 20 mM EDTA.  Pellets were centrifuged at 5000 rpm for 5 min at
4° C and separated from the DEB wash buffer.  300 µL of a DNAse free RNAse was
added to each nuclear pellet mixed well and incubated in a 37° C water bath for 1 hr with
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frequent mixing during the 1 hr duration.  The RNAse solution was composed of the
following reagents:  33 U of RNAse T1, 200 µg RNAse A (Roche Applied Science,
Indianapolis, IN) suspended in DEB buffer.  An additional 300 µL of proteinase-
detergent solution was added to each sample and incubated in a 37° C water bath for an
additional 1 hr with frequent mixing during the 1 hr duration.  The solution consisted of
the following: 300 µg Proteinase K, and 1 % sodium dodecyl sulfate suspended in DEB
buffer.  The protein fraction was separated from genomic DNA using three consecutive
organic extractions.
Organic extraction #1 was performed by adding 750 µL of phenol, mixed well and
centrifuged at 5000 rpm for 5 min at 4° C allowing the reaction mixture to separate into
two different phases; an organic (bottom) and aqueous (top) phase.
Organic extraction #2 was performed by removal and transfer of the aqueous phase (top
layer) of organic extraction 1 to a Light Phase Lock gel separation tube (Brinkmann
Instruments Inc., Westbury, NY).  250 µL of a 25:24:1 ratio of
phenol:chloroform:isoamyl alcohol mixture was added to each sample, mixed and
centrifuged at 5000 rpm for 15 min at 25° C.
Organic extraction #3 was performed by removal and transfer of the aqueous layer of
organic extraction 2 to a Light Phase Lock gel separation tube.  250 µL of a 24:1 ratio
of chloroform:isoamyl alcohol mixture was added to each sample, mixed well and
centrifuged at 10000 rpm for 15 min at 25° C.
The DNA was precipitated by the addition of 30 µL 3 M sodium acetate pH = 5.0
and 1 mL of ice cold 100 % ethanol, inverted gently multiple times and incubated
overnight at – 20° C.  Following overnight incubation, samples were centrifuged at 3200
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rpm for 30 min at 4° C.  Following centrifugation the 100 % ethanol was carefully
removed from the precipitated DNA pellet and 1 mL of 70 % ethanol was added, mixed
well and then centrifuged at 4000 rpm for 25 min at 4° C.  Following the second
centrifugation, the 70 % ethanol was carefully removed so at to not disturb the
precipitated DNA pellet.  Samples were inverted on bench paper for approximately 10 to
15 min to allow removal of any residual ethanol.  Precipitated genomic DNA was then
hydrolyzed to resolve DNA bases into their deoxynucleoside components.  This was first
accomplished by adding 100 µL of 20 mM sodium acetate pH = 5.0 to each sample.
DNA pellets were mixed well and incubated for 3 min at 95° C in a heating block in
order to denature the DNA.  Samples were removed to ice and 10 µL (1 U/µL) of
Nuclease P1 (suspended in 20 mM sodium acetate pH = 5.0) was added to each sample
for 45 to 60 sec subsequent to transfer to ice.  Samples were mixed well and incubated for
30 min in a 37° C water bath with frequent mixing occurring during the 30 min duration.
20 µL of 1 M Tris-Hcl pH = 8.0 was added to each sample and mixed well.  5 µL (2
U/µL) of Alkaline Phosphatase (suspended in 1 M Tris-HCl pH = 8.0) was added to each
sample, mixed well and incubated for 1 hr in a 37° C water bath with frequent mixing
occurring during the 1 hr duration.  20 µL of 3 M sodium acetate was added to each
sample and mixed well.  Samples were spun down briefly to collect residual liquids
together and transferred to an Ultrafree-MC (30 Kda) filtration tube (Millipore Corp.,
Bedford, MA) and centrifuged at 4500 rpm for 25 min at 25° C.  Subsequent to
centrifugation, samples were lyophilized using a speed vac for approximately 2 hr or until
samples were dry, and stored at – 20° C until analyzed by HPLC.
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Analysis of the levels of oxo8dG, expressed as the ratio of oxo8dG / 2-
deoxyguanosine (2-dG) was performed as follows. Oxo8dG and 2-dG were resolved by
HPLC with a reverse phase YMCbasic column (4.6 mm x 150 mm; particle size 3 µm)
(YMC Inc., Wilmington, NC) and quantified using a CoulArray electrochemical
detection system (ESA Inc., Chelmsford, MA).  An isocratic mobile phase consisting of
100 mM sodium acetate, pH 5.2, 4 % methanol (HPLC Grade) was prepared in sterile
H2O passed through C18 Sep-Pak cartridges (Waters Corp., Milford, MA) and then
utilized to elute DNA nucleosides from the column.  Prior to use the mobile phase was
filtered using a 0.2 µm nylon filter and degassed by sonication.  Potentials for the four
coulometric analytical cells of the CoulArray system, placed in series, were as follows:
50, 125, 175, 200, 250, 380, 500, 700, 785, 850, 890, 900 mV.  Calibration curves were
generated from standards of 2-dG ranging from 100 ng to 2 µg (0.350–7.01 nmol) and
oxo8dG (Cayman Chemical Company, Ann Arbor, MI) ranging from 5 to 100 pg
(17.6–353 fmol).  The calibration curve for oxo8dG was created based on the peak area of
the oxo8dG standard, eluting at 9.0 min, in the 250 mV channel.  The calibration curve
for 2-dG was created based on the sum of peak areas of the 2-dG standard, eluting at
7.8 min, in the 850, 890, and 900 mV channels.  The electrochemical cells were allowed
to equilibrate and wake up standards (three times the highest concentration of calibration
standards) were injected before calibration standards as suggested by ESA in order to
obtain highest sensitivity.  The ratio of oxo8dG and 2-dG was calculated by comparing
the peak area and sum of peak areas, respectively, from a 10 µL injection of reconstituted
enzymatic hydrolysate of the DNA sample with the calibration curves for oxo8dG and 2-
dG respectively.  Levels of oxo8dG in the samples were expressed relative to the content
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of 2-dG (e.g. the molar ratio of oxo8dG to 2-dG [fmol of oxo8dG  / nmol of 2-dG]).  Data
were recorded, analyzed, and stored using CoulArray for Windows data analysis software
(ESA Inc., Chelmsford, MA).
RNA Isolation
Total RNA from PC12 cells was isolated using TRIzol reagent (Invitrogen Life
Technologies, Carlsbad, CA) as described by the manufacturer.  Cell cultures were
harvested and washed 1X in sterile PBS.  Subsequent to washing the cells were
immediately processed for RNA isolation by adding 2 mL of TRIzol reagent and
sonicating the samples for 6 sec on ice using a VirSonic Ultrasonic Cell Disruptor 100
(VirTis, Gardiner, NY).  In between samples, the sonicator tip was washed with the
following reagents to ensure no RNA cross contamination could occur between samples.
The wash protocol was as follows:  wash vessel 1 – 0.1 % DEPC (v/v) sterile H2O; wash
vessel 2 – 1 % SDS (w/v); wash vessel 3 – 70 % ethanol; wash vessel 4 – 0.1 % DEPC
sterile H2O.  For each stage of the wash cycle the tip was submerged and activated for 3
sec.  Following sonication the samples were incubated for 5 min at room temperature to
completely dissociate nucleoprotein complexes.  Organic separations were then
performed by two successive chloroform extractions performed as follows:  400 µL of
chloroform was added to each sample, shaken vigorously by hand for 15 sec, and placed
on ice for 10 min.  Following incubation on ice, samples were centrifuged at 12000 x g
for 30 min at 4° C.  The aqueous layer was removed into a fresh sterile tube.  Following
the two successive chloroform extractions 1 mL of sterile, 100 % 2-propanol was added
to each sample, mixed well, incubated for 30 min at room temperature, shaken vigorously
for 15 sec, and incubated on ice for 10 min.  Samples were centrifuged at 12000 x g for
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10 min at 4° C to pellet the RNA down to the bottom of the tube, at this time the
supernatant was carefully removed from the RNA.  The RNA was washed with 2 mL of
sterile 75 % ethanol with vigorous pipetting of the RNA pellet.  Samples were
centrifuged at 7500 x g for 5 min at 4° C, supernatant removed, and samples inverted on
bench paper and allowed to air dry for 10 – 15 min or until no ethanol was observed.
RNA pellets were dissolved in 50 µL of sterile 0.1 % DEPC H2O and incubated for 10
min at 60° C.  Samples were analyzed spectrophotometrically to determine the
concentration of each sample (ng/µL), and the A260/280 to determine sample purity.  RNA
was stored at –80° C until utilized for quantitative RT-PCR.
Quantitative Real Time PCR Analysis
Real-time RT-PCR was performed using the ABI PRISM® 7700 Sequence Detection
System (Applied Biosystems, Foster City, CA).  Rat Ogg1 and hypoxanthine guanine
phosphoribosyl transferase (HPRT) sequences were obtained from NCBI using Genbank
accession numbers NM_030870 & XM_343829 respectively.  PCR primers and dual-
labeled probes specific for rat and Ogg1 and HPRT (Integrated DNA Technologies Inc.,
Coralville, IA) were designed using Primer Express® Version 1.5 (Applied Biosystems,
Foster City, CA).  Detailed sequences for primers & probes used for RT-PCR can be
referenced from Appendix A, Section I.
HPRT served as an endogenous control to account for any off target effects and
for normalization of Ogg1 transcript levels.  All samples were diluted and DNase-treated
prior to reverse transcription.  Reactions for DNAse treatment were set up in sterile 0.25
mL PCR vials (Axygen Scientific, Union City, CA) as follows: 1 µL of 10X reaction
buffer, 1 µL (1 U) of RNAse free DNAse (Promega, Madison, WI), 50 ng sample RNA,
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bring reaction mixture to a final volume of 8 µL with DEPC treated sterile H2O.   Each
sample was assayed in triplicate plus one no amplification control containing no reverse
transcriptase.  The RT reactions were set up in 96-well optical plates (Applied
Biosystems, Foster City, CA) with the reaction buffer composed of the following
reagents at a final volume of 10 µL: 1x reverse transcriptase buffer, 500 µM dNTP’s
(Roche Applied Science, Indianapolis, IN), 400 nM assay-specific reverse primer
(Integrated DNA Technologies Inc., Coralville, IA), 10 U reverse transcriptase
(Stratagene, Cedar Creek, TX), and 4 µL DNase-treated sample RNA (25 ng).  Cycling
conditions for the RT reaction were performed using a DNA Engine gradient thermal
cycler (MJ Research, Waltham, MA) as follows:  25° C for 10 min, 48° C for 30 min, and
95° C for 5 min, 8° C.  PCR reactions were carried out using the above generated cDNA
template.  50 µL of PCR master mix solution was then added to each sample.  The PCR
master mix solution was composed of the following reagents: 1X PCR buffer (Invitrogen
Life Technologies), 5 mM MgCl2 (Invitrogen Life Technologies, Carlsbad, CA), 200 µM
dNTP’s (Roche Applied Science, Indianapolis, IN), 1X ROX dye (Invitrogen Life
Technologies, Carlsbad, CA), 400 nM assay-specific forward primer, 400 nM assay-
specific reverse primer, 100 nM assay-specific dual-labeled probe (Integrated DNA
Technologies Inc., Coralville, IA), and 1.25 U Taq polymerase (Invitrogen Life
Technologies, Carlsbad, CA).  Thermal cycling conditions for the ABI PRISM® 7700
Sequence Detector were as follows:  95° C for 60 sec, 40 cycles of 95° C for 12 sec, and
60° C for 30 sec.  Analysis of raw data was performed using the SDS version 1.9 analysis
software (Applied Biosystems, Foster City, CA) to obtain a Ct value for each sample.  Ct
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values represent the cycle number that produced a significant change from baseline
fluorescence (ROX dye).
Final values were obtained by direct comparison.  This was accomplished by
multi step calculation of the raw data (Ct Values) obtained from each sample.  The
change in fluorescence between Ogg1 and HPRT was calculated first by the difference in
the respective threshold cycles (ΔCt1; Equation 1).  ΔCt1 values will be normalized to a
value deemed the calibrator (Equation 2).  The calibrator’s value was assigned by
calculating the mean ΔCt1 from control samples.
Equation 1 ΔCt1 = CtOgg1 – CtHPRT
Equation 2 ΔΔCt = ΔCt1 (individual sample) - ΔCt1 (Average of control)
Final values are presented as a percentage of untreated control values.  The comparative
Ct method was validated by comparison of PCR efficiencies between the target and
reference genes.  HPRT was chosen as the reference gene over the more commonly
used18s ribosomal RNA based on experimentally collected data.  The PCR efficiencies
of Ogg1 and HPRT have been determined to be approximately equal by previous
experimentation.
Nuclear Protein Extraction
Nuclear proteins from cultured PC12 cells were extracted according to the
protocol published by Basha et al. (Basha, Wei et al. 2005) with modifications.  Cell
cultures were removed using sterile PBS containing 1.3 % protease inhibitor cocktail
(Roche Applied Science, Indianapolis, IN), transferred to a 15 mL conical vial, and
centrifuged at 125 x g for 6 min.  Samples were washed again using 1 mL sterile PBS
with protease inhibitors, transferred to a sterile 1.5 mL eppendorf tube and centrifuged
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again at 125 x g for 5 min.  The wash step was repeated and the PBS supernatant
removed following centrifugation.  Sample pellets were suspended in 250 µL of buffer A
containing the following reagents: 10 mM HEPES buffer pH = 7.9, 1.5 mM MgCl2, 0.5
mM DTT, 0.5 mM EDTA, and 0.2 mM phenylmethanesulfonyl fluoride (PMSF).
Samples were mixed well and homogenization was performed using a VirSonic
Ultrasonic Cell Disruptor 100 (VirTis, Gardiner, NY) using five consecutive 2 sec
bursts on ice.  Following homogenization, samples were centrifuged at 6000 rpm for 2
min at 4° C with the supernatant carefully removed.  150 µL of buffer A was added and
samples were sonicated and centrifuged.  The supernatant was removed and samples
were suspended in 100 µL of buffer C composed of the following reagents: 20 mM
HEPES buffer pH = 7.9, 1.5 mM MgCl2, 0.5 mM DTT, 0.5 mM EDTA, 420 mM NaCl,
20% glycerol, 0.2 mM PMSF, 2 ng/mL aprotinin, 0.5 ng/mL leupeptin, 6 µL of 6 %
Triton X-100.  Samples were vortexed, sonicated for 2 sec on ice.  Final suspensions
were centrifuged at 14000 rpm for 10 min at 4° C, snap frozen in liquid N2 and stored at
– 80° C until utilized for gel mobility shift assays.  Total protein values were obtained
using the bicinchoninic acid (BCA) protein determination assay (Pierce, Rockford, IL).
Gel Mobility Shift Assay
Changes in Sp1 transcription factor binding were determined using the electrophoretic
mobility shift assay (EMSA).  Nuclear extracts were collected from PC12 cells as
described above.  Oligonucleotides containing sequences corresponding to Sp1 binding
sites in the human Ogg1 promoter (GENBank accession number AF_521807) were
obtained from a commercial source (Integrated DNA Technologies Inc., Coralville, IA)
containing the following sequences [Sp1-1, 5'-GCA AGG AGG GGG CGG GAC CTA
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CAC-3'; Anti-sense GTG TAG GTC CCG CCC CCT CCT TGC], [Sp1-2, Sense, TCC
TTG TCT GGG CGG GGT CTT TGG; Anti-sense, CCA AAG ACC CCG CCC AGA
CAA GGA].  Oligonucleotides were 5’ end radio labeled using [γ-32P] ATP as described
above.  Binding reactions were set up as follows:  30 µg of nuclear extract normalized to
equal volumes of 20 µL, 0.4 pmoles of labeled probe, 10 µL of binding buffer containing
the following reagents: 20 % glycerol, 5 mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 250
mM NaCl, 50 mM Tris-Hcl pH = 7.5, 0.2 ug/µL poly dI-dC.  Binding reactions were
incubated at room temperature for 30 min and separated on a 6 % native polyacrylamide
gel composed of the following reagents: 3.42 mL 40 % acrylamide/ bis-acrylamide, 2 mL
of 10X TBE buffer, 17.16 mL ddH2O, 210 µL 10 % ammonium persulfate, 21 µL
N,N,N',N'-Tetramethylethylenediamine (Bio-Rad Laboratories, Hercules, CA).  Gel
reagents were mixed well and cast into glass gel plates at a volume of 22.5 mL and
allowed to polymerize at room temperature.  Samples were loaded and run in 0.5X TBE
buffer for 2 hr at 200 V in order to resolve bound protein-DNA complexes.  Following
complex separation the gel was removed using a 7 x 9 inch piece of blot paper (Bio-Rad
Laboratories, Hercules, CA) and encased in cellophane plastic wrap into an imaging
cassette holder (Bio-Rad Laboratories, Hercules, CA).  An imaging plate (Fuji Film Life
Science, Stamford, CT) was then exposed to the gels for approximately 30 to 60 min.
Imaging plates were read using a FLA-3000 Series Fuji Film Fluorescent Image Analyzer
(Fuji Film Life Science, Stamford, CT) and ImageGauge version 4.22 analysis software
(Fuji Photo Film Co., LTD, Stamford, CT).
Data analysis and statistics
Differences in viability curves in PC12 cells were assessed using non-linear
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regression analysis and comparison of fit for the two dose-response curves.  Difference
from control viability was calculated using one-way analysis of variance (1-way
ANOVA) with Dunnet’s post hoc analysis.  Two-way analysis of variance (2-way
ANOVA) was used to determine an interaction between cell status and treatment for
antioxidants, Ogg1 activity, and oxo8dG with a Bonferroni posttest to determine group
differences.  A students t-test was used to evaluate differences in Ogg1 mRNA between
control and arsenite treated cells in actively dividing PC12 cells.  Statistical tests were




Cultures of actively dividing and NGF treated PC12 cells were exposed to sodium
arsenite for 24 hr.  Viability plots were determined by LDH leakage into the culture
media (Figure 16).  Goodness of fit analysis determined a statistical difference between
the two plots indicating that NGF treated PC12 cells are more susceptible to increasing
concentrations of sodium arsenite.  One-way ANOVA analysis with Dunnet’s post-hoc
analysis determined no significant difference in cell viability from control until a dose of
40 µM sodium arsenite.  This was equivalent in both actively dividing and NGF treated
PC12 cells (Figure 16).  Based on the viability plots, NGF treated PC12 cells are more






The effect of increasing doses of sodium arsenite on the viability of actively dividing and
NGF treated PC12 cells exposed for 24 hr as determined by release of lactate
dehydrogenase.  Values expressed as percent of untreated control cells for actively
dividing, open squares () and NGF treated populations, open circles ().  Data is
expressed as mean ± S.E.M. (n = 6).  * Denotes a significant difference from group
matched control, P < 0.05.
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A concentration of 10 µM sodium arsenite was chosen for further studies based
on the viability experiments (Figure 16) and additional in vitro studies exposing cell and
tissue cultures to non-lethal doses of inorganic arsenite (Parrish, Zheng et al. 1999; Hu,
Jin et al. 2002).  10µM is a dose that is potent enough to facilitate cellular responses
without inducing cell death therefore allowing us to determine any biochemical changes
preceding cellular demise.
An acute exposure to sodium arsenite elicited an increase in intracellular GSH
levels in both actively dividing and NGF treated PC12 cells.  Biochemical analysis in
actively dividing PC12 cells revealed a 5-fold increase in GSH while the NGF treated
PC12 cells had approximately a 2-fold increase (Figure 17).  Analysis by two-way
ANOVA identified a significant interaction effect between arsenite and cell status
(F=23.74; df=1,36; p < 0.05), as well as individual effects by arsenite (F=292.90;
df=1,36; p < 0.05) and cell status; defined as actively dividing or NGF treated (F=25.74;
df=1,36; p < 0.05).  It is interesting to note that although there is a difference in basal
levels of GSH between actively dividing and NGF treated PC12 cells, exposure to
arsenite led to a plateau in GSH suggesting that the ability of PC12 cells to respond to
toxic insult is independent of their cellular status.  The response could also be
characterized by a greater increase in GSH in actively dividing PC12 cells.  Under this
guise the actively dividing PC12 cells demonstrate a better response capacity to arsenite
treatment.  These disparities in levels of GSH could be further explained by examination
of components of the GSH synthetic pathway as well as rates of cellular GSH excretion






Levels of GSH were determined in actively dividing and NGF treated PC12 cells exposed
to 10 µM sodium arsenite for 24 hr.  Columns represent mean ± SEM.  (n= 10).  *
Indicates a statistical significant difference from control P < 0.05.  # Indicates a statistical
significant difference from untreated actively dividing PC12 cells P < 0.05.
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Cells maintain additional antioxidant systems to handle a variety of free radical
species produced during oxidative stress.  SOD isoforms are responsible for the
enzymatic dismutation of superoxide into H2O2 and are important mediators of oxidative
stress.  Table 4 summarizes the effects of both NGF treatment, and sodium arsenite
exposure on SOD activities in actively dividing and NGF treated PC12 cells.  Analysis by
two-way ANOVA for Cu/Zn SOD revealed no significant interaction or arsenite effect,
however, there was a significant effect for cell status (F=27.49; df=1,34; p < 0.05)
indicating that Cu/Zn SOD activity is significantly reduced as a consequence of NGF
exposure.  Two-way ANOVA for Mn SOD activity revealed a significant interaction
effect (F=5.13; df=1,35; p < 0.05), and a significant effect by arsenite on Mn SOD levels
in actively dividing PC12 cells (F=4.62; df=1,35; p < 0.05).
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TABLE 4.  Copper/Zinc and Manganese SOD levels in actively dividing and NGF
treated PC12 cells exposed for 24 hr to 10 µM sodium arsenite.
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Arsenic has been reported to have effects on both the transcription (Andrew,
Karagas et al. 2003) and activity of DNA repair enzymes (Tran, Prakash et al. 2002;
Hartwig, Blessing et al. 2003) however; studies have not demonstrated an effect of
arsenic on rat Ogg1 activity or expression.  Treatment with sodium arsenite for 24 hr
decreased the enzymatic activity of Ogg1 in both actively dividing and NGF treated PC
12 cells (Figure 18A).  A 3-fold decrease in excision activity was evident in the actively
dividing cells, which also had a larger increase in GSH (Figure 17).  Two-way ANOVA
analysis indicates a significant interaction between arsenite treatment and cell status on
Ogg1 excision activity (F=79.66; df=1,22; p < 0.05).  There was also an effect by arsenite
(F=179.30; df=1,22; p < 0.05) and cell status alone (F=79.31; df=1,22; p < 0.05).  Ogg1
activity remained attenuated even in the presence of increased total protein used in
reactions.  Nuclear extracts from actively dividing PC12 cells were used ranging from 0
to 40 µg total protein.  Decreased Ogg1 activity remained constant in the arsenite










Ogg1 activity in actively dividing and NGF treated PC12 cells 24 hr after exposure to 10
µM sodium arsenite (A).  Columns represent mean ± SEM.  (n = 5 - 9).  * Indicates a
statistical significant difference from control p < 0.05.  # Indicates a statistical significant
difference from actively dividing PC12 control cells p < 0.05.
(B) Typical gel image used for the analysis of extracts to cleave oxo8dG; each sample ran
in duplicate. Formamidopyrimidine-DNA glycosylase (3 U) activity was used as a
positive control; C = control, A = 10µM arsenite treatment.
(C) Ogg1 activity plot in nuclear extracts from actively dividing PC12 cells exposed to 10
µM sodium arsenite for 24 hr.  Activity expressed relative to increasing total protein
levels in reaction mixture.  Data points represent mean ± SEM.  (n = 4).
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Important to note is that the enzymatic activity of Ogg1 is lower basally by > 50 % in the
NGF treated control cells compared to the actively dividing control group (Figure 18A).
The NGF treated PC12 cell control group also had an increased level of GSH
approximately 2X higher than actively dividing control PC12 cells (Figure 17).  This
trend for a reduction in Ogg1 activity in the presence of increased GSH, either by NGF or
arsenite treatment was analyzed by Pearson test for correlation in both the actively
dividing and NGF treated PC12 cells (Figure 19).  Both actively dividing and NGF
treated PC12 cells demonstrated an inverse relationship between the levels of GSH and
Ogg1 activity in both untreated and arsenite treated samples; (actively dividing Pearson r
= -0.9473, r2 = 0.8973, p < 0.05; NGF treated Pearson r = -0.9400; r2 = 0.8835, p < 0.05).
These results suggest an association between Ogg1 activity and the cellular redox state as





Pearson plot of Ogg1 activity versus levels of GSH as a function of either NGF, or
arsenite treatment in actively dividing and NGF treated PC12 cells.  () Represents
actively dividing PC12 cells receiving no sodium arsenite treatment. () Represents
actively dividing PC12 cells exposed to 10 µM sodium arsenite for 24 hr. () represents
NGF treated PC12 cells receiving no sodium arsenite exposure.  () represents NGF
treated PC12 cells exposed to 10 µM sodium arsenite for 24 hr.
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Although in vitro biochemistry cannot completely mimic biological conditions,
previous work has shown no direct effects on DNA repair enzymes, other than Ogg1, via
arsenite exposure.  This was demonstrated in separate studies characterizing the effects of
arsenite on DNA ligase (Hu, Su et al. 1998) and Fpg; the bacterial homologue of Ogg1
(Asmuss, Mullenders et al. 2000).  Because a reduction in Ogg1 activity was seen
subsequent to arsenite exposure in both actively dividing and NGF treated PC12 cells,
any direct effect of arsenite on enzymatic function was determined by pre-treating
glycosylase protein extracts with sodium arsenite prior to incubation with the oxo8dG
substrate.  Glycosylase extracts obtained from actively dividing PC12 cells were
collected and 20µg total protein was pre-incubated for 30 min, 37oC with increasing
concentrations (0, 10, 50, and 100µM) of sodium arsenite.  Following pre-incubation the
assay was completed as described in materials and methods and activity was measured as
a function of incubation time of enzyme with substrate.  Figure 20 summarizes the direct
effects of sodium arsenite on Ogg1 activity.  There was no change in enzyme activity
even at concentrations of arsenite equivalent, or greater to, arsenite levels that resulted in
a significant loss in cell viability (Figure 16 and 20).  Additional glycosylase extracts
obtained from murine cerebellum were used in the same fashion as the PC12 cells.  There
was no inhibitory effect of arsenite (0 – 25 µM, data not shown) on mouse Ogg1 activity
as well.  This suggests that arsenite does not have a direct effect on enzyme activity under
these ex vivo experimental conditions and that the decreases previously seen (Figure 18)





Ogg1 activity in glycosylase extracts from actively dividing PC12 cells pre-incubated for
30 min with sodium arsenite (0, 10, 50, and 100µM).  Samples were run in duplicate at
each time point from 0 to 120 min.  (n = 2 per dose & time group).
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Since there was no direct inhibition by sodium arsenite on Ogg1 activity (Figure
20), and the degree of reduction in enzyme activity was not equivalent between actively
dividing and NGF treated PC12 cells (Figure 18), an assessment of Ogg1 mRNA was
performed to reveal any transcriptional changes.  Figure 21A demonstrates a significant
decrease in the levels of Ogg1 mRNA by ~ 30 % in actively dividing PC12 cells.
Actively dividing PC12 cells were solely measured for changes in transcription due to the







(A) Levels of Ogg1 mRNA in actively dividing PC12 cells exposed to 10 µM sodium
arsenite for 24 hr as a measure of transcriptional activity.  Columns represent mean ±
SEM.  (n = 8).  * Indicates a statistical significant difference from untreated actively
dividing PC12 cells P < 0.05.
(B) Representative fluorometric plot of real time PCR reactions measuring levels of Ogg1
and HPRT transcripts.
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Human Ogg1 has been suggested to be a constitutively expressed housekeeping
gene, and the promoter for hOgg1 has been previously sequenced (Dhenaut, Boiteux et
al. 2000).  Distinct Sp1 binding sites have been identified in the promoter upstream of the
transcription initiation site (Figure 4, Chapter 1) and have been validated by gel shift
binding analysis (Youn, Kim et al. 2005).  Arsenic exposure has been associated with
decreased Sp1 binding activities.   Decreased Sp1 binding was suggested to be due to
protein oxidation occurring at levels of arsenic below 1µM (Chou, Chen et al. 2005).
Based on the evidence that arsenite induces oxidative stress, Sp1 binding activities were
assessed by EMSA in actively dividing PC12 cells exposed to 10 µM arsenite for 24 hr
(Figure 22).  Two different double stranded oligonucleotides representing Sp1 binding
sites from the hOgg1 promoter were used for binding analysis.  The lanes containing
extract from untreated PC12 cells exhibited strong binding with a substantial decrease in
binding seen in the arsenite treated cells.  Co-incubating nuclear extracts with labeled and
unlabeled Sp1 oligonucleotides resulted in a complete attenuation of binding, while co-
incubation with a non-specific unlabeled oligonucleotide containing a consensus Nrf-2
transcription factor sequence resulted in recovery of binding, showing specificity of
protein-DNA interaction at these Sp1 sites.
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FIGURE 22
                       Left Panel      Right Panel
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Figure 22
Representative gel of EMSA analysis of two independent Sp1 sites originating from the
hOgg1 promoter.  Binding differences were measured from nuclear extracts of untreated
and arsenite treated actively dividing PC12 cells.  Competition EMSA were performed
using γ-32P labeled, double stranded oligonucleotide probes containing the two Sp1 sites.
The Sp1 shifted bands and unbound probe are indicated.  Competition EMSA using 30
µg nuclear extracts from untreated PC12 cells.  Labeled Sp1 probes were co-incubated
with either 100X unlabeled Sp1 probe, or unlabeled consensus Nrf2 probe.
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Conditions where DNA repair is continually compromised can lead to increased
levels of oxo8dG; a situation that can have deleterious effects in both actively dividing
and differentiated cells.  Although arsenite induced increased levels of GSH (Figure 17),
decreased Ogg1 activity and Ogg1 mRNA (Figures 18 and 20), this did not translate into
higher levels of oxo8dG in either actively dividing or NGF treated PC12 cells exposed to
10 µM arsenite (Figure 23).  Two-way ANOVA analysis showed no significant effect
from arsenite or cell status as well as no significant interaction.  Basal levels of oxo8dG
tend to be higher in NGF treated controls; an observation that can be attributed to the
lower Ogg1 activity seen in that group (Figure 18A).  It is important to reiterate that non-
lethal levels of sodium arsenite were used in these experiments. It is possible that
exposure to higher levels of arsenite would result in similar changes in GSH, Ogg1
activity/transcription, and would also yield higher levels of oxo8dG.  Longer exposure
times, indicative of a chronic exposure to arsenic, would be worthy of consideration to






Levels of oxo8dG as an indication of DNA damage from exposure to 10µM sodium
arsenite for 24 hr were measured in actively dividing and NGF treated PC12 cells.
Columns represent mean ± SEM.  (n = 6 - 12).
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Conclusions
Acute low-level exposure to sodium arsenite facilitates multiple changes in
cellular defenses that are both dependent and independent of cell status in PC12 cells;
actively dividing or NGF exposed.  Susceptibility to sodium arsenite is increased in
differentiated cellular populations as shown in the NGF treated PC12 cells when
compared to their actively dividing counterparts.  Increased susceptibility occurred
despite increases in the cellular antioxidants subsequent to both NGF treatment and
arsenite exposure.  NGF treatment alone led to a decrease in Ogg1 activity implicating a
potential role for growth factor signal pathways in Ogg1 regulation.  Furthermore arsenite
is capable of affecting both antioxidant and DNA repair systems in actively dividing, and
NGF treated PC12 cells.  Decreased Ogg1 activity is dependent in part, on changes in the
transcriptional regulation measured by changes in Ogg1 mRNA.  This was further
demonstrated in ex vivo exposures showing no attenuation of Ogg1 enzymatic activity
pre-incubated with sodium arsenite (Figure 20).  Gel shift assays further revealed a
promising direction for investigation as Sp1 binding was decreased subsequent to arsenite
exposure.  This suggests an additional component of transcriptional regulation for Ogg1
potentially involved in its arsenic-mediated down regulation.  Overall, the decreased
repair capacities caused by arsenite exposure suggest a link between attenuated genomic
repair DNA and arsenic related health concerns.  It also proposes further questions into
mechanisms of arsenic toxicity in cellular systems; this is based on the attenuation of
both Ogg1 transcription, and activity despite the induction of stress response systems
indicated by increases in cellular GSH.
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CHAPTER TWO DISCUSSION
 Despite the description of a putative Nrf2 recognition site in the promoter region
of Ogg1, no association has been made between Nrf2 and the regulation of Ogg1.  Mice
lacking Nrf-2 (Nrf2 -/-) have basal levels of oxo8dG in the liver and kidney that are
higher than wild type littermates (Li 2004).  Furthermore, accumulation of oxo8dG in
Nrf-2 -/- mice was higher after exposure to both diesel exhaust particles and cigarette
smoke (Aoki, Sato et al. 2001; Rangasamy, Cho et al. 2004).  However, in both studies
the transcription and activity of Ogg1 were not measured making it difficult in
determining a role for Ogg1 in those studies.  It has been reported that Nrf-2 is highly
regulated by the redox status of the cell and its ability to alter gene expression is therefore
highly sensitive to intracellular levels of GSH (Dinkova-Kostova, Holtzclaw et al. 2002;
Hyun, Jung et al. 2003; Hansen, Watson et al. 2004).  An attenuation of GSH can cause
shifts in the cellular redox state to more oxidizing conditions, and activate cytoprotective
transcriptional pathways.
As a compensatory mechanism for oxidative stress, Nrf2 can be released from a
cytosolic inhibitory protein, KEAP1, and translocate to the nucleus (Itoh, Wakabayashi et
al. 1999).  Once in the nucleus, Nrf2 interacts with its cognate binding sequence or
sequences on promoters of Nrf2 regulated genes including ones involved in GSH
synthesis and homeostasis; most notably glutamate cysteine ligase, GSH synthase, GSH
reductase.  Also included are free radical scavenging enzymes such as NADPH quinone
oxidoreductase, manganese superoxide dismutase, and GSH peroxidase (Venugopal and
Jaiswal; Lee, Calkins et al. 2003).  This response has been further characterized by work
showing activation of Nrf-2 after exposure to agents known to modulate levels of GSH
152
including tBHQ, sulforaphane (GST-mediated) and GSH itself (Lee, Moehlenkamp et al.
2001; Kim, Park et al. 2003; Hansen, Watson et al. 2004).  The use of these compounds
as pharmacologic tools provides a link between the modulation of the cellular redox state
and a subsequent induction of cytoprotective genes.  Ogg1 has been reported to be
responsive to redox changes (Cardozo-Pelaez, Stedeford et al. 2002); a finding further
supported by the presence of inducible elements in the promoter of the human Ogg1 gene
including binding sites for p53 and NF-YA transcription factors (Lee, Kim et al. 2004;
Chatterjee, Mambo et al. 2006).  A putative binding site for Nrf2 has also been identified
yet still remains unverified (Dhenaut, Boiteux et al. 2000).  The putative Nrf2 site is
important for basal transcription of hOgg1 as site-directed deletion experiments resulted
in a loss of GFP reporter gene expression under the regulation of the altered hOgg1
promoter (Figure 7A and B).  PCR analysis of these cultures revealed an equivalent
efficiency for transfection demonstrating that an alteration to the hOgg1 promoter
sequence (deleting Nrf2 binding site) is facilitating the changes in GFP expression
(Figure 7C).  In addition, the identification of protein interaction at this binding site that
is inducible by tBHQ (Figure 8), lends support that Nrf2 is interacting with this region of
the hOgg1 promoter.
Changes in GSH have also been associated with increased Ogg1 transcription,
expression, and activity in both in vivo and in vitro studies (Table 3).  In one study, a six
hr treatment with DEM increased the activity of Ogg1 in the cerebellum, cortex and pons
medulla of C57BL/J6 mice; however no mRNA or transcriptional changes were
measured.  In addition, a 24 hr exposure to 100 µM BSO caused increases in both the
activity and transcription of Ogg1 in PC12 cells that plateau between 12 - 18 hr (data not
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shown).  It was shown that decreased Ogg1 activity in extracts from cadmium treated
human lymphoblastoid cells was attributed to protein oxidation bringing another level of
redox regulation for Ogg1, via direct thiol modifications (Bravard, Vacher et al. 2006).  It
was found in our lab that addition of GSH directly to glycosylase extracts caused an
increase in Ogg1 activity compared to untreated extracts derived from the same source
(data not shown).  The two previous statements suggest that the enzymatic activity of
Ogg1 is dependent on a non-oxidizing environment.  However, administration of GSH-
mee decreased hOgg1 regulated luciferase activities (Figures 12C and 13) bringing forth
the question of how increases in cellular GSH are attenuating hOgg1 transcription.  It
implies the presence of additional factors involved in the transcriptional down-regulation
of hOgg1.  Changes in hOgg1-regulated reporter gene activity were evident in Figures 10
and 11 (tBHQ and DEM respectively) strengthening the argument that transcriptional
regulation of hOgg1 is a major cellular component of cellular defense.  Taken together,
previous and current data also suggest that Ogg1 is modulated in a manner similar to
genes under the regulation of Nrf2 as both compounds have been used as inducers of
Nrf2 mediated transcription.  Figure 24 illustrates a proposed pathway of hOgg1
transcriptional regulation by Nrf2.  This includes how modulation of promoter activity
can occur via modulation of intracellular GSH using the compounds tBHQ, DEM, and
GSH-mee.  Compounds that induce Nrf2 activation (DEM, tBHQ) facilitate the release of
Nrf2 from its inhibitory partner KEAP1 and allow translocation of Nrf2 into the nucleus
and increase the transcriptional activity of Ogg1.  Compounds that stabilize Nrf2/KEAP1
complexes (GSH-mee) via stabilization of sulfhydryl groups on KEAP1 keep Nrf2





Proposed model pathway for transcriptional regulation of hOgg1 by glutathione
modulating agents and the transcription factor Nrf2.
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In this study we have explored the promoter of the hOgg1 gene originally
sequenced and characterized by Dhenaut and colleagues (Dhenaut, Boiteux et al. 2000).
We have presented evidence indicating that modulation of the hOgg1 promoter is
sensitive to levels of intracellular GSH, and that activation/translocation of the
transcription factor Nrf2 is an integral component of this pathway.  By characterizing
different transcriptional regulators of Ogg1, a better understanding can be gleaned as to
how transcriptional changes in Ogg1 can participate in pathologies associated with aging,
carcinogenesis, and neurodegenerative disease.  It can also aid in understanding the
mechanisms of toxicity associated with increased levels of oxo8dG.
Linking Ogg1 to Nrf2 mediated regulation can allow the investigation of different
therapies designed to prevent oxidative damage to DNA (oxo8dG) by boosting repair
capacity (Ogg1).  This is due largely to the vast amount of published data pertaining to
Nrf2 and its upstream regulatory pathways such as map kinases (Yu, Chen et al. 2000)
and phosphatidylinositol 3 kinase (Martin, Rojo et al. 2004); two well characterized
protein kinases involved in signal transduction pathways.  In addition, compounds
capable of inducing an antioxidant response via Nrf2 can also be investigated as potential
therapies for limiting oxidative damage to DNA (Kim, Hu et al. 2003; Suh, Shenvi et al.
2004; Chen, Jang et al. 2005).  By linking Ogg1 transcriptional regulation to the
transcription factor Nrf2 we can advance our understanding of the relationship between
the cellular redox state and DNA repair.
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CHAPTER THREE DISCUSSION
Cultures of actively dividing and NGF treated PC12 cells were exposed to sodium
arsenite for 24 hr.  Analysis established a statistical difference between the two plots
shown in Figure 16, indicating that NGF treated PC12 cells are more susceptible to
increasing concentrations of sodium arsenite.  Differential susceptibility is a phenomenon
seen in a variety of tissues that contain actively dividing and differentiated cellular
populations.  A recent study suggested H2O2 induced apoptosis was dependent on cell
status in human keratinocytes with the differentiated suprabasal cells containing greater
resistance to H2O2 (Zuliani, Denis et al. 2005).  It has been established that neurons are
more susceptible than astrocytes to a variety of insults and furthermore astrocytes have
been shown to provide a protective response for neurons during oxidative stress
(Desagher, Glowinski et al. 1996; Shih, Johnson et al. 2003).  This sets up a symbiotic
relationship for neuroprotection because of the diminished ability for neurons to elicit an
antioxidant response in comparison to astrocytes (Murphy, Yu et al. 2001).  NGF has the
ability to stop PC12 cells from actively dividing and differentiates them into a neuronal
phenotype, including the formation of neurite extensions (Greene and Tischler 1976).  A
differential stress response can account for actively dividing PC12 cells having a greater
resistance to arsenite versus their NGF treated counterparts similar to the relationship
between neurons and astrocytes.  Ultimately it is unclear what signaling pathways are
affected following NGF-induced differentiation in PC12 cells that ultimately contribute
to an increased susceptibility to arsenite.
Other studies looking at differences between actively dividing and NGF treated
PC12 cells have produced varied results.  NGF treated PC12 cells were shown to have an
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increased resistance to the peroxide compounds H2O2 (Sung, Cheng et al. 2003), and t-
butyl hydroperoxide (TBH) (Ekshyyan and Aw 2005) whereas others have shown a
decreased resistance to tumor necrosis factor-α (TNF-α) and ROS including lipid- and
hydroperoxides including TBH (Sasaki, Baba et al. 2001).  In the context of this study,
sodium arsenite was able to elicit a decrease in cell viability in the NGF treated PC12
population (Figure 16).  A basis for the variation in results can be the culture conditions
in which PC12 cells are grown and differentiated.  The aforementioned studies have
differences in base media used, concentration of growth serum, and in the amount and
time used for NGF-induced differentiation.  It is difficult to compare results between
studies where the culture conditions are so diverse, regardless of common exposure
regiments and measured endpoints.  Regardless of response capacities between actively
dividing and NGF treated PC12 cells, it is evident from the viability plot (Figure 16) that
NGF treated PC12 cells are more susceptible to increasing concentrations of sodium
arsenite than their actively dividing counterparts.
Glutathione (GSH) is regarded as the first line of cellular defense against free
radicals and changes in cellular GSH can be utilized as a marker for oxidative stress, and
an indicator of the cellular redox state (Griffith 1999; Sies 1999).  Trivalent arsenic has
been reported to have a high affinity for vicinal sulfhydryl groups on various
macromolecules (Scott, Hatlelid et al. 1993) and there have been in vitro studies showing
a direct conjugation of methylated arsenic (III) species with GSH in both rat liver, and rat
endothelial cell lines (Hirano, Kobayashi et al. 2004; Sakurai, Ochiai et al. 2004).  In the
present study, basal levels of GSH were approximately twice as high in the NGF treated
PC12 cells (Figure 17).  This elevation has been previously reported in PC12 cells
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exposed to 50 ng/mL of NGF and it was suggested that the elevation was due to increased
uptake of the GSH precursors L-cystine and L-cysteine, and an increase in the activity of
glutamate-cysteine ligase (GCL); the enzyme responsible for glutathione synthesis (Pan
and Perez-Polo 1996).  Treatment of PC12 cells with NGF has been previously reported
to have cytoprotective effects.  Pre-treatment of PC12 cells for 24 hr with 50 ng/mL NGF
resulted in a recovery of cell viability from H2O2 generated by a glucose oxidase based
assay, an event that was suggested by the authors to be due to the induction of GSH (Pan
and Perez-Polo 1996).  Dugan et. al. reported a cytoprotective response initiated by NGF
to be a result of map kinase (MAPK) activation via the TrkA/NGF receptor the
endogenous receptor for NGF (Dugan, Creedon et al. 1997).  A cytoprotective
mechanism can be further corroborated by the ability of NGF to decrease the level of
superoxide in PC12 cells (Mills, Takeda et al. 1998).  The study utilized both a dominant
negative Ras, and MEK inhibitors to attenuate the protective effects of NGF, suggesting
that activation of MAPK pathways have a cytoprotective role in PC12 cells (Mills,
Takeda et al. 1998).  Additional evidence implicates the role of interleukin-6 in the
recovery of cell viability in PC12 cells exposed to 50µM 4-hydroxynonenal (HNE).  This
demonstrates a cytoprotective response via increases in GSH (Nakajima, Yamada et al.
2002) as HNE has been shown to elicit a strong induction of GSH synthesis by activation
of map kinase pathways (Forman and Dickinson 2003).
The promoter regions for both the catalytic (GCLC), and modulatory (GCLM)
sub-units of the GCL genes contain AP-1 and Nrf2 binding sites (Dickinson, Levonen et
al. 2004).  It is likely that NGF is acting via MAPK pathways to facilitate an AP-1
mediated induction of GCL as one of the pathways for stress response.  The transcription
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factor Nrf-2 has been reported to induce antioxidant response element (ARE) regulated
genes via MAPK’s (Yu, Lei et al. 1999) and could also be responsible for increased GSH
in PC12 cells exposed to NGF yet no definitive evidence has shown Nrf-2 activation and
translocation subsequent to NGF exposure.
An acute exposure to sodium arsenite also caused an increase in intracellular GSH
in both actively dividing and NGF treated PC12 cells.  Biochemical analysis in actively
dividing PC12 cells revealed a 5-fold increase in GSH while the NGF treated PC12 cells
had approximately a 2-fold increase (Figure 17).  Similar reports of GSH induction
subsequent to arsenite exposure have been demonstrated in different cell lines.  This
includes increased cystine uptake, cysteine utilization in Chinese hamster V79 cells, and
increased GCL activity and mRNA in human keratinocyte cell lines at 5 and 10µM
arsenite respectively; (Ochi 1997; Schuliga, Chouchane et al. 2002) concentrations also
similar to those used in this study.  Arsenite was reported to have no effect on the ratio of
reduced to oxidized glutathione (GSH/GSSG).  However, both glutathione reductase
mRNA and activity increased as a consequence of arsenite exposure revealing a plausible
explanation for the lack of change seen in the GSH/GSSG ratio (Schuliga, Chouchane et
al. 2002).  The previous examples demonstrate that a multitude of redundant systems
exist to maintain the homeostasis of cellular GSH despite arsenic exposure.
Another explanation for increased GSH from arsenite exposure can be due to the
activation of cellular stress pathways similar to the induction seen after NGF treatment.
PC12 cells exposed to higher levels of arsenite revealed a transient yet differential
increase in map kinase activities for p38, JNK1, and ERK2; listed from highest to lowest
induction respectively (Liu, Guyton et al. 1996).  Furthermore the activation of all three
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MAPK’s was attenuated by a 45 min pre-incubation of 20mM NAC thereby associating
levels of GSH, or non-protein thiols in general, as probable mediators for stress pathway
activation subsequent to arsenite exposure.
Studies have implicated arsenic as a causative agent of oxidative stress
(Barchowsky, Klei et al. 1999; Flora 1999) with increased GSH being an event associated
with a cellular stress response.  In this study, PC12 cells were able to elicit an acute
response to sodium arsenite by dramatically increasing intracellular glutathione (Figure
17).  Initially, increased GSH appears to be a protective mechanism in acute arsenite
exposures. However, chronic exposures can present an alternative scenario with the
depletion of GSH resulting in persistent oxidative insult to the cell (Flora 1999; Pi,
Yamauchi et al. 2002).  This is an important distinction to make when comparing cellular
stress response, as it is clear that exposure duration is producing a varied cellular
response.
Cells have additional antioxidant defenses to remove free radicals produced
during oxidative stress.  Catalase and glutathione peroxidase remove H2O2 while the
precursor for H2O2, superoxide is handled primarily by two enzymes; copper/zinc and
manganese superoxide dismutase (Cu/Zn SOD & Mn SOD respectively).  SOD’s are
responsible for the enzymatic dismutation of superoxide into H2O2 and are important
mediators of oxidative stress.  Mn SOD is the mitochondrial isoform and studies have
reported the deleterious effects of arsenic in mitochondria including disruption of both
organelle membrane potential, and enzymatic activities.  Sodium arsenite was previously
shown as having an inhibitory effect on pyruvate dehydrogenase; an integral
mitochondrial enzyme involved in glucose metabolism and energy production in the cell
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(Petrick, Ayala-Fierro et al. 2000).  Furthermore arsenic (III) oxide was capable of
disrupting the mitochondrial membrane potential in a variety of lymphoid cell lines
(Rojewski, Korper et al. 2004).  These studies demonstrate the diverse effects and
toxicity that trivalent arsenic can have on mitochondrial function.  A two-fold increase in
Mn SOD activity was seen in actively dividing PC12 cells exposed to arsenite while the
NGF treated cells remained unchanged. The increased Mn SOD activity demonstrated in
Table 4 corresponds to increased Mn SOD expression seen in cases where oxidative
stress was present (Blaauwgeers, Vianney de Jong et al. 1996; Warner, Stuart et al.
1996).  MnSOD has been reported as inducible via Nrf2 and NF-κB transcription factor
pathways (Xu, Krishnan et al. 1999).  The increased MnSOD activity seen in actively
dividing PC12 (Table 4) cells is consistent with the increased synthesis of GSH (Figure
17) as an indicator of stress response subsequent to arsenite exposure.  The GCLC and
GCLM subunits also contain regulatory elements similar to MnSOD and are inducible via
arsenite exposure (Dickinson, Levonen et al. 2004; Kann, Estes et al. 2005).  This also
can occur via Nrf2 activation and translocation, as current literature has not identified any
definitive NF-κB binding sites in the promoter regions of either GCL subunit (Dickinson,
Levonen et al. 2004).
A cross-sectional study of people chronically exposed to arsenic in drinking water
found that total SOD activities were unchanged (Pi, Yamauchi et al. 2002) which is
consistent with the data presented in Table 4.  The inconsistency in Cu/Zn SOD activities
among control groups is difficult to explain as others have shown an induction of Cu/Zn
SOD expression in non-transformed human epidermal keratinocytes subsequent to a 24-
hour exposure to 5 µM arsenite (Hamadeh, Trouba et al. 2002).  Analysis of SOD
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activities at earlier time points could reveal changes in Cu/Zn SOD activity that were
unobservable at 24 hr in this study (Table 4).  A caveat in study comparison is that data
involving different species is difficult to equate to the changes in SOD activities seen
here; a difficulty further compounded by comparing the effects seen in acute versus
chronic exposures to arsenite.
Despite the induction of GSH, increasing concentrations of arsenite resulted in
decreased cell viability (Figure 16).  In addition, arsenite did not change SOD activities in
a negative manner.  This sets up a role for other cellular defense systems as potential
targets for arsenic mediated mechanisms of toxicity.  As discussed in chapter one, DNA
repair systems are an additional component of cellular defense.  Ogg1 is the main enzyme
involved in removal of oxo8dG from DNA and plays an integral role in genomic
maintenence.  Differences in basal Ogg1 activity were identified between actively
dividing and NGF treated control groups.  The exposure to sodium arsenite lowered the
activity to equivalent levels in both the actively dividing and NGF treated PC12 cells
(Figure 18A).  This could indicate that although NGF treated PC12 cells have a lower
basal repair capacity their ability to maintain a minimal level of activity remains
equivalent to actively dividing PC12 cells (Figure 18A).  It is also plausible that the
decrease in Ogg1 activity after arsenite exposure could be due to an additive effect of
arsenic-induced changes to both the transcription and activity of Ogg1 and any direct or
pharmacological effect from arsenite is playing a minor role.  This can be supported by
the equivalent reductions in activity of Ogg1 in both the actively dividing and NGF
treated PC12 cells (Figure 18A).  It is reported that 10µM arsenite decreased DNA ligase
activities by 50% in human osteosarcoma cells, although the concentrations required to
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inhibit enzyme activity in this study were too high to be physiologically relevant (Hu, Su
et al. 1998).  An additional ex vivo experiment using the DNA repair enzyme
formamidopyrimidine DNA glycosylase (Fpg), a bacterial homologue of Ogg1, showed
no direct inhibition via arsenite at concentrations as low as 1µM (Asmuss, Mullenders et
al. 2000).  These studies suggest that decreased Ogg1 activities subsequent to arsenite
exposure in actively dividing and NGF treated PC12 cells are not occurring as a
consequence of any direct effect from arsenite.  Figure 20 also demonstrates that pre-
incubation of arsenite with glycosylase extracts has no direct effect on Ogg1 enzyme
activity.  In a study exposing rats to arsenite, or arsenite in combination with
benzo(a)pyrene (BP), showed similar results to the data in Figure 18.  An exposure of 2.5
µM sodium arsenite from 1 to 27 days resulted in no significant DNA adduct formation.
However, when arsenite was co-administered with BP, the level of DNA adducts
remained elevated compared to BP alone suggesting an attenuation of the DNA repair
systems because of arsenite (Tran, Prakash et al. 2002).  In addition, levels of oxo8dG
were increased when Ogg1 activity was attenuated post BP exposure (Stedeford,
Cardozo-Pelaez et al. 2001).  This study further suggests that arsenite may act through a
subtle mechanism that is not evident until an additional exposure is introduced.
A lack of data demonstrating a direct effect of arsenite on Ogg1 activity suggests
that alterations are due to some effect on the levels of the enzyme potentially due to
changes in gene transcription or translation.  The changes seen in Ogg1 activity can be a
result of changes in gene transcription.  To verify this, levels of Ogg1 mRNA were
assessed by quantitative RT-PCR revealing a decrease in Ogg1 transcript in actively
dividing PC12 cells exposed to arsenite.  Ogg1 mRNA was decreased by 30% in actively
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dividing PC12 cells exposed to arsenite.  Additional evidence for decreased Ogg1
transcription is demonstrated in Figure 18C.  Ogg1 activity remained consistently lower
despite increasing the amount of glycosylase protein used in the incision assay (Figure
18C) suggesting that the levels of Ogg1 were decreased as a consequence of arsenite
exposure; an event that can be attributed to decreased transcription of Ogg1.  Pre-treating
nuclear extracts with sodium arsenite also revealed no direct effect of arsenite on Ogg1
enzyme activity (Figure 20).  These findings further corroborate the idea that
transcriptional changes are facilitating decreased Ogg1 activities.  Acute exposure to
arsenic in previous work has demonstrated increased transcription of both NQO1 and
GCL; genes involved in antioxidant defense.  The transcript levels of both genes
recovered close to control levels 24 hr post-exposure (Schuliga, Chouchane et al. 2002;
Pi, Qu et al. 2003).  Temporal changes in gene transcription could account for the
disparity between the changes in Ogg1 mRNA (Figure 20) and more drastic decreases
shown in Ogg1 excision activity (Figure 18) suggesting a recovery of Ogg1 mRNA could
be occurring earlier.  Data collected at earlier time points could determine if the
transcriptional changes are more representative of enzyme activity.  Western blots of
Ogg1 protein levels could help corroborate the reductions seen in Ogg1 activity and
mRNA however, to date no reliable antibody has been found for Ogg1 by this laboratory
as validated by assays using protein extracts from Ogg1 knockout mice.
It has been suggested that the expression of Ogg1 can be modulated by the redox
status of the cell, a statement supported by the presence of the putative Nrf2 binding site
in the promoter of the human Ogg1 (Dhenaut, Boiteux et al. 2000).  Whether arsenic-
induced changes to cell redox status of PC12 cells are responsible for alterations in Ogg1
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expression remains uncertain, however the data presented indicate concomitant changes
in antioxidant systems (GSH), Ogg1 activity, and expression due to sodium arsenite
exposure. Ogg1 is the only enzyme to date known to initiate the repair of oxo8dG
(Klungland, Rosewell et al. 1999; Minowa, Arai et al. 2000).  Conditions where DNA
repair is continually compromised can lead to increased levels of oxo8dG; a situation that
can have deleterious effects in both actively dividing and differentiated cells.  Hyun et. al.
found that increased oxo8dG in an Ogg1 deficient human leukemia cell line (KG-1),
resulted in the induction of multiple apoptotic pathways despite the administration of
NAC.  In the same study, the induction of apoptotic pathways was dramatically reduced
in Ogg1 proficient cell lines suggesting that diminished DNA repair can result in the
induction of apoptotic pathways (Hyun, Jung et al. 2003).  Attenuated DNA repair can
also lead to the formation of oxo8dG and subsequently cause mutations by incorporating
adenine across from the oxidized guanine during DNA replication(Cheng, Jungst et al.
2002) (Figure 15).  Increased oxo8dG can also preclude cellular transformation having
been identified in the p53 tumor suppressor gene in lung and liver cancers (Hollstein, Peri
et al. 1991; Yu, Berlin et al. 2002).  Genomic maintenance becomes more relevant in
differentiated cellular populations that no longer have the capacity to initiate the repair of
DNA during cell cycle progression and replication.  The options for genomic
maintenance become limited to basal repair systems including constitutive, inducible, and
transcription-coupled repair; the latter being a process not associated with the removal of
oxo8dG from promoter regions.  This type of scenario can underscore the importance of
Ogg1 in maintaining not only genomic integrity, but the integrity of regulatory regions as
well.  The consequences of oxo8dG accumulation in post mitotic cells, such as neurons,
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could result in increased damage to promoter regions leading to the reduced transcription
of essential cellular proteins (Ghosh and Mitchell 1999; Lu, Pan et al. 2004).  Other
reports have suggested that activation of the cell cycle occurs as a response to DNA
damage and ultimately leads to apoptosis in primary cortical neurons (Kruman, Wersto et
al. 2004).  NGF treated PC12 showed an increasing trend for oxo8dG in both the control
and arsenite treated groups (Figure 23).  As stated earlier NGF causes the terminal
differentiation of PC12 cells giving them neuronal attributes.  In conjunction with a trend
in increased levels of DNA damage seen in Figure 23, the NGF treated PC12 cells may
undergo a similar mechanism of apoptosis suggested by Kruman et. al. (Kruman, Wersto
et al. 2004) thereby explaining their decreased resistance to sodium arsenite (Figure 16).
It is clear that a fundamental difference exists in antioxidants, DNA repair, and
DNA damage between actively dividing and NGF treated PC12 cells; a difference that
could account for the increased susceptibility in NGF treated PC12 cells exposed to
sodium arsenite.  Attenuated DNA repair in differentiated cellular populations can lead to
the accumulation of oxo8dG, an end result commonly found in correlation with
neurodegenerative disease (Sanchez-Ramos 1994; Gabbita, Lovell et al. 1998).  The
underlying question is whether oxo8dG is a precursor for cellular dysfunction, or a
product of the cellular dysfunction itself.
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SUMMARY
Using different structural and biochemical analyses, this study investigated two unique
mechanisms: (i) the role of transcription factor Nrf2 in the inducible transcription of
Ogg1 and (ii) the ability of sodium arsenite to disrupt the response capacity of Ogg1 in an
acute exposure model.  Results from structural analysis of the hOgg1 promoter reveal that
the putative Nrf2 binding site is an integral component of hOgg1 transcriptional
regulation.  This was confirmed by site-directed deletion of the binding site and
subsequent loss of transcription activity.
Binding analysis further showed a physical interaction occurred at this site that
was increased subsequent to treatments using tert-butylhydroquinone, a frequently used
chemical inducer of Nrf2.  Results from competitive binding revealed that binding to this
region of the hOgg1 promoter could be disrupted by a consensus Nrf2 sequence.  This
competition was unique as no competition was demonstrated between Sp1 and Nrf2
oligonucleotide sequences.  Results using reporter gene constructs revealed hOgg1
transcription is sensitive to Nrf2 modulating compounds and cellular redox changes.
Sensitivity to redox changes could be reversed with the over expression of mammalian
Nrf2.
Taken together, the results suggest the existence of an Nrf2 binding site in the
hOgg1 promoter.  Our proposed model in Figure 24 further suggests that hOgg1
transcription can be induced via Nrf2 as a consequence of cellular oxidative stress.  Nrf2
activation occurs via two main mechanisms: (1) changes in intracellular GSH, and (2)
direct interaction of electrophiles with Nrf2-KEAP1 complexes.  The model provides an
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additional transcription component for hOgg1 regulation for utilization in environmental
and/ or therapeutic studies.
Results from sodium arsenite exposure revealed changes in Ogg1 transcription
similar to the proposed model that can be best explained by increases in GSH.  The
model suggests that Ogg1 transcription can be down regulated in the presence of excess
intracellular GSH.  This was evident subsequent to arsenite exposure as GSH increased,
and Ogg1 mRNA and activities decreased.
170
REFERENCES
Achanta, G. and P. Huang (2004). "Role of p53 in sensing oxidative DNA damage in
response to reactive oxygen species-generating agents." Cancer Res 64(17): 6233-
9.
Agarwal, S. and R. S. Sohal (1994). "DNA oxidative damage and life expectancy in
houseflies." Proc Natl Acad Sci U S A 91(25): 12332-5.
Alam, J., D. Stewart, et al. (1999). "Nrf2, a Cap'n'Collar transcription factor, regulates
induction of the heme oxygenase-1 gene." J Biol Chem 274(37): 26071-8.
Andrew, A. S., M. R. Karagas, et al. (2003). "Decreased DNA repair gene expression
among individuals exposed to arsenic in United States drinking water." Int J
Cancer 104(3): 263-8.
Aoki, Y., H. Sato, et al. (2001). "Accelerated DNA adduct formation in the lung of the
Nrf2 knockout mouse exposed to diesel exhaust." Toxicol Appl Pharmacol
173(3): 154-60.
Aposhian, H. V., R. A. Zakharyan, et al. (2004). "A review of the enzymology of arsenic
metabolism and a new potential role of hydrogen peroxide in the detoxication of
the trivalent arsenic species." Toxicol Appl Pharmacol 198(3): 327-35.
Asmuss, M., L. H. Mullenders, et al. (2000). "Interference by toxic metal compounds
with isolated zinc finger DNA repair proteins." Toxicol Lett 112-113: 227-31.
Aspinwall, R., D. G. Rothwell, et al. (1997). "Cloning and characterization of a
functional human homolog of Escherichia coli endonuclease III." Proc Natl Acad
Sci U S A 94(1): 109-14.
Barber, T., E. Borras, et al. (2000). "Vitamin A deficiency causes oxidative damage to
liver mitochondria in rats." Free Radic Biol Med 29(1): 1-7.
Barchowsky, A., L. R. Klei, et al. (1999). "Stimulation of reactive oxygen, but not
reactive nitrogen species, in vascular endothelial cells exposed to low levels of
arsenite." Free Radic Biol Med 27(11-12): 1405-12.
Barchowsky, A., R. R. Roussel, et al. (1999). "Low levels of arsenic trioxide stimulate
proliferative signals in primary vascular cells without activating stress effector
pathways." Toxicol Appl Pharmacol 159(1): 65-75.
Barja, G. and A. Herrero (2000). "Oxidative damage to mitochondrial DNA is inversely
related to maximum life span in the heart and brain of mammals." Faseb J 14(2):
312-8.
Basha, M. R., W. Wei, et al. (2005). "The fetal basis of amyloidogenesis: exposure to
lead and latent overexpression of amyloid precursor protein and beta-amyloid in
the aging brain." J Neurosci 25(4): 823-9.
Bates, M. N., A. H. Smith, et al. (1992). "Arsenic ingestion and internal cancers: a
review." Am J Epidemiol 135(5): 462-76.
Bau, D. T., T. S. Wang, et al. (2002). "Oxidative DNA adducts and DNA-protein cross-
links are the major DNA lesions induced by arsenite." Environ Health Perspect
110 Suppl 5: 753-6.
Beckman, J. S. and W. H. Koppenol (1996). "Nitric oxide, superoxide, and peroxynitrite:
the good, the bad, and ugly." Am J Physiol 271(5 Pt 1): C1424-37.
Berg, M., H. C. Tran, et al. (2001). "Arsenic contamination of groundwater and drinking
water in Vietnam: a human health threat." Environ Sci Technol 35(13): 2621-6.
171
Bhakat, K. K., S. K. Mokkapati, et al. (2006). "Acetylation of human 8-oxoguanine-DNA
glycosylase by p300 and its role in 8-oxoguanine repair in vivo." Mol Cell Biol
26(5): 1654-65.
Blaauwgeers, H. G., J. M. Vianney de Jong, et al. (1996). "Enhanced superoxide
dismutase-2 immunoreactivity of astrocytes and occasional neurons in
amyotrophic lateral sclerosis." J Neurol Sci 140(1-2): 21-9.
Bloom, D. A. and A. K. Jaiswal (2003). "Phosphorylation of Nrf2 at Ser40 by protein
kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is
not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional
activation of antioxidant response element-mediated NAD(P)H:quinone
oxidoreductase-1 gene expression." J Biol Chem 278(45): 44675-82.
Bogdanov, M., R. H. Brown, et al. (2000). "Increased oxidative damage to DNA in ALS
patients." Free Radic Biol Med 29(7): 652-8.
Bohr, V. A. (2002). "Repair of oxidative DNA damage in nuclear and mitochondrial
DNA, and some changes with aging in mammalian cells." Free Radic Biol Med
32(9): 804-12.
Boiteux, S. and J. P. Radicella (2000). "The human OGG1 gene: structure, functions, and
its implication in the process of carcinogenesis." Arch Biochem Biophys 377(1):
1-8.
Bolin, C. M., R. Basha, et al. (2006). "Exposure to lead and the developmental origin of
oxidative DNA damage in the aging brain." Faseb J 20(6): 788-90.
Bravard, A., M. Vacher, et al. (2006). "Redox regulation of human OGG1 activity in
response to cellular oxidative stress." Mol Cell Biol 26(20): 7430-6.
Breen, A. P. and J. A. Murphy (1995). "Reactions of oxyl radicals with DNA." Free
Radic Biol Med 18(6): 1033-77.
Brown, K. G. and G. L. Ross (2002). "Arsenic, drinking water, and health: a position
paper of the American Council on Science and Health." Regul Toxicol Pharmacol
36(2): 162-74.
Bunderson, M., D. M. Brooks, et al. (2004). "Arsenic exposure exacerbates
atherosclerotic plaque formation and increases nitrotyrosine and leukotriene
biosynthesis." Toxicol Appl Pharmacol 201(1): 32-9.
Cadenas, E. and K. J. Davies (2000). "Mitochondrial free radical generation, oxidative
stress, and aging." Free Radic Biol Med 29(3-4): 222-30.
Cadenas, S. and G. Barja (1999). "Resveratrol, melatonin, vitamin E, and PBN protect
against renal oxidative DNA damage induced by the kidney carcinogen KBrO3."
Free Radic Biol Med 26(11-12): 1531-7.
Cardozo-Pelaez, F., P. J. Brooks, et al. (2000). "DNA damage, repair, and antioxidant
systems in brain regions: a correlative study." Free Radic Biol Med 28(5): 779-85.
Cardozo-Pelaez, F., D. P. Cox, et al. (2005). "Lack of the DNA repair enzyme OGG1
sensitizes dopamine neurons to manganese toxicity during development." Gene
Expr 12(4-6): 315-23.
Cardozo-Pelaez, F., S. Song, et al. (1998). "Attenuation of age-dependent oxidative
damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice." Neurobiol
Aging 19(4): 311-6.
Cardozo-Pelaez, F., S. Song, et al. (1999). "Oxidative DNA damage in the aging mouse
brain." Mov Disord 14(6): 972-80.
172
Cardozo-Pelaez, F., T. J. Stedeford, et al. (2002). "Effects of diethylmaleate on DNA
damage and repair in the mouse brain." Free Radic Biol Med 33(2): 292-8.
Chan, J. Y. and M. Kwong (2000). "Impaired expression of glutathione synthetic enzyme
genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein."
Biochim Biophys Acta 1517(1): 19-26.
Chance, B., H. Sies, et al. (1979). "Hydroperoxide metabolism in mammalian organs."
Physiol Rev 59(3): 527-605.
Chatterjee, A., E. Mambo, et al. (2006). "The effect of p53-RNAi and p53 knockout on
human 8-oxoguanine DNA glycosylase (hOgg1) activity." Faseb J 20(1): 112-4.
Chen, C. Y., J. H. Jang, et al. (2005). "Resveratrol upregulates heme oxygenase-1
expression via activation of NF-E2-related factor 2 in PC12 cells." Biochem
Biophys Res Commun 331(4): 993-1000.
Chen, Q., J. Marsh, et al. (1996). "Detection of 8-oxo-2'-deoxyguanosine, a marker of
oxidative DNA damage, in culture medium from human mesothelial cells exposed
to crocidolite asbestos." Carcinogenesis 17(11): 2525-7.
Cheng, B., C. Jungst, et al. (2002). "[Potential role of human DNA-repair enzymes
hMTH1, hOGG1 and hMYHalpha in the hepatocarcinogenesis]." J Huazhong
Univ Sci Technolog Med Sci 22(3): 206-11, 215.
Chou, W. C., H. Y. Chen, et al. (2005). "Arsenic suppresses gene expression in
promyelocytic leukemia cells partly through Sp1 oxidation." Blood 106(1): 304-
10.
Cox, D. P., Cardozo-Pelaez, F. (2007). "High Throughput Method for Assessment of
Cellular Reduced Glutathione in Mammalian Cells." Journal of Environmental
Protection Science 1: 23-28.
Crespo-Hernandez, C. E., D. M. Close, et al. (2007). "Determination of Redox Potentials
for the Watson-Crick Base Pairs, DNA Nucleosides, and Relevant Nucleoside
Analogues." J Phys Chem B.
Dalton, T. P., H. G. Shertzer, et al. (1999). "Regulation of gene expression by reactive
oxygen." Annu Rev Pharmacol Toxicol 39: 67-101.
Dantzer, F., L. Luna, et al. (2002). "Human OGG1 undergoes serine phosphorylation and
associates with the nuclear matrix and mitotic chromatin in vivo." Nucleic Acids
Res 30(11): 2349-57.
de Souza-Pinto, N. C., L. Eide, et al. (2001). "Repair of 8-oxodeoxyguanosine lesions in
mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and
8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice."
Cancer Res 61(14): 5378-81.
Desagher, S., J. Glowinski, et al. (1996). "Astrocytes protect neurons from hydrogen
peroxide toxicity." J Neurosci 16(8): 2553-62.
Devasagayam, T. P., S. Steenken, et al. (1991). "Formation of 8-
hydroxy(deoxy)guanosine and generation of strand breaks at guanine residues in
DNA by singlet oxygen." Biochemistry 30(25): 6283-9.
Dhenaut, A., S. Boiteux, et al. (2000). "Characterization of the hOGG1 promoter and its
expression during the cell cycle." Mutat Res 461(2): 109-18.
Dickinson, D. A., A. L. Levonen, et al. (2004). "Human glutamate cysteine ligase gene
regulation through the electrophile response element." Free Radic Biol Med
37(8): 1152-9.
173
Dinkova-Kostova, A. T., W. D. Holtzclaw, et al. (2002). "Direct evidence that sulfhydryl
groups of Keap1 are the sensors regulating induction of phase 2 enzymes that
protect against carcinogens and oxidants." Proc Natl Acad Sci U S A 99(18):
11908-13.
Dinkova-Kostova, A. T., W. D. Holtzclaw, et al. (2005). "Keap1, the sensor for
electrophiles and oxidants that regulates the phase 2 response, is a zinc
metalloprotein." Biochemistry 44(18): 6889-99.
Dizdaroglu, M., P. Jaruga, et al. (2002). "Free radical-induced damage to DNA:
mechanisms and measurement." Free Radic Biol Med 32(11): 1102-15.
Dugan, L. L., D. J. Creedon, et al. (1997). "Rapid suppression of free radical formation
by nerve growth factor involves the mitogen-activated protein kinase pathway."
Proc Natl Acad Sci U S A 94(8): 4086-91.
Eftekharpour, E., A. Holmgren, et al. (2000). "Thioredoxin reductase and glutathione
synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in
cortical neurons." Glia 31(3): 241-8.
Ekshyyan, O. and T. Y. Aw (2005). "Decreased susceptibility of differentiated PC12 cells
to oxidative challenge: relationship to cellular redox and expression of apoptotic
protease activator factor-1." Cell Death Differ 12(8): 1066-77.
Engel, R. R. and A. H. Smith (1994). "Arsenic in drinking water and mortality from
vascular disease: an ecologic analysis in 30 counties in the United States." Arch
Environ Health 49(5): 418-27.
Flora, S. J. (1999). "Arsenic-induced oxidative stress and its reversibility following
combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic
acid in rats." Clin Exp Pharmacol Physiol 26(11): 865-9.
Forman, H. J. and D. A. Dickinson (2003). "Oxidative signaling and glutathione
synthesis." Biofactors 17(1-4): 1-12.
Fraga, C. G., M. K. Shigenaga, et al. (1990). "Oxidative damage to DNA during aging: 8-
hydroxy-2'-deoxyguanosine in rat organ DNA and urine." Proc Natl Acad Sci U S
A 87(12): 4533-7.
Fridovich, I. (1995). "Superoxide radical and superoxide dismutases." Annu Rev
Biochem 64: 97-112.
Fukae, J., M. Takanashi, et al. (2005). "Expression of 8-oxoguanine DNA glycosylase
(OGG1) in Parkinson's disease and related neurodegenerative disorders." Acta
Neuropathol (Berl) 109(3): 256-62.
Gabbita, S. P., M. A. Lovell, et al. (1998). "Increased nuclear DNA oxidation in the brain
in Alzheimer's disease." J Neurochem 71(5): 2034-40.
Gabelova, A., Z. Valovicova, et al. (2007). "Assessment of oxidative DNA damage
formation by organic complex mixtures from airborne particles PM(10)." Mutat
Res.
Germolec, D. R., J. Spalding, et al. (1998). "Arsenic enhancement of skin neoplasia by
chronic stimulation of growth factors." Am J Pathol 153(6): 1775-85.
Ghosh, R. and D. L. Mitchell (1999). "Effect of oxidative DNA damage in promoter
elements on transcription factor binding." Nucleic Acids Res 27(15): 3213-8.
Giulivi, C., A. Boveris, et al. (1995). "Hydroxyl radical generation during mitochondrial
electron transfer and the formation of 8-hydroxydesoxyguanosine in
mitochondrial DNA." Arch Biochem Biophys 316(2): 909-16.
174
Greene, L. A. and A. S. Tischler (1976). "Establishment of a noradrenergic clonal line of
rat adrenal pheochromocytoma cells which respond to nerve growth factor." Proc
Natl Acad Sci U S A 73(7): 2424-8.
Griffith, O. W. (1982). "Mechanism of action, metabolism, and toxicity of buthionine
sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis." J
Biol Chem 257(22): 13704-12.
Griffith, O. W. (1999). "Biologic and pharmacologic regulation of mammalian
glutathione synthesis." Free Radic Biol Med 27(9-10): 922-35.
Hailer, M. K., P. G. Slade, et al. (2005). "Nei deficient Escherichia coli are sensitive to
chromate and accumulate the oxidized guanine lesion spiroiminodihydantoin."
Chem Res Toxicol 18(9): 1378-83.
Halliwell, B., Gutteridge, J.M.C. (1999). Free Radicals in Biology and Medicine. Oxford,
NY, Oxford University Press.
Hamadeh, H. K., K. J. Trouba, et al. (2002). "Coordination of altered DNA repair and
damage pathways in arsenite-exposed keratinocytes." Toxicol Sci 69(2): 306-16.
Hamilton, M. L., Z. Guo, et al. (2001). "A reliable assessment of 8-oxo-2-
deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium
iodide method to isolate DNA." Nucleic Acids Res 29(10): 2117-26.
Hansen, J. M., W. H. Watson, et al. (2004). "Compartmentation of Nrf-2 redox control:
regulation of cytoplasmic activation by glutathione and DNA binding by
thioredoxin-1." Toxicol Sci 82(1): 308-17.
Hartwig, A., H. Blessing, et al. (2003). "Modulation of DNA repair processes by arsenic
and selenium compounds." Toxicology 193(1-2): 161-9.
Hazra, T. K., T. Izumi, et al. (1998). "The presence of two distinct 8-oxoguanine repair
enzymes in human cells: their potential complementary roles in preventing
mutation." Nucleic Acids Res 26(22): 5116-22.
Hedley, D. W. and S. Chow (1994). "Evaluation of methods for measuring cellular
glutathione content using flow cytometry." Cytometry 15(4): 349-58.
Helbock, H. J., K. B. Beckman, et al. (1998). "DNA oxidation matters: the HPLC-
electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine."
Proc Natl Acad Sci U S A 95(1): 288-93.
Hirano, S., Y. Kobayashi, et al. (2004). "The accumulation and toxicity of methylated
arsenicals in endothelial cells: important roles of thiol compounds." Toxicol Appl
Pharmacol 198(3): 458-67.
Hirano, T., R. Yamaguchi, et al. (1996). "8-hydroxyguanine levels in nuclear DNA and
its repair activity in rat organs associated with age." J Gerontol A Biol Sci Med
Sci 51(5): B303-7.
Hodges, N. J. and J. K. Chipman (2002). "Down-regulation of the DNA-repair
endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate
in cultured human A549 lung carcinoma cells." Carcinogenesis 23(1): 55-60.
Hollstein, M., D. Sidransky, et al. (1991). "p53 mutations in human cancers." Science
253(5015): 49-53.
Hollstein, M. C., L. Peri, et al. (1991). "Genetic analysis of human esophageal tumors
from two high incidence geographic areas: frequent p53 base substitutions and
absence of ras mutations." Cancer Res 51(15): 4102-6.
175
Horan, A. D., C. Y. Chan, et al. (1997). "Analysis of tumor thiol concentrations:
comparison of flow cytometric with chemical and biochemical techniques."
Cytometry 29(1): 76-82.
Hu, J., S. Z. Imam, et al. (2005). "Phosphorylation of human oxoguanine DNA
glycosylase (alpha-OGG1) modulates its function." Nucleic Acids Res 33(10):
3271-82.
Hu, Y., X. Jin, et al. (2002). "Effect of arsenic on transcription factor AP-1 and NF-
kappaB DNA binding activity and related gene expression." Toxicol Lett 133(1):
33-45.
Hu, Y., L. Su, et al. (1998). "Arsenic toxicity is enzyme specific and its affects on
ligation are not caused by the direct inhibition of DNA repair enzymes." Mutat
Res 408(3): 203-18.
Huang, C. S., M. E. Anderson, et al. (1993). "Amino acid sequence and function of the
light subunit of rat kidney gamma-glutamylcysteine synthetase." J Biol Chem
268(27): 20578-83.
Hyun, J. W., Y. C. Jung, et al. (2003). "8-hydroxydeoxyguanosine causes death of human
leukemia cells deficient in 8-oxoguanine glycosylase 1 activity by inducing
apoptosis." Mol Cancer Res 1(4): 290-9.
Itoh, K., T. Chiba, et al. (1997). "An Nrf2/small Maf heterodimer mediates the induction
of phase II detoxifying enzyme genes through antioxidant response elements."
Biochem Biophys Res Commun 236(2): 313-22.
Itoh, K., K. I. Tong, et al. (2004). "Molecular mechanism activating Nrf2-Keap1 pathway
in regulation of adaptive response to electrophiles." Free Radic Biol Med 36(10):
1208-13.
Itoh, K., N. Wakabayashi, et al. (1999). "Keap1 represses nuclear activation of
antioxidant responsive elements by Nrf2 through binding to the amino-terminal
Neh2 domain." Genes Dev 13(1): 76-86.
Jeong, H. G., C. K. Youn, et al. (2004). "Metallothionein-III prevents gamma-ray-
induced 8-oxoguanine accumulation in normal and hOGG1-depleted cells." J Biol
Chem 279(33): 34138-49.
Kalyanaraman, B., H. Karoui, et al. (1996). "Detection of thiyl radical adducts formed
during hydroxyl radical- and peroxynitrite-mediated oxidation of thiols--a high
resolution ESR spin-trapping study at Q-band (35 GHz)." Anal Biochem 241(1):
75-81.
Kamendulis, L. M., J. Jiang, et al. (1999). "Induction of oxidative stress and oxidative
damage in rat glial cells by acrylonitrile." Carcinogenesis 20(8): 1555-60.
Kann, S., C. Estes, et al. (2005). "Butylhydroquinone protects cells genetically deficient
in glutathione biosynthesis from arsenite-induced apoptosis without significantly
changing their prooxidant status." Toxicol Sci 87(2): 365-84.
Kasai, H., P. F. Crain, et al. (1986). "Formation of 8-hydroxyguanine moiety in cellular
DNA by agents producing oxygen radicals and evidence for its repair."
Carcinogenesis 7(11): 1849-51.
Kaur, P., S. Kalia, et al. (2006). "Effect of diethyl maleate induced oxidative stress on
male reproductive activity in mice: redox active enzymes and transcription factors
expression." Mol Cell Biochem 291(1-2): 55-61.
176
Kehrer, J. P. (2000). "The Haber-Weiss reaction and mechanisms of toxicity."
Toxicology 149(1): 43-50.
Kehrer, J. P. and L. G. Lund (1994). "Cellular reducing equivalents and oxidative stress."
Free Radic Biol Med 17(1): 65-75.
Ketterer, B. (1988). "Protective role of glutathione and glutathione transferases in
mutagenesis and carcinogenesis." Mutat Res 202(2): 343-61.
Kim, B. R., R. Hu, et al. (2003). "Effects of glutathione on antioxidant response element-
mediated gene expression and apoptosis elicited by sulforaphane." Cancer Res
63(21): 7520-5.
Kim, H. N., Y. Morimoto, et al. (2001). "Changes in DNA 8-hydroxyguanine levels, 8-
hydroxyguanine repair activity, and hOGG1 and hMTH1 mRNA expression in
human lung alveolar epithelial cells induced by crocidolite asbestos."
Carcinogenesis 22(2): 265-9.
Kim, J. I., Y. J. Park, et al. (2003). "hOGG1 Ser326Cys polymorphism modifies the
significance of the environmental risk factor for colon cancer." World J
Gastroenterol 9(5): 956-60.
Klungland, A. and S. Bjelland (2007). "Oxidative damage to purines in DNA: role of
mammalian Ogg1." DNA Repair (Amst) 6(4): 481-8.
Klungland, A., I. Rosewell, et al. (1999). "Accumulation of premutagenic DNA lesions in
mice defective in removal of oxidative base damage." Proc Natl Acad Sci U S A
96(23): 13300-5.
Kruman, II, R. P. Wersto, et al. (2004). "Cell cycle activation linked to neuronal cell
death initiated by DNA damage." Neuron 41(4): 549-61.
Lan, J., W. Li, et al. (2003). "Inducible repair of oxidative DNA lesions in the rat brain
after transient focal ischemia and reperfusion." J Cereb Blood Flow Metab
23(11): 1324-39.
Lardinois, O. M. (1995). "Reactions of bovine liver catalase with superoxide radicals and
hydrogen peroxide." Free Radic Res 22(3): 251-74.
Lee, J. M., M. J. Calkins, et al. (2003). "Identification of the NF-E2-related factor-2-
dependent genes conferring protection against oxidative stress in primary cortical
astrocytes using oligonucleotide microarray analysis." J Biol Chem 278(14):
12029-38.
Lee, J. M. and J. A. Johnson (2004). "An important role of Nrf2-ARE pathway in the
cellular defense mechanism." J Biochem Mol Biol 37(2): 139-43.
Lee, J. M., J. D. Moehlenkamp, et al. (2001). "Nrf2-dependent activation of the
antioxidant responsive element by tert-butylhydroquinone is independent of
oxidative stress in IMR-32 human neuroblastoma cells." Biochem Biophys Res
Commun 280(1): 286-92.
Lee, M. R., S. H. Kim, et al. (2004). "Transcription factors NF-YA regulate the induction
of human OGG1 following DNA-alkylating agent methylmethane sulfonate
(MMS) treatment." J Biol Chem 279(11): 9857-66.
Lewis, D. R., J. W. Southwick, et al. (1999). "Drinking water arsenic in Utah: A cohort
mortality study." Environ Health Perspect 107(5): 359-65.
Li, J., Stein, T.D., Johnson, J.A. (2004). "Genetic dissection of systemic autoimmune
disease in Nrf2-deficient mice." Physiol Genomics 18: 261-272.
177
Lin, L. H., S. Cao, et al. (2000). "Up-regulation of base excision repair activity for 8-
hydroxy-2'-deoxyguanosine in the mouse brain after forebrain ischemia-
reperfusion." J Neurochem 74(3): 1098-105.
Liu, F. and K. Y. Jan (2000). "DNA damage in arsenite- and cadmium-treated bovine
aortic endothelial cells." Free Radic Biol Med 28(1): 55-63.
Liu, Y., K. Z. Guyton, et al. (1996). "Differential activation of ERK, JNK/SAPK and
P38/CSBP/RK map kinase family members during the cellular response to
arsenite." Free Radic Biol Med 21(6): 771-81.
Liu, Z., J. Shen, et al. (2002). "Arsenite transport by mammalian aquaglyceroporins
AQP7 and AQP9." Proc Natl Acad Sci U S A 99(9): 6053-8.
Lu, T., Y. Pan, et al. (2004). "Gene regulation and DNA damage in the ageing human
brain." Nature 429(6994): 883-91.
Lyras, L., N. J. Cairns, et al. (1997). "An assessment of oxidative damage to proteins,
lipids, and DNA in brain from patients with Alzheimer's disease." J Neurochem
68(5): 2061-9.
Martin, D., A. I. Rojo, et al. (2004). "Regulation of heme oxygenase-1 expression
through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription
factor in response to the antioxidant phytochemical carnosol." J Biol Chem
279(10): 8919-29.
Martin, J. and I. N. White (1991). "Fluorimetric determination of oxidised and reduced
glutathione in cells and tissues by high-performance liquid chromatography
following derivatization with dansyl chloride." J Chromatogr 568(1): 219-25.
Matsui, M., C. Nishigori, et al. (1999). "The role of oxidative DNA damage in human
arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-
related Bowen's disease." J Invest Dermatol 113(1): 26-31.
McMahon, M., N. Thomas, et al. (2004). "Redox-regulated turnover of Nrf2 is
determined by at least two separate protein domains, the redox-sensitive Neh2
degron and the redox-insensitive Neh6 degron." J Biol Chem 279(30): 31556-67.
Mecocci, P., U. MacGarvey, et al. (1993). "Oxidative damage to mitochondrial DNA
shows marked age-dependent increases in human brain." Ann Neurol 34(4): 609-
16.
Meister, A. and M. E. Anderson (1983). "Glutathione." Annu Rev Biochem 52: 711-60.
Merrill, C. L., H. Ni, et al. (2002). "Etomoxir-induced oxidative stress in HepG2 cells
detected by differential gene expression is confirmed biochemically." Toxicol Sci
68(1): 93-101.
Mills, E. M., K. Takeda, et al. (1998). "Nerve growth factor treatment prevents the
increase in superoxide produced by epidermal growth factor in PC12 cells." J Biol
Chem 273(35): 22165-8.
Minowa, O., T. Arai, et al. (2000). "Mmh/Ogg1 gene inactivation results in accumulation
of 8-hydroxyguanine in mice." Proc Natl Acad Sci U S A 97(8): 4156-61.
Mo, J., Y. Xia, et al. (2006). "Chronic arsenic exposure and oxidative stress: OGG1
expression and arsenic exposure, nail selenium, and skin hyperkeratosis in inner
mongolia." Environ Health Perspect 114(6): 835-41.
Moi, P., K. Chan, et al. (1994). "Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like
basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1
178
repeat of the beta-globin locus control region." Proc Natl Acad Sci U S A 91(21):
9926-30.
Murphy, T. H., J. Yu, et al. (2001). "Preferential expression of antioxidant response
element mediated gene expression in astrocytes." J Neurochem 76(6): 1670-8.
Nakajima, A., K. Yamada, et al. (2002). "Interleukin-6 protects PC12 cells from 4-
hydroxynonenal-induced cytotoxicity by increasing intracellular glutathione
levels." Free Radic Biol Med 32(12): 1324-32.
Nguyen, T., P. J. Sherratt, et al. (2003). "Increased protein stability as a mechanism that
enhances Nrf2-mediated transcriptional activation of the antioxidant response
element. Degradation of Nrf2 by the 26 S proteasome." J Biol Chem 278(7):
4536-41.
Nguyen, T., C. S. Yang, et al. (2004). "The pathways and molecular mechanisms
regulating Nrf2 activation in response to chemical stress." Free Radic Biol Med
37(4): 433-41.
Nishioka, K., T. Ohtsubo, et al. (1999). "Expression and differential intracellular
localization of two major forms of human 8-oxoguanine DNA glycosylase
encoded by alternatively spliced OGG1 mRNAs." Mol Biol Cell 10(5): 1637-52.
Nordstrom, D. K. (2002). "Public health. Worldwide occurrences of arsenic in ground
water." Science 296(5576): 2143-5.
Ochi, T. (1997). "Arsenic compound-induced increases in glutathione levels in cultured
Chinese hamster V79 cells and mechanisms associated with changes in gamma-
glutamylcysteine synthetase activity, cystine uptake and utilization of cysteine."
Arch Toxicol 71(12): 730-40.
Ongwijitwat, S. and M. T. Wong-Riley (2004). "Functional analysis of the rat
cytochrome c oxidase subunit 6A1 promoter in primary neurons." Gene 337: 163-
71.
Pan, Z. and R. Perez-Polo (1996). "Increased uptake of L-cysteine and L-cystine by nerve
growth factor in rat pheochromocytoma cells." Brain Res 740(1-2): 21-6.
Pan, Z. and R. Perez-Polo (1996). "Regulation of gamma-glutamylcysteine synthetase
activity by nerve growth factor." Int J Dev Neurosci 14(5): 559-66.
Parrish, A. R., X. H. Zheng, et al. (1999). "Enhanced transcription factor DNA binding
and gene expression induced by arsenite or arsenate in renal slices." Toxicol Sci
50(1): 98-105.
Petrick, J. S., F. Ayala-Fierro, et al. (2000). "Monomethylarsonous acid (MMA(III)) is
more toxic than arsenite in Chang human hepatocytes." Toxicol Appl Pharmacol
163(2): 203-7.
Pi, J., W. Qu, et al. (2003). "Transcription factor Nrf2 activation by inorganic arsenic in
cultured keratinocytes: involvement of hydrogen peroxide." Exp Cell Res 290(2):
234-45.
Pi, J., H. Yamauchi, et al. (2002). "Evidence for induction of oxidative stress caused by
chronic exposure of Chinese residents to arsenic contained in drinking water."
Environ Health Perspect 110(4): 331-6.
Piao, F., N. Ma, et al. (2005). "Oxidative DNA damage in relation to neurotoxicity in the
brain of mice exposed to arsenic at environmentally relevant levels." J Occup
Health 47(5): 445-9.
179
Potts, R. J., R. D. Watkin, et al. (2003). "Cadmium exposure down-regulates 8-
oxoguanine DNA glycosylase expression in rat lung and alveolar epithelial cells."
Toxicology 184(2-3): 189-202.
Prosperi, M. T., D. Ferbus, et al. (1998). "The pag gene product, a physiological inhibitor
of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact
with agents inducing oxidative stress." FEBS Lett 423(1): 39-44.
Pu, Y. S., K. Y. Jan, et al. (2007). "8-Oxoguanine DNA glycosylase and MutY homolog
are involved in the incision of arsenite-induced DNA adducts." Toxicol Sci 95(2):
376-82.
Qi, W., R. J. Reiter, et al. (2000). "Chromium(III)-induced 8-hydroxydeoxyguanosine in
DNA and its reduction by antioxidants: comparative effects of melatonin,
ascorbate, and vitamin E." Environ Health Perspect 108(5): 399-402.
Rahman, M., M. Tondel, et al. (1999). "Hypertension and arsenic exposure in
Bangladesh." Hypertension 33(1): 74-8.
Ramanathan, K., B. S. Balakumar, et al. (2002). "Effects of ascorbic acid and alpha-
tocopherol on arsenic-induced oxidative stress." Hum Exp Toxicol 21(12): 675-
80.
Rangasamy, T., C. Y. Cho, et al. (2004). "Genetic ablation of Nrf2 enhances
susceptibility to cigarette smoke-induced emphysema in mice." J Clin Invest
114(9): 1248-59.
Remiao, F., H. Carmo, et al. (2000). "Simultaneous determination of reduced and
oxidized glutathione in freshly isolated rat hepatocytes and cardiomyocytes by
HPLC with electrochemical detection." Biomed Chromatogr 14(7): 468-73.
Rojewski, M. T., S. Korper, et al. (2004). "Depolarization of mitochondria and activation
of caspases are common features of arsenic(III)-induced apoptosis in myelogenic
and lymphatic cell lines." Chem Res Toxicol 17(1): 119-28.
Rosenquist, T. A., D. O. Zharkov, et al. (1997). "Cloning and characterization of a
mammalian 8-oxoguanine DNA glycosylase." Proc Natl Acad Sci U S A 94(14):
7429-34.
Rushmore, T. H. and C. B. Pickett (1990). "Transcriptional regulation of the rat
glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-
responsive element controlling inducible expression by phenolic antioxidants." J
Biol Chem 265(24): 14648-53.
Sakurai, T., M. Ochiai, et al. (2004). "Role of glutathione in dimethylarsinic acid-induced
apoptosis." Toxicol Appl Pharmacol 198(3): 354-65.
Salinas, M., R. Diaz, et al. (2003). "Nerve growth factor protects against 6-
hydroxydopamine-induced oxidative stress by increasing expression of heme
oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner." J Biol Chem
278(16): 13898-904.
Sanchez-Ramos, J., Overvik, Eva., Ames, B. (1994). "A Marker of Oxyradical-Mediated
DNA Damage (8-Hydroxy-2'-Deoxyguanosine) is Increased in Nigro-Striatum of
Parkinson's Disease Brain." Neurodegeneration 3: 197-204.
Sasaki, H., H. Sato, et al. (2002). "Electrophile response element-mediated induction of
the cystine/glutamate exchange transporter gene expression." J Biol Chem
277(47): 44765-71.
180
Sasaki, N., N. Baba, et al. (2001). "Cytotoxicity of reactive oxygen species and related
agents toward undifferentiated and differentiated rat phenochromocytoma PC12
cells." Biol Pharm Bull 24(5): 515-9.
Schuliga, M., S. Chouchane, et al. (2002). "Upregulation of glutathione-related genes and
enzyme activities in cultured human cells by sublethal concentrations of inorganic
arsenic." Toxicol Sci 70(2): 183-92.
Scott, N., K. M. Hatlelid, et al. (1993). "Reactions of arsenic(III) and arsenic(V) species
with glutathione." Chem Res Toxicol 6(1): 102-6.
Sebastia, J., R. Cristofol, et al. (2003). "Evaluation of fluorescent dyes for measuring
intracellular glutathione content in primary cultures of human neurons and
neuroblastoma SH-SY5Y." Cytometry A 51(1): 16-25.
Senft, A. P., T. P. Dalton, et al. (2000). "Determining glutathione and glutathione
disulfide using the fluorescence probe o-phthalaldehyde." Anal Biochem 280(1):
80-6.
Shibutani, S., M. Takeshita, et al. (1991). "Insertion of specific bases during DNA
synthesis past the oxidation-damaged base 8-oxodG." Nature 349(6308): 431-4.
Shih, A. Y., D. A. Johnson, et al. (2003). "Coordinate regulation of glutathione
biosynthesis and release by Nrf2-expressing glia potently protects neurons from
oxidative stress." J Neurosci 23(8): 3394-406.
Sies, H. (1999). "Glutathione and its role in cellular functions." Free Radic Biol Med
27(9-10): 916-21.
Slade, P. G., M. K. Hailer, et al. (2005). "Guanine-specific oxidation of double-stranded
DNA by Cr(VI) and ascorbic acid forms spiroiminodihydantoin and 8-oxo-2'-
deoxyguanosine." Chem Res Toxicol 18(7): 1140-9.
Smith, K. R., L. R. Klei, et al. (2001). "Arsenite stimulates plasma membrane NADPH
oxidase in vascular endothelial cells." Am J Physiol Lung Cell Mol Physiol
280(3): L442-9.
Stedeford, T., F. Cardozo-Pelaez, et al. (2001). "Organ-specific differences in 8-
oxoguanosine glycosylase (OGG1) repair following acute treatment with
benzo[a]pyrene." Res Commun Mol Pathol Pharmacol 109(1-2): 73-85.
Suh, J. H., S. V. Shenvi, et al. (2004). "Decline in transcriptional activity of Nrf2 causes
age-related loss of glutathione synthesis, which is reversible with lipoic acid."
Proc Natl Acad Sci U S A 101(10): 3381-6.
Sung, Y. J., C. L. Cheng, et al. (2003). "Distinct mechanisms account for beta-amyloid
toxicity in PC12 and differentiated PC12 neuronal cells." J Biomed Sci 10(4):
379-88.
Tauskela, J. S., K. Hewitt, et al. (2000). "Evaluation of glutathione-sensitive fluorescent
dyes in cortical culture." Glia 30(4): 329-41.
Tietze, F. (1969). "Enzymic method for quantitative determination of nanogram amounts
of total and oxidized glutathione: applications to mammalian blood and other
tissues." Anal Biochem 27(3): 502-22.
Tran, H. P., A. S. Prakash, et al. (2002). "Arsenic inhibits the repair of DNA damage
induced by benzo(a)pyrene." Toxicol Lett 133(1): 59-67.
Tsurudome, Y., T. Hirano, et al. (1999). "Changes in levels of 8-hydroxyguanine in
DNA, its repair and OGG1 mRNA in rat lungs after intratracheal administration
of diesel exhaust particles." Carcinogenesis 20(8): 1573-6.
181
Upadhyay, S., A. Chatterjee, et al. (2007). "TAp63gamma regulates hOGG1 and repair of
oxidative damage in cancer cell lines." Biochem Biophys Res Commun.
Venugopal, R. and A. K. Jaiswal (1996). "Nrf1 and Nrf2 positively and c-Fos and Fra1
negatively regulate the human antioxidant response element-mediated expression
of NAD(P)H:quinone oxidoreductase1 gene." Proc Natl Acad Sci U S A 93(25):
14960-5.
Venugopal, R. and A. K. Jaiswal (1998). "Nrf2 and Nrf1 in association with Jun proteins
regulate antioxidant response element-mediated expression and coordinated
induction of genes encoding detoxifying enzymes." Oncogene 17(24): 3145-56.
Wallace, S. S. (1998). "Enzymatic processing of radiation-induced free radical damage in
DNA." Radiat Res 150(5 Suppl): S60-79.
Wanibuchi, H., E. I. Salim, et al. (2004). "Understanding arsenic carcinogenicity by the
use of animal models." Toxicol Appl Pharmacol 198(3): 366-76.
Warner, B. B., L. Stuart, et al. (1996). "Redox regulation of manganese superoxide
dismutase." Am J Physiol 271(1 Pt 1): L150-8.
Welch, K. D., T. Z. Davis, et al. (2002). "Deleterious iron-mediated oxidation of
biomolecules." Free Radic Biol Med 32(7): 577-83.
Wilson, D. M., 3rd and L. H. Thompson (1997). "Life without DNA repair." Proc Natl
Acad Sci U S A 94(24): 12754-7.
Xu, Y., A. Krishnan, et al. (1999). "Mutations in the promoter reveal a cause for the
reduced expression of the human manganese superoxide dismutase gene in cancer
cells." Oncogene 18(1): 93-102.
Yamanaka, K., F. Takabayashi, et al. (2001). "Oral exposure of dimethylarsinic acid, a
main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-
deoxyguanosine level, specifically in the target organs for arsenic
carcinogenesis." Biochem Biophys Res Commun 287(1): 66-70.
Youn, C. K., S. H. Kim, et al. (2005). "Cadmium down-regulates human OGG1 through
suppression of Sp1 activity." J Biol Chem 280(26): 25185-95.
Yu, D., J. A. Berlin, et al. (2002). "Reactive oxygen species generated by PAH o-
quinones cause change-in-function mutations in p53." Chem Res Toxicol 15(6):
832-42.
Yu, R., C. Chen, et al. (2000). "Activation of mitogen-activated protein kinase pathways
induces antioxidant response element-mediated gene expression via a Nrf2-
dependent mechanism." J Biol Chem 275(51): 39907-13.
Yu, R., W. Lei, et al. (1999). "Role of a mitogen-activated protein kinase pathway in the
induction of phase II detoxifying enzymes by chemicals." J Biol Chem 274(39):
27545-52.
Zharkov, D. O. and T. A. Rosenquist (2002). "Inactivation of mammalian 8-oxoguanine-
DNA glycosylase by cadmium(II): implications for cadmium genotoxicity." DNA
Repair (Amst) 1(8): 661-70.
Zuliani, T., V. Denis, et al. (2005). "Hydrogen peroxide-induced cell death in normal







SECTION I:  Oligonucleotide Sequences for RT-PCR Primers and Probes
I.i  Rat Ogg1 RT-PCR Primer and Probe Set
Transcript Target
GENBank  #
Oligonucleotide Sequence  5´ – 3´
Forward Primer; Fluorescent Probe; Reverse Primer
Rat Ogg1
NM_030870
GGC CTC TAT TCC GTG TCC AC
FAM/TCT GAG CTG CGT CTG GAC CTG GTT T/TAMTph
CGG AAG GAC TGT CCA GAA GC
Rat HPRT
XM_343829
GCT CGA GAT GTC ATG AAG GAG A
HEX/CAT CAC ATT GTG GCC CTC TGT GTG CT/BHQ2
AGG TCA GCA AAG AAC TTA TAG CCC
I.ii  Mouse Ogg1 RT-PCR Primer and Probe Set
Transcript Target
GENBank #
Oligonucleotide Sequence  5´ – 3´
Forward Primer; Fluorescent Probe; Reverse Primer
Mouse Ogg1
U96711
GCC CAA GCA GTG CTG TTC A
FAM/TGC TGA CCT TCG CCA ACC AAG CC/TAMTph
GCT GGT GGC TCC CGA AA
Mouse HPRT
BC004686
GCT CGA GAT GTC ATG AAG GAG A
HEX/CAT CAC ATT GTG GCC CTC TGT GTG CT/BHQ2
AGG TCA GCA AAG AAC TTA TAG CCC
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SECTION II:  Oligonucleotide Sequences for EMSA Probe Sets
II.i  Consensus Nrf2 and hOgg1 Nrf2 EMSA Probes
Transcription Factor
Binding Site
Oligonucleotide Sequence  5´ – 3´
Sense; Anti-sense
Consensus Nrf2 GAA ATG ACA TTG CTA ATG GTG ACA AAG CAA C
GTT GCT TTG TCA CCA TTA GCA ATG TCA TTT C
hOgg1-Nrf2 TGA GCC CTA CTT CCG GTG GTG CTG
CAG CAC CAC CGG AAG TAG GGC TCA
II.ii  Sp1 EMSA Probes
Transcription Factor
Binding Site
Oligonucleotide Sequence  5´ – 3´
Sense; Anti-sense
Sp1 Oligo Set 1
GCA AGG AGG GGG CGG GAC CTA CAC
GTG TAG GTC CCG CCC CCT CCT TGC
Sp1 Oligo Set 2
TCC TTG TCT GGG CGG GGT CTT TGG
CCA AAG ACC CCG CCC AGA CAA GGA
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SECTION III:  Oligonucleotide Sequences of PCR Primers Used for Reporter Gene
   Expression Vector Construction
III.i  Human Ogg1 Promoter PCR Primer Oligonucleotides
PCR Product
(Size)








GGT ACC TTT ACT GCT GTG CAT GCT ACA TT




SECTION IV:  Oligonucleotide Sequences of PCR Primers Used for Site Directed
             Deletion of Nrf2
IV.i  Primer Sequences of Oligonucleotides Used in Site Directed Deletion of the
Putative Nrf2 Binding Site in the Human Ogg1 Promoter
Deletion Target Oligonucleotide Sequence  5´ – 3´
Forward, Reverse
Putative Nrf2 Site GGT TGA GCC CTA CGG TGG TGC TGT
 CCA CAG CAC CAC CGT AGG GCT CAA CC
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SECTION V.  Vector Maps of Reporter Gene and Mammalian Expression Vectors




























Plasmid name: pAM/CAG-EGFP-WPRE-BGH polyA
Plasmid size: 6305 bp
Constructed by: Helen
Construction date: March 2000
Comments: 716 bp EGFP was removed from pAM/NSE-EGFP-WPRE with Nco I (blunt) and Eco RI 
and inserted into Bam HI (blunt) and Eco RI of pAM/NSE-hGAD65-WPRE (EGFP replaces hGAD65). 
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Plasmid name: pAM/CAG-EGFP-WPRE-BGH polyA
Plasmid size: 6305 bp
Constructed by: Dave Cox
Construction date: September 2004
Comments: 716 bp EGFP was removed from pAM/NSE-EGFP-WPRE with Nco I (blunt) and Eco RI and 
inserted into Bam HI (blunt) and Eco RI of pAM/NSE-hGAD65-WPRE (EGFP replaces hGAD65). 
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Figure III.  Vector Map of pGL3/hOgg1-Luc+
Kpn I 5
Xho II, Dpn I 2143
Hind III 2160
Nco I 2193




Xba I  3849











SV40 late poly(A) signal
              (for luc+ reporter)
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Plasmid size: 8421 bp
Constructed by: Orkin. S
Construction date: 1995
Comments: pBluescript with addition of human elongation factor 1-a promoter (pEF) in Hind III-Not I 
sites, neomycin phosphotransferase (NPT II) under control of phosphoglycerate kinase promoter 
(PGK) cloned into Xho I-Cla I sites, and Nrf2 in Not I 
192

























Plasmid size: 8421 bp
Constructed by: Orkin. S
Construction date: 1995
Comments: pBluescript with addition of human elongation factor 1-a promoter (pEF) in Hind III-Not I 
sites, neomycin phosphotransferase (NPT II) under control of phosphoglycerate kinase promoter 
(PGK) cloned into Xho I-Cla I sites, and Nrf2 in Not I 
193
Appendix B
High Throughput Method for Assessment of Cellular Reduced Glutathione in
Mammalian Cells
Abstract
Reduced glutathione (GSH) is an intracellular molecule essential for many aspects
of cell physiology and defense.  Determination of GSH has been used to identify
potential anti-cancer drugs and for the assessment of drug toxicity via generation of
oxidative stress.  The described protocol was designed to modify existing protocols for
the fluorescent detection of intracellular GSH in a high throughput 96-well microplate
format.  Dibromobimane was used to label intracellular GSH, and an additional dye,
Hoechst 33342 was used to measure cell density for data normalization.  Cell density
curves were performed using HEK 293T cells to determine the optimal starting cell
density, (< 8.0 x 104 cells/well) for fluorescent analysis.  Fluorescent dyes were also
analyzed for compatibility and spectral overlap.  The method was further validated by
exposing HEK 293T cells to GSH modulating agents; tert-butylhydroquinone a potent
inducer of GSH, and L-buthionine-(SR)-sulfoximine a potent inhibitor of GSH.  This
study provides a fast, simple method for the high throughput screening of GSH in a
widely available 96-well format.  It also addresses the pitfalls associated with fluorescent
compounds in cell culture and proper data normalization.
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Introduction
Glutathione (GSH) is a low molecular weight molecule considered to be the first
line of cellular defense in mammalian cells (Ketterer 1988).  Composed of three amino
acids, cysteine is the moiety capable of reacting with oxygen radicals and other
electrophilic compounds.  In addition to its antioxidant activities GSH also participates in
other processes including xenobiotic metabolism, gene regulation, intracellular signal
transduction, and homeostasis of the cellular redox state (Dalton, Shertzer et al. 1999;
Sies 1999).  GSH is the most abundant intracellular non-protein thiol followed by
cysteine; a substrate in the GSH synthetic pathway.  Ultimately, changes in GSH can
indicate a global antioxidant, or redox status in cells and has led researchers to monitor its
levels; particularly in the context of induction of antioxidant systems, or assessment of
oxidative stress.
Traditional methods for measuring GSH have involved biochemical assays
dependent on the reaction of compounds with GSH such as 5,5′-dithio-bis-2-nitrobenzoic
acid (Tietze 1969), or ο-phthalaldehyde (Senft, Dalton et al. 2000) that readily form
chromophoric or fluorescent compounds respectively, measurable by ultra-violet/visible
or fluorescent spectroscopy.  This method is considered reliable and highly quantitative,
however, the preparation of tissue or cellular samples requires an investment of time and
effort before measurement of GSH can be accomplished.
High performance liquid chromatography (HPLC) is an additional method for
measuring GSH and is considered the most specific.  HPLC utilizes a variety of systems
including electrochemical detection (Remiao, Carmo et al. 2000) or a lengthier process
using fluorescent detection requiring derivatization prior to analysis (Martin and White
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1991).  Despite the quantitative aspect of HPLC, there is a large reliance on sample
preparation to account for, and in some cases depending on sample size and run times,
analysis can take 12 to 24 h to complete.  In addition, analysis by HPLC will require
increased costs for the startup, and for running and maintaining the instrument.
An alternatively accepted method for GSH measurement is to label intracellular
thiols with fluorescent bimane compounds and analyze cells via fluorescent activated cell
sorting (FACS) (Hedley and Chow 1994; Horan, Chan et al. 1997).  FACS analysis of
GSH does not demand as much time and can be simpler than biochemical methods;
however, there are limitations.  Sample preparation can require fewer steps than the
aforementioned assays yet ultimately the preparation requires the extraction and
resuspension of cells before analysis can occur.  Similar to HPLC, the availability of
FACS instrumentation can also be problematic due to the initial costs and maintenance
required for operation of the instrument.  The sensitivity of FACS is another limitation to
consider if the instrument is not equipped with the proper excitation or emission filters.
Accurate measurement at optimal wavelengths is essential for FACS especially if you are
using compounds with similar emission spectra.
Micro-plate readers are another technique for measuring fluorescent signals and
can offer high throughput sample analysis by using a 96 or 384-well format.  A large
advantage of high throughput assays is the screening of several compounds, or conditions
in the same plate can be performed, thereby decreasing the variable conditions that can
occur between separate cell culture dishes.  Fluorescent bimane dyes have also been
previously characterized for use in the microplate format however an inherent problem
with cell culture in the micro-plate format is that loss of cells can occur as a consequence
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of physical stressors such as media addition or removal.  Thus, accuracy of the signal
obtained could be skewed as a result of cell loss.  The presence of an additional dye can
be used in order to normalize each well to the cellular density actually contained therein,
and allow a more accurate assessment of your target endpoint.
This work describes a modification to previously published protocols for
measuring GSH.  It is a method designed for a high throughput assay to measure cellular
GSH levels using 96-well microplates and a bimane compound, dibromobimane that is
fluorescently activated upon conjugation with thiol groups.  The method is performed in
combination with a viable nuclear stain, Hoechst 33342.  Hoechst 33342 staining allows
GSH levels to be normalized to the cell density contained in the well, and therefore report
a more accurate value.  Along with the high throughput capacity of this assay there is the
benefit of a short time interval between addition of target and reference compounds, and
subsequent fluorescent measurement.  By reducing time intervals there is a decreased





HEK 293T cells purchased from American Type Culture Collection were grown in flat
bottomed, tissue culture treated 96-well microplates (Costar, Corning Inc., Corning, NY,
USA) at 37° C, 5% CO2 under the following media conditions; 1X Dulbecco’s
Modification of Eagle’s Medium with 4.5 g/L glucose and L-glutamine, 10% fetal bovine
serum, 1 mM sodium pyruvate, 1X non-essential amino acids, 1000 international units
penicillin – 1 mg/mL streptomycin, 50 µg/mL gentamicin sulfate; all media reagents
were purchased from CellGro technologies (Mediatec Inc., Herndon, VA, USA).  HEK
293T cells were plated at starting densities between 5.0 x 104 – 2.0 x 105 per well, (n = 6
wells per cell density) in a final volume of 200 µL media and grown for a period of 16 hr.
Nuclear & Glutathione Fluorescent Labeling
Media containing 1.5 µg/mL Hoechst 33342 (Molecular Probes, Carlsbad, CA,
USA) was gently added at a volume of 100 µL to each well yielding a final concentration
of 0.5 µg/mL Hoechst 33342/well and incubated for 30 min at 37° C.  Plates were then
drained of media by inversion and gentle shaking; any residual media at this point was
removed by blotting the plate on bench paper.  A stock solution of 4 mM dibromobimane
(CAS # 68654-25-1; Sigma-Aldrich, St. Louis, MO, USA) suspended in 100% sterile-
filtered dimethyl sulphoxide (Sigma-Aldrich, St. Louis, MO, USA) was made
immediately prior to Hoechst 33342 media removal and diluted to a final concentration
of 40 µM in sterile phosphate buffered saline, pre-warmed to 37° C.  The dibromobimane
was gently added to a final volume of 200 µL/well and incubated at 37° C for 30 min.
(Horan, Chan et al. 1997; Sebastia, Cristofol et al. 2003).
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Fluorescent Measurement
Fluorescence was measured using a SPECTRAmax Gemini XS fluorescent plate
reader (Molecular Devices, Sunnyvale, CA, USA) at the following wavelengths:
[Hoechst 33342 Exλ = 340, Emλ = 450], [dibromobimane Exλ = 393, Emλ = 477].
Fluorescent values were quantified using SOFTmax PRO version 3.1.2 software
(Molecular Devices, Sunnyvale, CA, USA).
Raw fluorescent results reported as fluorescent arbitrary units (F.A.U.) were
obtained by first subtracting the mean blank value from all wells [F.A.U.experimental –
F.A.U.blank].  Final results for GSH levels were reported as the ratio of dibromobimane
normalized to Hoechst 33342 [dibromobimane F.A.U./ Hoechst 33342 F.A.U.].  For the
validation studies cells were grown as described above and exposed to GSH modulating
compounds.  Following a 24 hr exposure of either 25µM tert-butylhydroquinone (tBHQ)
or 100 µM L-buthionine-(SR)-sulfoximine (BSO), cells were stained and measured for
GSH content as described above.
Statistical Analysis
Statistical analysis involved the use of one-way ANOVA with student Newman-
Keuls post-test for GSH modulating agents; Dunnet’s post-test was used for assessment
of signal overlap between dibromobimane and Hoechst 33342.
Results and Discussion
Cultures of HEK 293T cells were set up in 96-well microplates in a range
between 5.0 x 103 – 2.0 x 105 cells/well.  The objective was to determine the response of
Hoechst 33342 over a range of starting cell densities.  As seen in Figure 1A and Table 1,
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the Hoechst 33342 signal showed a linear response up to 8.0 x 104 cells/well.  Cultures
started at densities above that value had both an increase in their standard error of the
mean (SEM, Figure 1A), and a decrease in the r2 value of the linear response (Table 1).
Increasing the starting density from 8.0 x 104 to 1.0 x 105 cells/well results in an
attenuation of r2 value from 0.9948 down to 0.7880, a trend that continued to yield a
lower r2 with increased starting cell density.
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Table 1.  Linear Regression Summaries of Cell Density and Hoechst 33342 Response in
HEK 293T cells
201
           This experiment sets up some important parameters for both cell type and assay
conditions; (a) optimizing the starting cell density for the experiment (b) determining the
response of the experimental and reference stains and, (c) determining if any signal
overlap exists between the experimental and reference stains.
As shown in Figure 1A and Table 1 the Hoechst 33342 dye is only effective up to
a starting cell density of 8.0 x 104 cells/well for HEK 293T cells as indicated by the loss
of linearity with higher starting cell densities.  Cultures were then analyzed using the
excitation wavelength for dibromobimane (393nm) and the emission wavelength for
Hoechst 33342 (450nm).  Hoechst 33342 showed no signal when exposed to the
dibromobimane excitation wavelength (393nm) thereby ensuring no signal overlap was
occurring between the two stains at that particular excitation wavelength (Figure 1A).  A
similar scan was performed on the dibromobimane by using the excitation wavelength for
Hoechst 33342 (340nm) and scanning at the emission wavelength for dibromobimane
(477nm) to determine if the dibromobimane is creating a signal overlap while measuring
the Hoechst 33342 dye (Figure 1B).  As seen in figure 1B there is some response of
dibromobimane at the Hoechst 33342 excitation wavelength (340nm).  When analyzed in
comparison to the mean value for the blank wells, the dibromobimane signal excited at
the Hoechst 33342 wavelength (340nm) does not differ statistically until the cell density
is higher than 8.0 x 104 cells/well as determined by one-way ANOVA using a Dunnet’s
post-hoc test.  This finding further supports the idea that the maximum starting cell
density should be no greater than 8.0 x 104 cells/well for this particular cell type based on
(i) the loss of linearity of the Hoechst 33342 signal (Figure 1A, Ex. λ = 340 nm plot) and
(ii) the increase in signal overlap between dyes at the higher cell densities (Figure 1B, Ex.
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Measurement of fluorescent signal for Hoechst 33342 and dibromobimane in HEK 293T
cells as a function of increased starting cell density.  (A) Hoechst 33342 signal at [λex340
nm, λem450 nm; open circles O], and at [λex 393 nm, λem450 nm; closed circles ] in
HEK 293T cells  (B) Dibromobimane signal at [λex 393 nm, λem 477 nm; open circles O],
and at [λex340 nm, λem 477 nm; closed circles ] in HEK 293T cells. Values are reported
as fluorescent arbitrary units (F.A.U.) and are reported as mean ± SEM.
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Contrary to the Hoechst 33342 in Figure 1A, dibromobimane is linear up to the
maximum starting cell density of 2.0 x 105 cells/well (Figure 1B).  This reinforces the
importance of normalizing your data as demonstrated by the linear response of the
dibromobimane.  By measuring dibromobimane alone, it is possible that the results could
yield inaccurate values if the cell density in the well does not remain constant throughout
the experiment.  Previous publications demonstrate the use of GSH probes in a 96-well
format, however it is unclear what type of normalization if any was performed (Sebastia,
Cristofol et al. 2003).  During these types of assays the opportunity exists for loss of cell
density due to cell death, or physical agitation during media addition or removal.  Figure
1C shows the dibromobimane signal normalized by the Hoechst 33342 signal over
increased starting cell densities (values calculated as F.A.U. dibromobimane/ F.A.U.
Hoechst 33342).  The range of starting cell densities between 6.0 x 104 cells/well and 1.5
x 105 cells/well yields a balanced measurement of GSH levels.  However, taking into
account the Hoechst 33342 plot in Figure 1A, and the change in the r2 values indicated in






Measurement of fluorescent signal for Hoechst 33342 and dibromobimane in HEK 293T
cells as a function of increased starting cell density.  (C) Changes in dibromobimane
fluorescence normalized to the Hoechst 33342 as a function of increasing cell density in
HEK 293T cells; dibromobimane F.A.U. were normalized by the Hoechst 33342 F.A.U.
of the same well.  Values were calculated by the following formula; [dibromobimane
F.A.U./ Hoechst 33342 F.A.U.] and reported as mean ± SEM.
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To further scrutinize this assay, cell cultures were set up at a starting density of
7.0 x 104 cells/well.  Sixteen hr later, cells were exposed to compounds shown to
modulate cellular GSH levels; 25 µM tBHQ an inducer of GSH synthesis (Hansen,
Watson et al. 2004), and 100 µM BSO an inhibitor of GSH synthesis (Griffith 1982).
Figure 2 demonstrates the importance of normalizing the dibromobimane fluorescent
signal rather than assuming equal cell density.
Figure 2A shows the changes in dibromobimane signal in control, and cells
exposed to BSO for 24 hr.  The data is displayed prior to Hoechst 33342 normalization
and carries the assumption of equal starting cell density (Figure 2A).  Although the
results of this experiment display the expected outcome, (reduced GSH), the degree of
reduction is less than levels reported using biochemical or HPLC methods (Griffith 1982;
Horan, Chan et al. 1997).  Normalization of the dibromobimane signal with the Hoechst
33342 signal yields values more in accord with the published effects of BSO (Figure 2C).
Treatment of cells with tBHQ has been reported to lead to an increase in levels of GSH
however, Figure 2B shows a reduction in GSH levels in the cells exposed to 25 µM
tBHQ for 24 hr.  Once normalized to the Hoechst 33342 dye, the data shows an increase
in GSH levels (Figure 2C); changes that are comparable with previous publications using










Changes in GSH status of HEK 293T cells exposed to GSH modulating agents. A) HEK
293T cells exposed to 100 µM BSO or B) 25 µM tBHQ for 24 hr.  All values are reported






Figure 2.  Changes in GSH status of HEK 293T cells exposed to GSH modulating agents.
(C) Normalized values of dibromobimane from Figure 2A and 2B, indicative of the GSH
levels in the cells.  All values are reported as mean ± SEM.  * Indicates a significant
fluorescent difference from control at p < 0.05.
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Conclusions
This method demonstrates a high throughput assay for determining changes in
cellular GSH in a semi-quantitative manner.  It combines the use of well-characterized
fluorescent dyes, ultimately allowing the measurement of target endpoint (GSH) and cell
density in the same well of a standard microplate.  This technique can be useful in
screening compounds capable of modulating GSH; a strategy often used in the
identification of potential chemotherapeutic compounds.  It can also be used in the
assessment of cytotoxicity for multiple compounds in one plate, as decreased GSH is
often associated with conditions of oxidative stress and can therefore serve as a reliable
marker of compromised cell status.
The assay can be utilized with immortalized cell lines and more importantly,
primary cell cultures (Tauskela, Hewitt et al. 2000) where oftentimes there is a limitation
on the starting tissue and or cell number. The high throughput format allows for the
screening of multiple fluorescent compounds, however proper dye selection is an
important parameter to consider due to signal overlap being a potential confounder for
this type of assay.  This assay also addresses the pitfalls that can occur in 96-well
microplate assays if the normalization to cell density is not performed.
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